
<html lang="en"     class="pb-page"  data-request-id="6951d2a7-fcd0-4292-854d-7d8dad8fe9c9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-3;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm401782h;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators" /></meta><meta name="dc.Creator" content="Martin  Pettersson" /></meta><meta name="dc.Creator" content="Douglas S.  Johnson" /></meta><meta name="dc.Creator" content="Chakrapani  Subramanyam" /></meta><meta name="dc.Creator" content="Kelly R.  Bales" /></meta><meta name="dc.Creator" content="Christopher W.  am Ende" /></meta><meta name="dc.Creator" content="Benjamin A.  Fish" /></meta><meta name="dc.Creator" content="Michael E.  Green" /></meta><meta name="dc.Creator" content="Gregory W.  Kauffman" /></meta><meta name="dc.Creator" content="Patrick B.  Mullins" /></meta><meta name="dc.Creator" content="Thayalan  Navaratnam" /></meta><meta name="dc.Creator" content="Subas M.  Sakya" /></meta><meta name="dc.Creator" content="Cory M.  Stiff" /></meta><meta name="dc.Creator" content="Tuan P.  Tran" /></meta><meta name="dc.Creator" content="Longfei  Xie" /></meta><meta name="dc.Creator" content="Liming  Zhang" /></meta><meta name="dc.Creator" content="Leslie R.  Pustilnik" /></meta><meta name="dc.Creator" content="Beth C.  Vetelino" /></meta><meta name="dc.Creator" content="Kathleen M.  Wood" /></meta><meta name="dc.Creator" content="Nikolay  Pozdnyakov" /></meta><meta name="dc.Creator" content="Patrick R.  Verhoest" /></meta><meta name="dc.Creator" content="Christopher J.  O’Donnell" /></meta><meta name="dc.Description" content="Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system. To align improved potency with favorable A..." /></meta><meta name="Description" content="Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system. To align improved potency with favorable A..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 28, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401782h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401782h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401782h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401782h" /></link>
        
    
    

<title>Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401782h" /></meta><meta property="og:title" content="Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0015.jpeg" /></meta><meta property="og:description" content="Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system. To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochemical property-driven design coupled with parallel medicinal chemistry techniques to arrive at a novel series containing a conformationally restricted core. Lead compound 51 exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile. Furthermore, robust reduction of brain Aβ42 was observed in guinea pig at 30 mg/kg dosed orally. Through chemical biology efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401782h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401782h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401782h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401782h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401782h&amp;href=/doi/10.1021/jm401782h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1046-1062</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401768t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401752p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Pettersson">Martin Pettersson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+S.++Johnson">Douglas S. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chakrapani++Subramanyam">Chakrapani Subramanyam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+R.++Bales">Kelly R. Bales</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+W.++am+Ende">Christopher W. am Ende</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+A.++Fish">Benjamin A. Fish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+E.++Green">Michael E. Green</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+W.++Kauffman">Gregory W. Kauffman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+B.++Mullins">Patrick B. Mullins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thayalan++Navaratnam">Thayalan Navaratnam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Subas+M.++Sakya">Subas M. Sakya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cory+M.++Stiff">Cory M. Stiff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tuan+P.++Tran">Tuan P. Tran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longfei++Xie">Longfei Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liming++Zhang">Liming Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie+R.++Pustilnik">Leslie R. Pustilnik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beth+C.++Vetelino">Beth C. Vetelino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen+M.++Wood">Kathleen M. Wood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolay++Pozdnyakov">Nikolay Pozdnyakov</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+R.++Verhoest">Patrick R. Verhoest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++O%E2%80%99Donnell">Christopher J. O’Donnell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (617) 395-0705. E-mail: <a href="/cdn-cgi/l/email-protection#2c614d5e584542027c495858495e5f5f43426c5c4a4556495e024f4341"><span class="__cf_email__" data-cfemail="1d507c6f697473334d786969786f6e6e72735d6d7b7467786f337e7270">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401782h&amp;href=/doi/10.1021%2Fjm401782h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1046–1062</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 15, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 November 2013</li><li><span class="item_label"><b>Published</b> online</span>28 January 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401782h" title="DOI URL">https://doi.org/10.1021/jm401782h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1046%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BPettersson%252C%2BDouglas%2BS.%2BJohnson%252C%2BChakrapani%2BSubramanyam%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D3%26contentID%3Djm401782h%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BPyridopyrazine-1%252C6-dione%2B%25CE%25B3-Secretase%2BModulators%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1062%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401782h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2033</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401782h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Pettersson&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;S. Johnson&quot;},{&quot;first_name&quot;:&quot;Chakrapani&quot;,&quot;last_name&quot;:&quot;Subramanyam&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;R. Bales&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;W. am Ende&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;A. Fish&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;E. Green&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;W. Kauffman&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;B. Mullins&quot;},{&quot;first_name&quot;:&quot;Thayalan&quot;,&quot;last_name&quot;:&quot;Navaratnam&quot;},{&quot;first_name&quot;:&quot;Subas&quot;,&quot;last_name&quot;:&quot;M. Sakya&quot;},{&quot;first_name&quot;:&quot;Cory&quot;,&quot;last_name&quot;:&quot;M. Stiff&quot;},{&quot;first_name&quot;:&quot;Tuan&quot;,&quot;last_name&quot;:&quot;P. Tran&quot;},{&quot;first_name&quot;:&quot;Longfei&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Liming&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;R. Pustilnik&quot;},{&quot;first_name&quot;:&quot;Beth&quot;,&quot;last_name&quot;:&quot;C. Vetelino&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;M. Wood&quot;},{&quot;first_name&quot;:&quot;Nikolay&quot;,&quot;last_name&quot;:&quot;Pozdnyakov&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;R. Verhoest&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. O’Donnell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1046-1062&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401782h&quot;},&quot;abstract&quot;:&quot;Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system. To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochemical property-driven design coupled with parallel medicinal chemistry techniques to arrive at a novel series containing a conformationally restricted core. Lead compound 51 exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile. Furthermore, robust reduction of brain Aβ42 was observed in guinea pig at 30 mg/kg dosed orally. Through chemical biology efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401782h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401782h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401782h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401782h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401782h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401782h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401782h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401782h&amp;href=/doi/10.1021/jm401782h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401782h" /></input><a href="/doi/pdf/10.1021/jm401782h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401782h%26sid%3Dliteratum%253Aachs%26pmid%3D24428186%26genre%3Darticle%26aulast%3DPettersson%26date%3D2014%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BPyridopyrazine-1%252C6-dione%2B%25CE%25B3-Secretase%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D3%26spage%3D1046%26epage%3D1062%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jmcmar.2014.57.issue-3/production/jmcmar.2014.57.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system. To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochemical property-driven design coupled with parallel medicinal chemistry techniques to arrive at a novel series containing a conformationally restricted core. Lead compound <b>51</b> exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile. Furthermore, robust reduction of brain Aβ42 was observed in guinea pig at 30 mg/kg dosed orally. Through chemical biology efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), first described in 1906 by German neuropathologist and psychiatrist Alois Alzheimer, is a progressive, neurodegenerative disorder that leads to cognitive impairment, loss of motor function, and ultimately death. Current therapies such as acetylcholinesterase inhibitors and NMDA receptor antagonists temporarily reduce the symptoms of AD but do not affect progression of the underlying disease. Currently, 1 in 8 people in America over the age of 65, or 5.2 million people, are affected by AD, and this number is expected to more than double by 2040 as the population ages.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD represents a significant burden to the afflicted patients, caregivers, and the healthcare system, and effective treatments to reduce or halt the progression of this devastating disease present a major unmet medical need.</div><div class="NLM_p">Genetic and histopathological evidence points to the aberrant production and accumulation of amyloid β (Aβ) peptides as a causative process in AD.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Oligomers of Aβ42 have been shown to be neurotoxic in vitro, and these hydrophobic species have a high propensity for aggregation to generate insoluble amyloid plaques, a hallmark of AD pathology.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Formation of Aβ42 is initiated by cleavage of the amyloid precursor protein (APP) by the β-aspartyl secretase cleaving enzyme (BACE). The resultant membrane-bound C-terminal fragment undergoes a subsequent cleavage by γ-secretase to afford amyloid peptides ranging from 37 to 43 amino acids in length. Thus, suppression of the de novo synthesis of neurotoxic Aβ42 peptides via inhibition of BACE and/or modulation of γ-secretase represents a promising therapeutic avenue for the treatment of AD.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Consequently, this approach is being aggressively pursued throughout the pharmaceutical industry as well as in academic laboratories.</div><div class="NLM_p">Development of γ-secretase inhibitors (GSIs) has provided agents that successfully reduced Aβ in cerebrospinal fluid (CSF) in humans;<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> however, a phase III study with GSI LY450139 (semagacestat) was recently halted due to adverse events including decline in cognition and increased incidence of skin cancer.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Likewise, development of BMS-708,163 (avagacestat) was terminated after completion of phase II trials in which gastrointestinal and skin-related adverse events were observed.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Part of the explanation for these failures may be that, in addition to APP, γ-secretase cleaves multiple other substrates; inhibition of such processing may result in detrimental side effects. For example, S3 cleavage of the Notch 1 receptor by γ-secretase within the membrane domain releases the notch intracellular domain (NICD). This translocates to the nucleus, where it activates transcription of target genes that play an important role in cell differentiation including neuronal development.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Inhibition of Notch processing by GSIs is thought to be responsible, at least in part, for the gastrointestinal adverse events and increased risk of skin cancer that have been observed in the clinic. Furthermore, the accumulation of APP β-C-terminal fragment (β-CTF) that results from γ-secretase inhibition has been implicated in neurotoxicity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">In contrast to GSIs, γ-secretase modulators (GSMs) selectively alter the cleavage site of APP to reduce the formation of the neurotoxic peptides Aβ42 and in many cases Aβ40 as well, while increasing formation of Aβ37 and/or Aβ38, which are less prone to aggregation. Importantly, processing of other substrates including Notch 1 is not inhibited by GSMs.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, GSMs do not cause an accumulation of γ-secretase substrates such as the APP β-CTF. Focus has therefore shifted away from GSIs in favor of the development of GSMs, which may offer an improved safety profile.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Early efforts focused on lipophilic acid derivatives such as (<i>R</i>)-flurbiprofen (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which originated from nonsteroidal anti-inflammatory agents (NSAIDS).<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> Although <b>1</b> entered clinical development, it was unsuccessful in slowing cognitive decline in a phase III trial.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This may be attributed to its low in vitro potency (ca. 200 μM) in combination with inadequate exposure at the target site due to poor brain penetration. Further efforts resulted in significant improvements in Aβ-lowering activity to afford acids such as <b>2</b> (GSM-1, Aβ42 IC<sub>50</sub> value of 120–348 nM).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, examination of the patent literature suggests that a majority of the researchers in the field have shifted their efforts away from the NSAID-derived acids in favor of nonacid or heteroaryl-type series of GSMs, as exemplified by <b>3</b> (E2012).<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a, 11b)</a> This chemotype was initially discovered at Neurogenetics and was further developed by scientists at Eisai, who advanced <b>3</b> into phase I clinical trials.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Further development of this compound was halted in favor of a second generation analogue with an improved potency and safety profile.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative acid GSMs <b>1</b>, <b>2</b>, and heteroaryl GSM <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">γ-Secretase is an intramembrane-cleaving aspartyl protease that is composed of four subunits: presenilin, Pen-2, Aph-1, and nicastrin.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although the exact mechanism of APP processing by γ-secretase is unknown, we and others have developed photoaffinity probes from both the acid and arylimidazole series of GSMs and demonstrated that these compounds bind to the N-terminal fragment of presenilin (PS1-NTF) at distinct binding sites.<a onclick="showRef(event, 'cit13b cit13c ref16'); return false;" href="javascript:void(0);" class="ref cit13b cit13c ref16">(13b, 13c, 16)</a> Importantly, GSIs did not compete with photolabeling of presenilin using either acid or imidazole probes, indicating that these GSMs do not share the binding site(s) of GSIs. As an aspartyl protease located within the membrane, γ-secretase presents a formidable challenge for the development of potent modulators with aligned absorption, distribution, metabolism, and excretion (ADME) attributes along with favorable physicochemical properties. This is evident when examining the patent literature, where on average, GSMs have significantly higher lipophilicities and molecular weights as compared to marketed CNS drugs.<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a, 11b)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have previously described our efforts in the heteroaryl series using <b>3</b> as a starting point (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>):<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Aβ42 IC<sub>50</sub> = 143 nM, clogP = 4.8,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> lipophilic efficiency (LipE) = 2.3,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and a central nervous system multiple parameter optimization score (CNS MPO) = 3.7/6.0.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Our primary design objectives were to remove the cinnamide olefin and to improve overall physicochemical properties. In particular we sought to reduce lipophilicity, as a high clogP value has been linked to increased promiscuity and a higher risk of adverse findings in exploratory toxicology studies.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Furthermore, targeting less lipophilic, more polar chemical space may increase the probability of achieving good alignment of potency with critical ADME parameters such as clearance, permeability, and brain penetration.<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21, 23)</a> These efforts resulted in the discovery of the dihydrobenzofuran amide series exemplified by <b>4</b> (Aβ42 IC<sub>50</sub> = 521 nM, clogP = 3.96, LipE = 3.55, CNS MPO = 4.8) and <b>5</b> (Aβ42 IC<sub>50</sub> = 188 nM, clogP = 3.96, LipE = 4.12, CNS MPO = 4.8).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Both compounds demonstrated robust reduction of brain Aβ42 at 100 mg/kg in guinea pig, and while <b>5</b> is less potent than <b>3</b>, it achieved an improvement in LipE of approximately two log units. However, our efforts to further improve potency through additional optimization of the right-hand dihydrobenzofuran amide moiety, while maintaining favorable alignment of ADME and physicochemical properties, were unsuccessful. Furthermore, the in vitro safety profile of this series emerged as a significant concern: although <b>4</b> and <b>5</b> did not pose a DDI risk, with IC<sub>50</sub> values for inhibition of CYP 2D6 and 3A4 greater than 30 μM, CYP inhibition increasingly became a problem with more potent GSMs in this series. This finding is consistent with observations in related heteroaryl series reported in the literature.<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of the Amide Series from Heteroaryl GSM <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the challenges of aligning potency, clearance, brain penetration, and in vitro safety (DDI) in the amide series, we opted to focus our efforts on modifying the arylimidazole A-B moiety through design of a novel, conformationally restricted core with increased polarity. By introducing conformational constraint, we anticipated the opportunity to (a) lock the molecule into the putative active conformation and therefore increase potency, and (b) reduce rotatable bonds and the number of hydrogen bond donors, which should improve permeability and brain penetration. As shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, constraining the amide moiety of <b>6</b> by tying back the nitrogen onto the aryl ring forms a bicyclic core. Given the presence of the methoxy group, which is important for potency, this structural modification gives rise to two possible regioisomers, exemplified by <b>7</b> and <b>8</b>. Preparation of both of these novel cores would therefore provide valuable insights into the GSM pharmacophore, as it would lock the methoxy group and lactam carbonyl on either the same or opposite sides of the bicyclic ring system. The arylimidazole region of the non-NSAID derived GSMs is highly conserved, and only limited exploration of the aryl core had been exemplified in the GSM patent literature at the time.<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a, 11b)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design of Constrained Amide GSMs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of <b>15</b>, an example of regioisomer <b>7</b>, involved the rearrangement of an isoquinoline <i>N</i>-oxide as a key step (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Imine <b>10</b>, obtained from the condensation of aldehyde <b>9</b> with 2,2-dimethoxyethanamine, could not be directly cyclized to isoquinoline <b>12</b>. This transformation, known as the Pomeranz–Fritsch reaction,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> typically works best with aromatic systems bearing multiple electron-donating substituents. One of the observed side reactions in this case involved hydrolysis of <b>10</b> back to aldehyde <b>9</b> under the acidic reaction conditions. This problem was circumvented by first masking imine <b>10</b> as the carbamate phosphonate <b>11</b> prior to cyclization.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Thus, refluxing <b>11</b> in dichloromethane in the presence of TiCl<sub>4</sub> afforded isoquinoline <b>12</b> in good yield as a single regioisomer. Next, oxidation with <i>m-</i>CPBA furnished isoquinoline <i>N</i>-oxide <b>13</b>, which underwent a rearrangement to form isoquinolone <b>14</b> upon refluxing in acetic anhydride; this was followed by hydrolytic removal of the acetate group with sodium hydroxide. Following N-alkylation to introduce the side chain, the 4-methylimidazole moiety was installed via a nucleophilic aromatic substitution. This reaction was complicated by the presence of the methoxy substituent ortho to the aryl fluoride. Nevertheless, heating a mixture of fluoroquinolone, 4-methylimidazole, and potassium carbonate in DMSO to 135 °C afforded the target compound <b>15</b>, along with the corresponding regioisomeric imidazole adduct (not shown) in a 2.5:1 ratio, in 53% yield; this mixture was readily separable by preparative HPLC.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2-dimethoxyethanamine, toluene, reflux; (b) EtOCOCl, THF, −10 °C to rt; then P(OMe)<sub>3</sub>; (c) TiCl<sub>4</sub>, dichloromethane, reflux, 57% over three steps; (d) <i>m-</i>CPBA, dichloromethane, rt, 46%; (e) Ac<sub>2</sub>O, reflux; (f) sodium hydroxide, 100 °C, 84% over two steps; (g) NaH, 1-(2-bromoethyl)-3-chlorobenzene, DMA, rt, 62%; (h) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 135 °C, 7%.</p></p></figure><div class="NLM_p">Synthesis of the 5,6-disubstituted isoquinolones <b>25a</b> and <b>25b</b>, examples of regioisomer <b>8</b>, commenced via condensation of aldehyde <b>16</b> with malonic acid, followed by decarboxylation to furnish <b>18</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The carboxylic acid was then converted to the acyl azide <b>20</b> in preparation for the key tandem Curtius rearrangement/Friedel–Crafts acylation. In contrast to the transformation using diphenylphosphoryl azide (DPPA), the acyl azide was prepared in excellent overall yield by using thionyl choride followed by addition of sodium azide. With acyl azide <b>20</b> in hand, the Curtius rearrangement/intramolecular Friedel–Crafts cascade afforded the 5,6-disubstituted isoquinolone intermediate <b>22</b> in 51% yield over three steps. The synthesis was then completed by alkylation with 1-(2-bromoethyl)-3-chlorobenzene followed by CuI-mediated coupling with 4-methylimidazole. Interestingly, the latter transformation resulted in complete demethylation of the methoxy group when the reaction mixture was heated at 130 °C: hydroxy-substituted quinolone <b>25a</b> was isolated in 74% yield as a 4:3 mixture of imidazole regioisomers, which were readily separated by preparative-HPLC. The demethylation could be suppressed by reducing the temperature to 100 °C, affording <b>25b</b> in 20% yield after separation of regioisomers by preparative-HPLC. The synthesis of 3-trifluoromethylbenzyl analogue <b>27</b> was completed in an analogous manner. Finally, the double bond of the isoquinolone in <b>27</b> was reduced via H-Cube flow hydrogenation to afford the saturated analogue <b>28</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>25b</b>, <b>27</b>, and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) malonic acid, piperidine, pyridine, 120 °C, 50% (<b>18</b>), 19% (<b>19</b>); (b) SOCl<sub>2</sub>, rt, then 90 °C; (c) NaN<sub>3</sub>, H<sub>2</sub>O, acetone, 0 °C; (d) 1,2-dichlorobenzene, 140 °C, 1 h; then catalytic I<sub>2</sub>, 185 °C, 1.5 h, 51% (<b>22</b>, three steps), 16% (<b>23</b>, three steps); (e) NaH, 1-(2-bromoethyl)-3-chlorobenzene, DMA, rt 45%; (f) NaH, 3-CF<sub>3</sub>-benzyl bromide, DMA, rt, 97%; (g) 4-methylimidazole, CuI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 20%; (h) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 27%. (i) H<sub>2</sub>, Pd/C, H-Cube, 97%.</p></p></figure><div class="NLM_p">Next, we determined Aβ42-lowering activity in a whole-cell assay using Chinese hamster ovary (CHO) cells that overexpress wild type human APP (hereafter expressed as Aβ42 IC<sub>50</sub>). Key compounds were spot-checked for inhibition of Notch signaling in HEK 293 NdeltaE cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> A majority of the analogues were also tested in several in vitro ADME assays, including stability in human liver microsomes.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The potential for P-glycoprotein (P-gp)-mediated efflux was examined by measuring the efflux ratio (MDR Er) in a Madin–Darby canine kidney (MDCK) cell line that had been transfected with the human MDR1 gene encoding P-gp.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Interestingly, constraining the amide according to path A (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to form <b>15</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) resulted in complete loss of activity, whereas cyclization according to path B to afford the isomeric lactam <b>25b</b> preserved Aβ42-lowering activity (Aβ42 IC<sub>50</sub> = 3.4 μM). This finding provided valuable insight into the GSM pharmacophore, as it suggested that the two polar functional groups need to be situated on opposing sides of the scaffold to enable the key interactions with the binding site.</div><div class="NLM_p">Next, we introduced a <i>m</i>-CF<sub>3</sub>-benzyl substituent on the amide nitrogen, as we had observed in our amide series that <i>N</i>-benzyl groups generally have comparable potency to <i>N</i>-phenethyl groups but offer improved metabolic stability.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> During the S<sub>N</sub>Ar reaction to introduce the 4-methylimidazole moiety, the corresponding desmethyl (phenol) derivative <b>27</b> was isolated as the major product. Phenol <b>27</b> was found to be 3-fold more potent (Aβ42 IC<sub>50</sub> = 920 nM) than <b>25b</b>. We previously observed in the amide series (e.g., <b>4</b> and <b>5</b>) that introduction of hydrogen bond donors, such as hydroxyl groups, generally results in increased P-gp liability as measured by an increased MDR efflux ratio.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, polar functional groups tend to have reduced MDR Er liability when introduced onto the aryl core (B-ring) as opposed to the lipophilic right-hand section of the molecule (C- and D-rings).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Given these prior observations, we were intrigued to note that phenol <b>27</b> maintained a low MDR efflux ratio (MDR Er = 1.1). This provided the potential to incorporate polarity into the molecule and to bring the series into better physicochemical property space without impairing penetration into the brain.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Pharmacology and Disposition Data for Constrained Amide GSMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Aβ42 IC<sub>50</sub> values were obtained in a whole cell assay using CHO APP<sub>wt</sub> cells. Aβ42 IC<sub>50</sub> values shown here are the geometric mean of at least three experiments.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">MDR efflux ratio in a MDR1/MDCK assay utilizing MDCK cells transfected with the gene that encodes human P-glycoprotein.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Human liver microsome-derived intrinsic clearance.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></div><div></div></div><div class="NLM_p">We next sought to reduce the planarity of the bicyclic core by introducing sp<sup>3</sup> centers into the system. Toward this end, <b>27</b> was subjected to hydrogenation, affording the saturated lactam <b>28</b>. This compound represented an important advancement for the program, as it successfully aligned moderate in vitro potency with an improved ADME profile: the Aβ42 IC<sub>50</sub> of <b>28</b> compared favorably to that of the monocyclic parent amide <b>29</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (0.40 μM vs 0.66 μM, respectively), while also maintaining a low MDR efflux ratio (MDR Er = 1.9) and good passive permeability (RRCK <i>P</i><sub>app,A→B</sub> = 10.4 × 10<sup>–6</sup> cm/s).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Furthermore, <b>28</b> achieved excellent stability in human liver microsomes (HLM CL<sub>int,app</sub> < 8.0 mL/min/kg). The presence of a phenol, however, was cause for some concern, as phenols are known to undergo secondary metabolism through glucuronidation.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Consequently, <b>28</b> was evaluated for metabolic stability in human hepatocytes and was found to have only moderate stability (HHEP CL<sub>int,app</sub> = 90.5 mL/min/kg; <i>T</i><sub>1/2</sub> = 19.3 min). This indirectly suggested that the phenol may indeed be a metabolic liability. Therefore, the next phase of the design process focused on identifying alternative heterocyclic templates that would maintain or increase the polarity while avoiding the liability associated with the phenol.</div><div class="NLM_p">Evaluation of the heterocyclic cores that had been prepared thus far suggested that the bicyclic lactam of <b>28</b> (as its generalized template <b>31</b>) could be combined with the pyridyl amide core of <b>5</b> (as its generalized template <b>30</b>) (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Introduction of a two-carbon linker to connect the amide nitrogen of <b>30</b> to the pyridyl nitrogen would require conversion of the methoxypyridine into a pyridone, as shown in <b>32</b>. The resultant pyridopyrazine-1,6-dione structural motif maintains a polar functional group in the 5-position, allowing for increased potency and improved properties, but the carbonyl of the pyridone should not carry the metabolic liabilities associated with a phenol. We therefore decided to invest in the development of an efficient synthetic route to this novel GSM core.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Design Strategy Leading to a Novel Pyridopyrazine-1,6-dione Series</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are only a limited number of published synthetic approaches to bicyclic heterocycles related to pyridone <b>32</b>, none of which were directly applicable to incorporation of the requisite substitution pattern.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> We therefore developed a facile synthesis that features a novel one-pot, HATU<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>-mediated amide coupling/cyclization reaction. Details of the development, scope, and limitations of this transformation have recently been described.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The known pyridyl ester <b>33</b><a onclick="showRef(event, 'ref17 ref34'); return false;" href="javascript:void(0);" class="ref ref17 ref34">(17, 34)</a> was heated in the presence of HBr and AcOH to afford the desired acid <b>34</b> as the HBr salt (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Alternatively, ester <b>33</b> could be converted to the HCl salt <b>35</b> in quantitative yield by heating in HCl/1,4-dioxane. Continuing from pyridone acids <b>34</b> or <b>35</b>, we had originally envisioned a stepwise approach whereby an amide coupling reaction would be carried out with amino alcohol <b>38</b> followed by conversion of the hydroxyl group to a suitable leaving group and finally intramolecular alkylation. To our surprise, subjecting a mixture of <b>34</b> or <b>35</b> and amino alcohol <b>38</b> (derived from 1-phenylethylamine) to 1 equiv of HATU in the presence of <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) did not produce the targeted alcohol intermediate <b>39</b> as the major product (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>); instead, cyclized product <b>32</b> was isolated, as a mixture with <b>39</b> and unreacted acid <b>34</b> (3:2:5 ratio, respectively).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The cyclization step was found to be promoted by the HATU coupling reagent, and the one-pot conversion to <b>32</b> could be enhanced by running the reaction in the presence of 2.5 equiv of HATU. Further optimization resulted in a useful protocol that allowed access to a diverse set of pyridopyrazine-1,6-dione derivatives.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The utility of this transformation was further expanded by successfully incorporating parallel medicinal chemistry techniques and utilizing in situ monomer synthesis. We initially prepared the requisite amino alcohols <b>38</b> via reductive amination of ethanolamine with substituted benzaldehydes; however, the range of monomers that could be prepared using this approach was rather limited. Therefore, an improved sequence was developed that took advantage of the large diversity of our amine reagent collection. As shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, reductive amination of various amines <b>37</b> with 2-(<i>tert</i>-butyldimethylsilyloxy)acetaldehyde (<b>36</b>) gave TBS-protected ethanolamine derivatives in good yield. These intermediates were then deprotected by exposure to methanolic HCl. The resulting HCl salts were obtained cleanly and could be used without further purification in the ensuing coupling reaction. An alternative to this approach involved monoalkylation of amines <b>37</b> with 2-bromoethanol. All three in situ monomer syntheses have been successfully applied to the preparation of pyridopyrazine-1,6-diones in parallel medicinal chemistry format.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis Employed for Preparation of <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBr, HOAc, 150 °C, 79%; (b) HCl, 1,4-dioxane, 150 °C, quant; (c) NaBH(OAc)<sub>3</sub>, DIPEA, THF; (d) HCl, MeOH, (e) HATU, DIPEA, dichloromethane, rt, 30–80%.</p></p></figure><div class="NLM_p">We soon identified the phenoxyethyl moiety as an amide substituent warranting further investigation (vide infra) and elected to deconstruct this <i>enabled monomer</i> to facilitate SAR exploration of the aryl substitution pattern. Toward this end, we found that pyridone acid <b>35</b> underwent a one-pot coupling/cyclization reaction with bis(2-chloroethyl)amine (<b>40</b>) to deliver chloroethyl derivative <b>41</b> in 42% yield (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). With ready access to this valuable intermediate, we then carried out alkylations with a diverse set of phenols in parallel format. In particular, by running the alkylation reactions in DMSO as solvent, only a filtration was necessary upon completion of the reaction, whereupon the mixture could be directly purified via prep-HPLC; this protocol was ideal for rapid exploration of SAR on small scale. For the purpose of scale-up of key compounds, the preferred method involved the original coupling/cyclization reaction (vide supra) using amino alcohols prepared by alkylation of phenols with dibromoethane, followed by reaction with ethanolamine to provide the requisite compounds <b>38</b> (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>).</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis Employed for Initial Preparation of <b>46</b>–<b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 56%; (b) K<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C, 30–60%.</p></p></figure><div class="NLM_p">With a facile approach to the novel pyridopyrazine dione GSM template in hand, we set out to explore SAR in this series. Compound <b>44</b>, bearing a 3-CF<sub>3</sub>-benzyl N-substituent, was prepared first, as a direct comparison to phenol <b>28</b>. Although <b>44</b> was less potent than <b>28</b> (Aβ42 IC<sub>50</sub> = 1.6 μM vs 400 nM), it resided in superior physicochemical space as indicated by a CNS MPO of 5.7/6.0, versus 4.6/6.0 for phenol <b>28</b>, and improvement in LipE from 2.3 to 3.5. Furthermore, <b>44</b> maintained excellent stability in human liver microsomes. Most importantly, the increase in polarity of <b>44</b> did not lead to an increase in P-gp efflux liability (MDR Er = 1.5). The favorable ADME and physicochemical property profile of <b>44</b>, coupled with the fact that we had developed a facile, parallel-enabled synthesis, prompted further investigation of this series to determine the extent to which potency could be optimized. Consequently, GSM <b>45</b>, which incorporated an extended linker, was rapidly identified. This compound demonstrated that reasonable potency (Aβ42 IC<sub>50</sub> = 410 nM) could indeed be attained within this series while maintaining excellent physicochemical properties (clogP = 2.52; CNS MPO = 5.6/6.0) and microsomal stability in HLMs (HLM CL<sub>int,app</sub> = 8.1 mL/min/kg). Furthermore, in contrast to phenol <b>28</b>, GSM <b>45</b> was also found to have very good stability in human hepatocytes (HHEP CL<sub>int,app</sub> < 2.8 mL/min/kg), thus achieving one of the key design objectives that had prompted the development of this novel, conformationally constrained core.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Pharmacology and Disposition Data for Pyridopyrazine-1,6-dione GSMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Aβ42 IC<sub>50</sub> values were obtained in a whole cell assay using CHO APP<sub>wt</sub> cells. Aβ42 IC<sub>50</sub> values are the geometric mean of at least three experiments.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">MDR efflux ratio using a MDR1/MDCK assay utilizing MDCK cells transfected with the gene that encodes human P-glycoprotein.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Human liver microsome-derived intrinsic clearance.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Rat liver microsome-derived intrinsic clearance.</p></div></div><div></div></div><div class="NLM_p">A disadvantage to the extended linker of <b>45</b> was that it exhibited high turnover in rat liver microsomes (RLM CL<sub>int,app</sub> = 482 mL/min/kg) despite excellent human microsomal stability (HLM CL<sub>int,app</sub> = 8.1 mL/min/kg). This was undesirable because many of our in vivo efficacy and safety studies are conducted in rodents. On the other hand, compound <b>46</b>, which incorporates a phenoxyethyl moiety as the amide N-substituent, was found to have improved rat microsomal stability (RLM CL<sub>int,app</sub> = 97.0 mL/min/kg) along with slightly improved potency (Aβ42 IC<sub>50</sub> = 311 nM). The presence of the phenol ether linkage in <b>46</b> rendered this substituent an <i>enabled monomer</i>, providing a valuable synthetic disconnection to facilitate further SAR efforts. This allowed us to use our extensive phenol monomer set to rapidly explore various substitution patterns using phenol alkylation chemistry in parallel (vide supra). As a result, we quickly established that an <i>o</i>-CF<sub>3</sub> group was key to optimal potency. For example, the corresponding <i>o</i>-chloro-substituted analogue <b>47</b> was >4-fold less active. Likewise, moving the CF<sub>3</sub> group to the meta<i>-</i> (<b>48</b>) or para<i>-</i>position (<b>49</b>) resulted in a loss of Aβ-lowering activity. Compound <b>46</b> had the best overall in vitro profile thus far; however, it only exhibited 23% oral bioavailability in rat. We reasoned that this may in part be due to inadequate rat microsomal stability, leading to extensive first-pass metabolism. Furthermore, it was conceivable that the terminal aryl ring might undergo cytochrome P450 (CYP)-mediated hydroxylation in the para-position, as a result of activation by the electron-donating alkoxy linker. To test this hypothesis, GSM <b>50</b> was prepared, in which the metabolically labile para-position was blocked by a fluoro substituent. Not only was this compound more potent (Aβ42 IC<sub>50</sub> = 252 nM), but the rat microsomal clearance was reduced from 97.0 to 44.1 mL/min/kg. Moreover, this modification may have contributed to a significant improvement in rat oral bioavailability: compound <b>50</b> had 100% oral bioavailability, which stands in sharp contrast to the 23% found for desfluoro analogue <b>46</b>. In addition to low clearance (HLM CL<sub>int,app</sub> = 8.8 mL/min/kg), GSM <b>50</b> was found to have excellent permeability (RRCK <i>P</i><sub>app,A→B</sub> = 17.7 × 10<sup>–6</sup> cm/s and MDR<sub>A→B</sub> = 13.1 × 10<sup>–6</sup> cm/s) as well as a low efflux ratio (MDR Er = 1.5). In terms of physicochemical properties, <b>50</b> is considerably less lipophilic than <b>3</b> (cLogP = 2.75 vs 4.8), which contributes to an improvement CNS MPO and LipE relative to <b>3</b>. GSMs <b>50</b> and <b>3</b> have CNS MPO scores of 4.6 and 3.7, and LipE values of 3.6 and 2.3, respectively.</div><div class="NLM_p">The design of the pyridopyrazine-1,6-dione series and the subsequent discovery of GSM <b>50</b> allowed us to significantly improve upon our previous amide series by successfully aligning potency, clearance, permeability, and MDR efflux ratio within excellent CNS property space. However, further gains in potency were necessary to approach an acceptable human dose projection. Toward this end we identified <b>51</b>, wherein the <i>p</i>-fluoro substituent of <b>50</b> has been replaced with a chloro substituent. GSM <b>51</b> maintained an in vitro ADME profile similar to that of <b>50</b>, but was more potent (Aβ42 IC<sub>50</sub> = 101 nM). This compared favorably to the reference compound <b>3</b> (Aβ42 IC<sub>50</sub> = 143 nM), which had served as the original starting point for our program. Compound <b>51</b> maintained good permeability (RRCK <i>P</i><sub>app,A→B</sub> = 10.5 × 10<sup>–6</sup> cm/s and MDR<sub>A→B</sub> = 5.8 × 10<sup>–6</sup> cm/s) and low efflux ratio (MDR Er = 1.8). Although <b>51</b> was more lipophilic (cLogP = 3.32) than <b>50</b>, it remained within good CNS physicochemical property space, as indicated by a CNS MPO score of 4.6. Additional chemistry efforts suggested that potency could be improved further in this series. For example, naphthyl analogue <b>52</b> had an Aβ42 IC<sub>50</sub> of 15 nM; however, this compound had insufficient stability in rat liver microsomal stability to warrant further studies. Ultimately, GSMs <b>50</b> and <b>51</b> were selected for further profiling in vitro and in vivo.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes the overall physicochemical profiles of <b>50</b> and <b>51</b>, which compare favorably to those of the majority of GSMs in the patent literature.<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> These compounds achieved adequate aqueous kinetic solubility, which in part may be attributed to increased sp<sup>3</sup>/sp<sup>2</sup> ratio. An additional advantage of this series was an improvement in the cytochrome P450 inhibition profile, which had plagued the earlier phenylimidazole series;<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> GSMs <b>50</b> and <b>51</b> had IC<sub>50</sub> values greater than 30 μM against the major CYP isoforms, although they exhibited moderate inhibition of CYP 2C8 and CYP 2C9 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Finally, in accordance with the typical profile of γ-secretase modulators, both lead compounds <b>50</b> and <b>51</b> were inactive against Notch (IC<sub>50</sub> > 50 μM). This was the case for all compounds in this series that were spot-checked for inhibition of Notch signaling.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Physicochemical Properties of GSMs <b>50</b> and <b>51</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">ClogP</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">TPSA</th><th class="colsep0 rowsep0" align="center" char=".">MW</th><th class="colsep0 rowsep0" align="center" char=".">CNS MPO<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">solubility, pH 6.5 (μM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">2.75</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">450</td><td class="colsep0 rowsep0" align="char" char=".">5.35</td><td class="colsep0 rowsep0" align="char" char=".">177</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">3.32</td><td class="colsep0 rowsep0" align="char" char=".">3.12</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">466</td><td class="colsep0 rowsep0" align="char" char=".">4.64</td><td class="colsep0 rowsep0" align="char" char=".">95.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Shake flask log <i>D</i>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Central nervous system multiple parameter optimization score.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Kinetic solubility was measured at Analiza, Inc.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CYP Inhibition by GSMs <b>50</b> and <b>51</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">CYP 1A2 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2C19 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2C8 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2C9 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2D6 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 3A4 IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">19.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">12.3</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td><td class="colsep0 rowsep0" align="char" char=".">>30.0</td></tr></tbody></table></div></div><div class="NLM_p">The lead compounds exhibited good pharmacokinetic parameters in rat, including high oral bioavailability (%<i>F</i>), low to moderate clearance (CL), and reasonable half-life (<i>T</i><sub>1/2</sub>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). When dosed orally at 5 mg/kg, <b>50</b> and <b>51</b> reached plasma concentrations of 964 ng/mL and 4140 ng/mL, respectively, at the 1 h time point. The lead compounds also exhibited acceptable brain penetration, as evidenced by unbound brain (<i>C</i><sub>b,u</sub>) to unbound plasma (<i>C</i><sub>p,u</sub>) concentration ratios of 0.43 and 0.32 for <b>50</b> and <b>51</b>, respectively. The extent to which GSM <b>51</b> was able to reduce Aβ40/42 in vivo was evaluated in a guinea pig efficacy model. The compound was administered orally in doses of 10, 30, and 90 mg/kg, and levels of brain Aβ42, Aβ40, Aβ total, and Aβ38 were measured 4 h postdose along with compound exposure. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, de novo synthesis of brain Aβ42 was reduced in a dose-dependent manner with reductions of 19%, 44%, and 68% at the 10, 30, and 90 mg/kg doses, respectively. Dose-dependent suppression of Aβ40 was also observed, but the effect of <b>51</b> on Aβ40 was slightly less than for Aβ42. While there was a trend toward reduction of Aβ total at the higher doses, this change was not statistically significant. Furthermore, at the highest dose, an increase in the formation of Aβ38 was observed, which is consistent with the profile of a γ-secretase modulator. The Aβ profile of a related compound in guinea pig brain was also examined by immunoprecipitation followed by MALDI-TOF MS (IP/MS) analysis of Aβ peptides. Aβ37 was found to be increased more than Aβ38 (data not shown), which is consistent with what has been reported for other arylimidazole GSMs.<a onclick="showRef(event, 'cit14b ref37'); return false;" href="javascript:void(0);" class="ref cit14b ref37">(14b, 37)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of GSMs <b>50</b> and <b>51</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Vdss (L/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">plasma concentration (ng/mL)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">brain concentration (ng/mL)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>B</i>/<i>P</i><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">14.3</td><td class="colsep0 rowsep0" align="char" char=".">2.09</td><td class="colsep0 rowsep0" align="char" char=".">1.91</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">964</td><td class="colsep0 rowsep0" align="char" char=".">718</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="char" char=".">6.88</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">4140</td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Determined from 1 mg/kg intravenous dose.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Calculated using the exposure from 1 mg/kg intravenous dose and 5 mg/kg oral dose.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">5 mg/kg oral dose, 1 h time point.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Plasma free fractions in rat for <b>50</b> and <b>51</b> were 5.5% and 0.63%, respectively, and rat brain free fractions for <b>50</b> and <b>51</b> were 3.2% and 0.84%, respectively.</p></div></div></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response of <b>51</b> in guinea pig efficacy model reported as percent of vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Plasma, Brain, and CSF Exposure of GSM <b>51</b> in the Guinea Pig Efficacy Model, at 4 h Postdose</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (po, mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±">plasma (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">brain (μM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">CSF (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">0.367 ± 0.182</td><td class="colsep0 rowsep0" align="char" char="±">2.91 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">12.7 ± 7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char="±">0.819 ± 0.056</td><td class="colsep0 rowsep0" align="char" char="±">9.16 ± 4.91</td><td class="colsep0 rowsep0" align="char" char="±">35.7 ± 5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="char" char="±">7.30 ± 2.76</td><td class="colsep0 rowsep0" align="char" char="±">52.4 ± 17.6</td><td class="colsep0 rowsep0" align="char" char="±">239 ± 57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Free fraction of <b>51</b> in guinea pig plasma (<i>F</i><sub>u,p</sub>) was 7%.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Free fraction of <b>51</b> in guinea pig brain (<i>F</i><sub>u,b</sub>) was 0.8%.</p></div></div></div><div class="NLM_p">To determine the target of this novel class of GSMs within the γ-secretase complex, we synthesized a clickable photoaffinity probe containing a benzophenone photoreactive group to effect covalent capture of the binding partner(s) upon UV irradiation and an alkyne handle to enable subsequent click chemistry-mediated conjugation of biotin (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref16 ref38'); return false;" href="javascript:void(0);" class="ref ref16 ref38">(16, 38)</a> The resulting photoprobe, GSM-827-BPyne (<b>53</b>), maintained good potency, exhibiting an Aβ42 IC<sub>50</sub> of 135 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). With a promising photoprobe in hand, we performed photoaffinity labeling studies in HeLa cell membranes, which are known to have high γ-secretase activity.<a onclick="showRef(event, 'cit13c cit16b cit16c'); return false;" href="javascript:void(0);" class="ref cit13c cit16b cit16c">(13c, 16b, 16c)</a> The photoprobe <b>53</b> was incubated with HeLa cell membranes in the presence or absence of GSM or GSI competitor compounds followed by UV irradiation to initiate photo-cross-linking to nearby proteins. The labeled proteins were tagged with biotin via click chemistry with biotin azide and enriched by affinity chromatography with streptavidin. The eluted proteins were separated by SDS-PAGE, and Western blot analysis demonstrated that presenilin N-terminal fragment (PS1-NTF) was labeled by <b>53</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The labeling was deemed specific, because it was competed by pyridopyrazine-1,6-dione GSMs <b>52</b> and <b>54</b> (lanes 2 and 3). Despite the structural similarity to E2012-BPyne,<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> our data indicate that <b>53</b> binds differently to PS1-NTF because the labeling is not competed by <b>3</b> (lane 5). Furthermore, unlike E2012-BPyne, labeling by <b>53</b> in the presence of GSI L458 did not result in a dramatic increase in the labeling of PS1-NTF (lane 4).<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSM-827-BPyne (<b>53</b>) specifically labels PS1-NTF in HeLa membranes. Photoaffinity labeling of <b>53</b> (5 μM, lanes 1–5) in HeLa membranes in the absence (lane 1) or presence of 50 μM GSM <b>52</b> (lane 2), 50 μM GSM <b>54</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (lane 3), 1 μM GSI L458 (lane 4) or 50 μM <b>3</b> (lane 5), followed by click chemistry with biotin azide, streptavidin pull-down, and Western blot analysis with PS1-NTF antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, starting from our previously described amide series (i.e., <b>4</b> and <b>5</b>), we have designed a novel series of GSMs. Our primary design objective was to identify a new heterocyclic core as a replacement for the pyridyl amide moiety of <b>5</b>, to improve physicochemical properties. We also sought to improve the alignment of potency and ADME parameters such as clearance, permeability, and MDR efflux ratio. These objectives were achieved through incorporation of conformational constraint, which ultimately led to the discovery of a novel GSM series containing a pyridopyrazine-1,6-dione bicyclic core. Within this series we have highlighted compounds that exhibit a 7-fold improvement in Aβ-lowering activity in vitro as compared to reference compound <b>3</b> and possess significantly improved physicochemical properties. Lead compound <b>51</b> has good CNS-like physicochemical properties, as evidenced by improved CNS MPO and LipE relative to <b>3</b> (GSMs <b>51</b> and <b>3</b> have CNS MPO scores of 4.6 and 3.7, and LipE values of 3.9 and 2.3, respectively). This in turn translated into low clearance in vitro and in vivo, and excellent permeability and oral bioavailability. Robust in vivo efficacy was observed in a guinea pig model at 30 mg/kg, and reduction of brain Aβ42 was achieved in a dose-dependent manner. Of note is that this new GSM series successfully addresses the problems of CYP-inhibition and off-target activity that were observed with previous arylimidazole series. Our efforts also led to important insights into the GSM pharmacophore. By breaking the symmetry around the core and by locking rotamers through introduction of conformational constraint, we were able to establish directionality for the key polar interactions between heteroaryl-type γ-secretase modulators and the target binding site. Finally, chemical biology efforts involving design and synthesis of photoaffinity probe <b>53</b> demonstrated that the pyridinone class of GSMs binds to the N-terminal fragment of presenillin (PS1-NTF) within the of γ-secretase complex at a site that is distinct from that targeted by γ-secretase inhibitors. Additional efforts to further improve potency while maintaining the favorable physicochemical properties, ADME, and safety profiles of <b>50</b> and <b>51</b> will be disclosed in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Methods</h3><div class="NLM_p">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous sodium sulfate or magnesium sulfate. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepR<sub>f</sub> 4 to 120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage horizon automatic purification system. Microwave reactions were carried out in a microwave reactor manufactured by Smithcreator of Personal Chemistry. <sup>1</sup>H NMR spectra were recorded on Varian INOVA spectrometers (300, 400, or 500 MHz) (Varian Inc., Palo Alto, CA) at room temperature. Chemical shifts are expressed in parts per million δ relative to residual solvent as an internal reference. Peak multiplicities are expressed as follows: singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad singlet (br s). HPLC purity analysis of final test compounds was carried out using one of the following three methods unless otherwise indicated. Method A: Compounds <b>46</b>–<b>49</b>, <b>52</b>, and <b>53</b>: liquid chromatography/photodiode array detector/evaporative light scattering detection coupled to single quadrupole mass spectrometry (LC/UV/ELSD/MS), Waters Atlantis dC18 4.6 × 50 mm, 5 μm; mobile phase A: 0.05% TFA in water (v/v); mobile phase B: 0.05% TFA in acetonitrile (v/v); gradient begins at 95.0% A, 5% B increasing to 5% A, 95% B over 4.0 min, hold at 5% A, 95% B until 5.0 min. Flow rate: 2 mL/min. Method B: Compounds <b>50</b> and <b>51</b>: UPLC/UV/MS using Waters CSH C18 2.1 × 50 mm with 1.7 μm particles; UV purity detected at 215 nm; mass spectrometer ESI positive negative switching acquiring from <i>m</i>/<i>z</i> 160 to 1000. Mobile phase A = 0.1% formic acid in water (v/v); mobile phase B = 0.1% formic acid in acetonitrile (v/v); gradient begins at 95% A, 5% B increasing to 100% B over 1.2 min, hold at 100% B until 1.5 min. Flow rate: 1.0 mL/min. Method C: Compounds <b>15</b>, <b>25b</b>, <b>27</b>, <b>28</b>, and <b>44</b>: UPLC/UV/MS. Mobile phase A: 0.05% TFA in water (v/v); mobile phase B: 0.05% TFA in acetonitrile (v/v); gradient begins at 95.0% A, 5% B increasing to 5% A, 95% B. All final test compounds were found to have purity >95% unless otherwise indicated.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(4-Fluoro-3-methoxybenzylidene)-2,2-dimethoxyethanamine (<b>10</b>)</h4><div class="NLM_p last">A solution of 4-fluoro-3-methoxybenzaldehyde (<b>9</b>) (7.00 g, 45.4 mmol) and 2,2-dimethoxyethanamine (5.88 mL, 54.5 mmol) in toluene (60 mL) was heated to reflux under a Dean–Stark trap for 1 h. The reaction mixture was allowed to cool to room temperature and concentrated under reduced pressure to provide the title compound (10.9 g, quantitative). LCMS <i>m</i>/<i>z</i> 242.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.42 (s, 6H), 3.77 (dd, <i>J</i> = 5.3, 1.2 Hz, 2H), 3.94 (s, 3H), 4.68 (t, <i>J</i> = 5.3 Hz, 1H), 7.09 (dd, <i>J</i> = 10.7, 8.4 Hz, 1H), 7.16 (ddd, <i>J</i> = 8.2, 4.7, 1.9 Hz, 1H), 7.50 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 8.21 (t, <i>J</i> = 1.4 Hz, 1H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 6-Fluoro-7-methoxyisoquinoline (<b>12</b>)</h4><div class="NLM_p last">Ethyl chloroformate (4.04 mL, 40.2 mmol) was added to a solution of <i>N</i>-(4-fluoro-3-methoxybenzylidene)-2,2-dimethoxyethanamine (<b>10</b>) (9.70 g, 40.2 mmol) in tetrahydrofuran (30 mL) at −10 °C. The reaction was stirred at −10 °C for 5 min and then warmed to room temperature, whereupon trimethyl phosphite (6.05 mL, 48.2 mmol) was added. The reaction mixture was stirred at room temperature for 18 h and then concentrated under reduced pressure to provide ethyl 2,2-dimethoxyethyl[(dimethoxyphosphoryl)(4-fluoro-3-methoxyphenyl)methyl]carbamate (<b>11</b>) (17.0 g, quantitative), which was used in the subsequent step without purification. Intermediate <b>11</b> (2.41 g, 5.70 mmol) was treated with a 1.0 M solution of titanium tetrachloride in dichloromethane (34.2 mL, 34.2 mmol). The mixture was heated to reflux for 24 h, whereupon it was allowed to cool to room temperature and was poured into an aqueous solution of sodium hydroxide (1 M, 150 mL) and ethyl acetate (50 mL). The resulting white precipitate was removed by filtration, and the filtrate was extracted with ethyl acetate (2 × 40 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 0% to 10% methanol in ethyl acetate) to provide the title compound (573 mg, 57%). LCMS <i>m</i>/<i>z</i> 178.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.03 (s, 3H), 7.31 (d, <i>J</i> = 8.2 Hz, 1H), 7.43 (d, <i>J</i> = 11.3 Hz, 1H), 7.53 (d, <i>J</i> = 5.7 Hz, 1H), 8.44 (d, <i>J</i> = 5.9 Hz, 1H), 9.12 (s, 1H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-Fluoro-7-methoxyisoquinoline 2-oxide (<b>13</b>)</h4><div class="NLM_p last"><i>m</i>-Chloroperoxybenzoic acid (1.57 g, 6.46 mmol) was added to a solution of 6-fluoro-7-methoxyisoquinoline (<b>12</b>) (573 mg, 3.23 mmol) in dichloromethane (20 mL). The mixture was stirred at room temperature for 3 h, whereupon it was poured into a mixture of aqueous sodium hydroxide solution (1 M, 50 mL) and 20% aqueous sodium thiosulfate solution (50 mL). The layers were separated, and the aqueous layer was extracted with dichloromethane (2 × 25 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 0% to 20% methanol in ethyl acetate) to provide the title compound (288 mg, 46%). LCMS <i>m</i>/<i>z</i> 193.9 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.02 (s, 3H), 7.50 (d, <i>J</i> = 8.2 Hz, 1H), 7.65 (d, <i>J</i> = 10.9 Hz, 1H), 7.85 (d, <i>J</i> = 7.0 Hz, 1H), 8.10 (dd, <i>J</i> = 7.0, 1.4 Hz, 1H), 8.88 (s, 1H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-Fluoro-7-methoxyisoquinolin-1(2<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">6-Fluoro-7-methoxyisoquinoline 2-oxide (<b>13</b>) (288 mg, 1.49 mmol) was dissolved in acetic anhydride (5.0 mL, 40 mmol) and heated to reflux for 3 h. The mixture was allowed to cool to room temperature and then was concentrated under reduced pressure. The resulting residue was treated with an aqueous solution of sodium hydroxide (2 M, 10 mL) and heated to 100 °C for 1 h. The mixture was cooled to room temperature and acidified to pH 6 with a 5% aqueous solution of citric acid. The resulting solid was isolated by filtration to provide the title compound (242 mg, 84%). LCMS <i>m</i>/<i>z</i> 193.9 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.03 (s, 3H), 6.49 (d, <i>J</i> = 7.2 Hz, 1H), 7.11 (d, <i>J</i> = 7.2 Hz, 1H), 7.25 (d, <i>J</i> = 11.5 Hz, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 1H), 10.77 (br s, 1H).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(3-Chlorophenethyl)-6-fluoro-7-methoxyisoquinolin-1(2<i>H</i>)-one</h4><div class="NLM_p last">Sodium hydride (60.2 mg, 60% dispersion in mineral oil, 1.50 mmol) was added to a solution of 6-fluoro-7-methoxyisoquinolin-1(2<i>H</i>)-one (<b>14</b>) (242 mg, 1.25 mmol) in <i>N</i>,<i>N</i>-dimethylacetamide (10 mL). The mixture was stirred at room temperature for 1 h and then treated with 1-(2-bromoethyl)-3-chlorobenzene (0.22 mL, 1.50 mmol). After being stirred for 18 h, the reaction was judged incomplete by TLC. Additional sodium hydride (30 mg, 60% dispersion in mineral oil, 0.75 mmol) and 1-(2-bromoethyl)-3-chlorobenzene (0.200 mL, 1.36 mmol) were added to the mixture. The reaction was stirred at room temperature for 24 h, whereupon it was poured into water (40 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 0% to 50% ethyl acetate in heptane) to provide the title compound (259 mg, 62%). LCMS <i>m</i>/<i>z</i> 332.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.05–3.11 (m, 2H), 4.02 (s, 3H), 4.17–4.23 (m, 2H), 6.32 (d, <i>J</i> = 7.4 Hz, 1H), 6.77 (d, <i>J</i> = 7.4 Hz, 1H), 7.05–7.10 (m, 1H), 7.18 (d, <i>J</i> = 11.3 Hz, 1H), 7.20–7.25 (m, 3H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(3-Chlorophenethyl)-7-methoxy-6-(4-methyl-1<i>H</i>-imidazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>15</b>)</h4><div class="NLM_p last">4-Methylimidazole (126 mg, 1.54 mmol) and potassium carbonate (425 mg, 3.08 mmol) were added to a solution of 2-(3-chlorophenethyl)-6-fluoro-7-methoxyisoquinolin-1(2<i>H</i>)-one (255 mg, 0.769 mmol) in dimethyl sulfoxide (5 mL). The mixture was heated to 135 °C for 14 h, whereupon it was cooled to room temperature and poured into water (20 mL). The aqueous mixture was extracted with dichloromethane (3 × 30 mL), and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (gradient: 0% to 6% [2 M ammonia in methanol] in ethyl acetate) to provide a 2.5:1 mixture of imidazole regioisomers (160 mg, 53%). This mixture was further purified by HPLC (Phenomenex Luna (2) C<sub>18</sub>, 21.2 × 150 mm, 5 μm; 0.1% formic acid modifier, 95% water/5% acetonitrile, linear gradient to 5% water/95% acetonitrile over 10.0 min, then 100% acetonitrile for 1.0 min; flow rate: 28 mL/min) to provide the title compound (20 mg, 7%). LCMS <i>m</i>/<i>z</i> 394.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.29–2.34 (m, 3H), 3.08 (t, <i>J</i> = 7.3 Hz, 2H), 4.01 (s, 3H), 4.18–4.25 (m, 2H), 6.36 (d, <i>J</i> = 7.4 Hz, 1H), 6.78 (d, <i>J</i> = 7.2 Hz, 1H), 7.03 (t, <i>J</i> = 1.0 Hz, 1H), 7.04–7.10 (m, 1H), 7.19–7.24 (m, 3H), 7.39 (s, 1H), 7.83 (d, <i>J</i> = 1.2 Hz, 1H), 8.01 (s, 1H). HPLC purity >95%.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>E</i>)-3-(3-Bromo-2-methoxyphenyl)acrylic Acid (<b>18</b>)</h4><div class="NLM_p last">To a solution of 3-bromo-2-methoxybenzaldehyde (<b>16</b>) (7.42 g, 34.5 mmol) in pyridine (25.1 mL) was added malonic acid (5.50 g, 51.8 mmol) followed by piperidine (1.06 mL, 10.4 mmol). The reaction mixture was heated to 120 °C for 6 h, whereupon it was allowed to cool to room temperature and acidified to pH < 3 using concentrated hydrochloric acid. The resulting solid was collected by filtration, and the residue was purified via chromatography on silica gel (5% [2 M acetic acid in ethyl acetate] in heptane) to provide the title compound (4.43 g, 50%). LCMS <i>m</i>/<i>z</i> 254.1 (M – 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.83 (s, 3H), 6.56 (d, <i>J =</i> 16.0 Hz, 1H), 7.09 (t, <i>J</i> = 8.0 Hz, 1H), 7.67 (dd, <i>J</i> = 1.6, 7.8 Hz, 1H), 7.64 (dd, <i>J</i> = 1.6, 8.0 Hz, 1H), 7.91 (d, <i>J</i> = 16.2 Hz, 1H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>E</i>)-3-(3-Fluoro-2-methoxyphenyl)acrylic Acid (<b>19</b>)</h4><div class="NLM_p last">A solution of 3-fluoro-2-methoxybenzaldehyde (<b>17</b>) (16.1 g, 104 mmol) and malonic acid (16.6 g, 157 mmol) in pyridine (51 mL) and piperidine (3.2 mL) was heated to 120 °C for 6 h. The reaction was allowed to cool to room temperature, and concentrated aqueous hydrochloric acid was added to reach pH < 3. The resulting precipitate was collected via filtration, washed with water, and recrystallized from ethyl acetate to provide the title compound as a solid (3.84 g, 19%). LCMS <i>m</i>/<i>z</i> 195.3 (M-1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.95 (d, <i>J</i> = 1.9 Hz, 3H), 6.54 (d, <i>J</i> = 16.0 Hz, 1H), 7.09 (ddd, <i>J</i> = 8.2, 8.0, 5.1 Hz, 1H), 7.18 (ddd, <i>J</i> = 11.5, 8.2, 1.6 Hz, 1H), 7.44 (br d, <i>J</i> = 7.8 Hz, 1H), 7.92 (d, <i>J</i> = 16.2 Hz, 1H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-3-(3-Fluoro-2-methoxyphenyl)acryloyl Azide (<b>21</b>)</h4><div class="NLM_p last">A mixture of (<i>E</i>)-3-(3-fluoro-2-methoxyphenyl)acrylic acid (<b>19</b>) (889 mg, 4.53 mmol) in thionyl chloride (3.3 mL, 45.3 mmol) was stirred at room temperature for 16 h and then heated to reflux for 2 h. The volatiles were evaporated under reduced pressure, and the crude material was azeotroped with toluene. The resulting residue (973 mg) was dissolved in acetone (3.2 mL) and cooled to 0 °C. A solution of sodium azide (383 mg, 5.9 mmol) in water (1.2 mL) was added, the cold bath was removed, and the reaction was stirred at room temperature for 2 h. The reaction mixture was poured into diethyl ether (30 mL) and water (30 mL), and the layers were separated. The aqueous layer was extracted with ether (2 × 30 mL), and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to provide the title compound (996 mg, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.00 (d, <i>J</i> = 2.3 Hz, 3H), 6.51 (d, <i>J</i> = 16.0 Hz, 1H), 6.99–7.07 (m, 1H), 7.15 (ddd, <i>J</i> = 11.5, 8.2, 1.6 Hz, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 8.01 (d, <i>J</i> = 16.0 Hz, 1H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Bromo-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">Thionyl chloride (2.5 mL, 34 mmol) was added to a round-bottom flask charged with (<i>E</i>)-3-(3-bromo-2-methoxyphenyl)acrylic acid (<b>18</b>) (0.88 g, 3.4 mmol). The reaction mixture was stirred for 16 h at room temperature followed by heating at 90 °C for 2 h. The reaction was then allowed to cool to room temperature, and the volatiles were removed under reduced pressure. After azeotroping with toluene, the resulting residue (0.95 g) was dissolved in acetone (3.2 mL) and cooled to 0 °C. Sodium azide (0.34 g, 5.3 mmol) in water (1.2 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. Diethyl ether (30 mL) and water (30 mL) were added, and the layers were separated. The aqueous layer was extracted with diethyl ether (2 × 30 mL), the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and filtered, and the solvent was removed under reduced pressure. The resulting residue (0.89 g) was dissolved in 1,2-dichlorobenzene (20 mL) and subsequently heated to 140 °C. After 1 h, when gas evolution had subsided, catalytic iodine was added to the reaction mixture and the temperature was increased to 185 °C for an additional 1.5 h. The reaction mixture was allowed to cool to room temperature, the solvent was partially removed, and the material was isolated through crystallization to afford the desired product (0.44 g, 51%). LCMS <i>m</i>/<i>z</i> 255.9 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.95 (s, 3H), 6.83 (d, <i>J</i> = 7.2 Hz, 1H), 7.22 (d, <i>J</i> = 7.6 Hz, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 8.06 (d, <i>J</i> = 8.6 Hz, 1H), 11.2 (br s, 1H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Fluoro-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last">A solution of (<i>E</i>)-3-(3-fluoro-2-methoxyphenyl)acryloyl azide (<b>21</b>) (996 mg, 4.50 mmol) in 1,2-dichlorobenzene (30 mL) was heated to 140 °C for 1 h until gas formation subsided. Catalytic iodine was added, and the temperature was increased to 185 °C. The reaction mixture was heated to 185 °C for 4 days, whereupon it was allowed to cool to room temperature. The reaction was concentrated under reduced pressure, and the residue was purified via chromatography on silica gel (gradient: 0% to 10% ethyl acetate in heptane, then 0% to 10% [10% methanol in ethyl acetate] in heptane). The resulting residue (469 mg) was purified further by prep-HPLC (Gemini 50 × 100 mm C18; mobile phase A: 0.1% formic acid in water; mobile phase B: acetonitrile; gradient: 25% to 75% B; flow rate: 75 mL/min) to afford the title compound (143 mg, 16%) as a solid. LCMS <i>m</i>/<i>z</i> 194.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.06 (d, <i>J</i> = 1.9 Hz, 3H), 6.87 (d, <i>J</i> = 7.4 Hz, 1H), 7.14 (d, <i>J</i> = 6.6 Hz, 1H), 7.24 (dd, <i>J</i> = 11.1, 9.0 Hz, 1H), 8.08–8.19 (m, 1H), 10.28 (br s, 1H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-Bromo-2-(3-chlorophenethyl)-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">Sodium hydride (60% dispersion in mineral oil, 0.61 g, 15.3 mmol) was added to a solution of 6-bromo-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>22</b>) (0.44 g, 1.7 mmol) in dimethylacetamide (20.0 mL), and the reaction mixture was stirred at room temperature for 1 h. 1-(2-Bromoethyl)-3-chlorobenzene (2.25 mL, 15.3 mmol) was added, and stirring was continued for 48 h. Additional sodium hydride (0.70 g, 17.6 mmol) and 1-(2-bromoethyl)-3-chlorobenzene (2.00 mL, 13.6 mmol) were added, and the reaction mixture was stirred for an additional 24 h, whereupon it was poured into water (40 mL) and ethyl acetate (30 mL). The layers were separated, and the aqueous layer was extracted twice with diethyl ether. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified via chromatography on silica gel (gradient: 0% to 50% ethyl acetate in heptane) to provide the desired product (0.30 g, 45%). LCMS <i>m</i>/<i>z</i> 393.8 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.07 (m, 2H), 3.92 (s, 3H), 4.18 (m, 2H), 6.63 (d, <i>J</i> = 7.6 Hz, 1H), 6.84 (d, <i>J</i> = 7.4 Hz, 1H), 7.08–7.06 (m, 1H), 7.22–7.20 (m, 3H), 7.63 (d, <i>J</i> = 8.6 Hz, 1H), 8.08 (d, <i>J</i> = 8.6, 1H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(3-Chlorophenethyl)-5-methoxy-6-(4-methyl-1<i>H</i>-imidazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>25b</b>)</h4><div class="NLM_p last">Cesium carbonate (0.16 g, 0.48 mmol) and 4-methylimidazole (30 mg, 0.36 mmol) were added to a solution of 6-bromo-2-(3-chlorophenethyl)-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>24</b>) (0.10 g, 0.24 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2.0 mL). Nitrogen was gently bubbled through the reaction mixture for 5 min, and copper(I) iodide (20 mg, 0.12 mmol) was added. Nitrogen was bubbled through the reaction mixture for an additional 30 min, and the reaction was then heated to 100 °C. After stirring the reaction at 100 °C for 3 days, it was allowed to cool to room temperature and filtered through Celite. The filtrate was concentrated under reduced pressure, and the residue was purified via reversed phase prep-HPLC (gradient: 5% to 15% acetonitrile in water containing 0.1% formic acid) to provide the desired product (20 mg, 20%). LCMS <i>m</i>/<i>z</i> 394.5 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.33 (s, 3H), 3.09 (m, 2H), 3.55 (s, 3H), 4.21 (m. 2H), 6.70 (d, <i>J</i> = 7.4 Hz, 1H), 6.88 (<i>J</i> = 7.6 Hz, 1H), 7.07–7.24 (m, 7H), 7.40 (d, <i>J</i> = 8.6 Hz, 1H). HPLC purity: 93%.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-Fluoro-5-methoxy-2-[3-(trifluoromethyl)benzyl]isoquinolin-1(2<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last">Sodium hydride (60% dispersion in mineral oil, 44.4 mg, 1.11 mmol) was added to a solution of 6-fluoro-5-methoxyisoquinolin-1(2<i>H</i>)-one (<b>23</b>) (143 mg, 0.74 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (5 mL). The mixture was stirred at room temperature for 1 h, whereupon 3-(trifluoromethyl)benzyl bromide (212 mg, 0.89 mmoL) was added. The reaction mixture was stirred at room temperature overnight, whereupon it was poured into ethyl acetate (10 mL) and water (30 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 0% to 40% ethyl acetate in heptane) to afford the title compound as a solid (253 mg, 97%). LCMS <i>m</i>/<i>z</i> 352.5 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.01 (s, 3H), 5.20 (s, 2H), 6.80 (d, <i>J</i> = 7.6 Hz, 1H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 7.14–7.26 (m, 1H), 7.37–7.57 (m, 4H), 8.11 (dd, <i>J</i> = 9.0, 4.9 Hz, 1H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-Hydroxy-6-(4-methyl-1<i>H</i>-imidazol-1-yl)-2-[3-(trifluoromethyl)benzyl]isoquinolin-1(2<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last">A mixture of 6-fluoro-5-methoxy-2-[3-(trifluoromethyl)benzyl]isoquinolin-1(2<i>H</i>)-one (<b>26</b>) (253 mg, 0.72 mmol), 4-methylimidazole (118 mg, 1.44 mmol), and potassium carbonate (398 mg, 2.88 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (5 mL) was stirred at 100 °C for 3 days and then at 120 °C for 12 h. The reaction was allowed to cool to room temperature and filtered, the solids were washed with acetonitrile, and the combined filtrate and washings were concentrated under reduced pressure. The resulting residue was purified by prep-HPLC (column: Gemini 50 × 100 mm C18 (acidic or basic, >150 mg), injection volume: 900 μL × 7; solvent A: 0.1% formic acid in water; solvent B: acetonitrile; gradient 30% to 80% B; collection time: 3–10 min; flow rate: 75 mL/min; wavelength 220 nm) to afford the desired product as a mixture containing the imidazole regioisomer side product (142 mg). The regioisomers were further separated by SFC prep-HPLC (column: Chiralcel OD-H (4.6 mm x 25 cm); mobile phase 25% methanol in carbon dioxide; flow rate: 2.5 mL/min) to afford the title compound as a solid (80 mg, 27%). LCMS <i>m</i>/<i>z</i> 400.5 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.30 (s, 3H), 5.35 (s, 2H), 7.10 (dd, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.23 (t, <i>J</i> = 1.2 Hz, 1H), 7.46 (d, <i>J</i> = 8.6 Hz, 1H), 7.50–7.60 (m, 2H), 7.60–7.66 (m, 2H), 7.68 (s, 1H), 7.95 (d, <i>J</i> = 8.6 Hz, 1H), 8.05 (d, <i>J</i> = 1.4 Hz, 1H). HPLC purity >95%.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-Hydroxy-6-(4-methyl-1<i>H</i>-imidazol-1-yl)-2-[3-(trifluoromethyl)benzyl]-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last">5-Hydroxy-6-(4-methyl-1<i>H</i>-imidazol-1-yl)-2-[3-(trifluoromethyl)benzyl]isoquinolin-1(2<i>H</i>)-one (<b>27</b>) (30 mg, 0.075 mmol) in 20 mL of methanol was subjected to H-Cube hydrogenation (10% Pd/C, 50 bar, 60 °C, 0.4 mL/min). The solvent was evaporated under reduced pressure to afford the title compound as an oil (29 mg, 97%). LCMS <i>m</i>/<i>z</i> 402.6 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.07 (s, 3H), 3.08 (t, <i>J</i> = 6.7 Hz, 2H), 3.52 (t, <i>J</i> = 6.7 Hz, 2H), 4.85 (s, 2H), 6.79 (s, 1H), 7.08 (d, <i>J</i> = 8.2 Hz, 1H), 7.36–7.42 (m, 1H), 7.48 (d, <i>J</i> = 7.2 Hz, 1H), 7.51–7.64 (m, 3H), 7.69 (d, <i>J</i> = 8.2 Hz, 1H). HPLC purity >95%.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-(4-Methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic Acid, Hydrobromide Salt (<b>34</b>)</h4><div class="NLM_p last">A solution of methyl 6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridine-2-carboxylate<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<b>33</b>) (3.82 g, 15.9 mmol) in acetic acid (30 mL) and aqueous hydrobromic acid (48%, 30 mL) was heated to reflux for 4 h. The reaction was allowed to cool to room temperature and then cooled further to 0 °C using an ice–water bath. The resulting precipitate was collected via filtration and washed with ice–water (30 mL). Recrystallization from ethanol (20 mL) provided the title compound as a light yellow solid (3.79 g, 79%). LCMS <i>m</i>/<i>z</i> 220.1 (M + 1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.34 (br s, 3H), 7.09 (d, <i>J =</i> 7.4 Hz, 1H), 7.88–7.91 (m, 1H), 8.07 (d, <i>J =</i> 7.6 Hz, 1H), 9.58–9.60 (m, 1H), 12.6 (br s, 1H).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 5-(4-Methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic Acid, Hydrochloride Salt (<b>35</b>)</h4><div class="NLM_p last">A solution of methyl 6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridine-2-carboxylate<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<b>33</b>) (34.3 g, 139 mmol) in aqueous hydrochloric acid (37%, 230 mL) and 1,4-dioxane (230 mL) was heated to reflux for 18 h, whereupon it was allowed to cool to room temperature. The reaction was filtered, and the solids were washed with 1,4-dioxane (2 × 100 mL). The solids were mixed with methanol (500 mL), and the volatiles were removed under reduced pressure. The residue was stirred with methanol (100 mL) for 15 min, and 1,4-dioxane (250 mL) was added. The resulting mixture was stirred for 15 min, whereupon the solids were collected by filtration and washed with 1,4-dioxane to provide the title compound as a beige solid (35.4 g, 99%). LCMS <i>m</i>/<i>z</i> 220.1 (M + 1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.33 (d, <i>J =</i> 0.9 Hz, 3H), 7.09 (d, <i>J =</i> 7.5 Hz, 1H), 7.84–7.87 (m, 1H), 8.04 (d, <i>J =</i> 7.5 Hz, 1H), 9.50 (d, <i>J =</i> 1.6 Hz, 1H).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(2-Chloroethyl)-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione (<b>41</b>)</h4><div class="NLM_p last">Potassium carbonate (195.4 g, 1414 mmol) was added to a mixture of 5-(4-methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrochloride salt (<b>35</b>) (34.5 g, 135 mmol) and bis(2-chloroethyl)amine hydrochloride (<b>40</b>) (37.8 g, 212 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (670 mL), and the reaction was stirred for 10 min. HATU (83.5 g, 219 mmol) was added, and stirring was continued for an additional 3 h and 40 min. The reaction mixture was poured into water (4 L), stirred for 30 min, and then extracted with dichloromethane (3 × 1 L). The combined organic layers were washed with saturated aqueous sodium chloride solution (3 × 3 L), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was stirred in ethyl acetate (approximately 50 mL) for 30 min, whereupon the solids were collected by filtration and washed with ethyl acetate and pentane to provide the title compound as a yellow solid (23.0 g, 56%). LCMS <i>m</i>/<i>z</i> 307.1 (M + 1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.29 (br s, 3H), 3.80–3.93 (m, 6H), 4.38–4.44 (m, 2H), 7.13–7.16 (m, 1H), 7.27 (d, <i>J =</i> 7.6 Hz, 1H), 7.45 (d, <i>J =</i> 7.6 Hz, 1H), 8.24 (d, <i>J =</i> 1.0 Hz, 1H).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-[3-(Trifluoromethyl)benzyl]-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-a]pyrazine-1,6-dione (<b>44</b>)</h4><div class="NLM_p last">To a solution of 5-(4-methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrochloride salt (<b>35</b>) (68 mg, 0.20 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (6.0 mL) was added HATU (140 mg, 0.36 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.30 mL, 2.0 mmol), and finally [2-(3-(trifluoromethyl)benzylamino]ethanol (50 mg, 0.23 mmol). The reaction mixture was stirred at room temperature for 14 h, whereupon additional HATU (102 mg, 0.26 mmol) was added. Stirring was continued for 4 h, and the reaction mixture was poured into saturated aqueous sodium bicarbonate solution (50 mL) and washed with ethyl acetate (2 × 50 mL). The combined organic layers were washed with saturated aqueous sodium chloride solution (2 × 50 mL), dried (NaSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified via chromatography on silica gel (gradient: 10% to 100% ethyl acetate in heptane) to afford the title compound as a tan solid (20 mg, 23%). LCMS <i>m</i>/<i>z</i> 403.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.25 (d, <i>J</i> = 1.0 Hz, 3H), 3.59 (dd, <i>J</i> = 6.5, 5.2 Hz, 2H), 4.29 (dd, <i>J</i> = 6.5, 5.2 Hz, 2H), 4.80 (s, 2H), 7.10 (t, <i>J</i> = 1.2 Hz, 1H), 7.31 (d, <i>J</i> = 7.6 Hz, 1H), 7.43 (d, <i>J</i> = 7.6 Hz, 1H), 7.47–7.51 (m, 2H), 7.52–7.60 (m, 2H), 8.19 (d, <i>J</i> = 1.2 Hz, 1H). HPLC purity >95%.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(<i>tert</i>-Butyldimethylsilyloxy)-<i>N</i>-{[1-(4-chlorophenyl)cyclopropyl]methyl}ethanamine</h4><div class="NLM_p last">A solution of [1-(4-chlorophenyl)cyclopropyl]methanamine (10.0 mg, 0.055 mmol) and (<i>tert-</i>butyldimethylsilyloxy)acetaldehyde (9.3 mg, 0.053 mmol) in dichloroethane (17.0 mL) was stirred for 5 min at room temperature, whereupon sodium triacetoxyborohydride (15.0 mg, 0.071 mmol) was added. The mixture was stirred at room temperature for 18 h and then poured into a saturated aqueous solution of sodium bicarbonate (50 mL) and washed with dichloromethane (2 × 20 mL). The combined organic layers were washed with brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to afford the title compound (20 mg, LCMS <i>m</i>/<i>z</i> 340.2 (M + 1) which was used directly in the next without further purification.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-{[1-(4-Chlorophenyl)cyclopropyl]methylamino}ethanol</h4><div class="NLM_p last">A solution of 0.4 M HCl in methanol at 0 °C (0.5 mL, 0.2 mmol) was added to a solution of 2-(<i>tert</i>-butyldimethylsilyloxy)-<i>N</i>-{[1-(4-chlorophenyl)cyclopropyl]methyl}ethanamine (20 mg, 0.059 mmol) in methanol (0.5 mL). The reaction was stirred at room temperature for 64 h, whereupon it was poured into a saturated solution of aqueous sodium bicarbonate (50 mL) and washed with ethyl acetate (50 mL). The layers were separated, and the organic layer was washed with brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by chromatography on silica gel (gradient: 10% to 100% ethyl acetate in heptane) to afford the title compound as a clear colorless oil (13 mg, quant.). LCMS <i>m</i>/<i>z</i> 226.2 (M + 1).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-{[1-(4-Chlorophenyl)cyclopropyl]methyl}-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione, Trifluoroacetate Salt (<b>45</b>)</h4><div class="NLM_p last">To a solution of 5-(4-methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrobromide salt (<b>34</b>) (22 mg 0.06 mmol) and 2-{[1-(4-chlorophenyl)cyclopropyl]methylamino}ethanol (13 mg, 0.06 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1.5 mL) were added HATU (50 mg, 0.13 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.30 mL, 2.0 mmol). The reaction mixture was stirred at room temperature for 17 h, whereupon it was partitioned between dichloromethane and water. The aqueous layer was extracted with dichloromethane, and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered through silica gel, and concentrated under reduced pressure. The residue was dissolved in dimethyl sulfoxide (1 mL) and purified by reversed-phase HPLC Column: Waters Sunfire C18 19 × 100, 5 μm; mobile phase A: 0.05% TFA in water (v/v); mobile phase B: 0.05% TFA in acetonitrile (v/v); gradient: 85.0% water/15.0% acetonitrile linear to 0% water/100% acetonitrile in 8.5 min, hold at 0% water/100% acetonitrile to 10.0 min. Flow rate: 25 mL/min. Purity was determined using liquid chromatography/photodiode array detector/evaporative light scattering detection coupled to single quadrupole mass spectrometry (LC/UV/ELSD/MS) using these standard conditions: Waters Atlantis dC<sub>18</sub> columns, 6 × 50 mm, 5 μm, at 2 mL/min flow rate; mobile phase A 0.05% trifluoroacetic acid in water (v/v); mobile phase B 0.05% trifluoroacetic acid in acetonitrile (v/v); 95% water/5% acetonitrile to 5% water/95% acetonitrile linear gradient over 4 min, and holding at final gradient for an additional 1 min. Retention time: 2.4 min. LCMS <i>m</i>/<i>z</i> 409.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (d, <i>J</i> = 1.2 Hz, 1H), 7.42 (d, <i>J</i> = 7.8 Hz, 1H), 7.31–7.22 (m, 4H), 7.17 (d, <i>J</i> = 7.8 Hz, 1H), 7.10 (s, 1H), 4.08–4.02 (m, 2H), 3.74 (s, 2H), 3.38–3.32 (m, 2H), 2.26 (d, <i>J</i> = 0.8 Hz, 3H), 1.04–0.99 (m, 2H), 0.95–0.91 (m, 2H). HPLC purity >95%.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Parallel Medicinal Chemistry Protocol for Preparation of 2-[2-(Aryloxy)ethyl]- and 2-[2-(heteroaryloxy)ethyl]-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-diones <b>46</b>–<b>49</b> and <b>52</b></h4><div class="NLM_p last">2-(2-Chloroethyl)-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione (<b>41</b>) (20–35 mg) and a suitably substituted phenol (1–1.5 equiv) were combined in dimethyl sulfoxide (1.0 mL). After addition of potassium carbonate (3.5 equiv), the reaction mixture was heated at 100 °C until the reaction was judged to be complete via LCMS analysis (generally 1 to 3 h). The mixture was allowed to cool to room temperature and filtered, and the filtrate was purified using reversed phase HPLC with an appropriate gradient using the following system: Column: Waters Sunfire C18 19 × 100, 5 μm; mobile phase A: 0.05% trifluoroacetic acid in water (v/v); mobile phase B: 0.05% trifluoroacetic acid in acetonitrile (v/v). Flow rate: 25 mL/min.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 7-(4-Methyl-1<i>H</i>-imidazol-1-yl)-2-{2-[2-(trifluoromethyl)phenoxy]ethyl}-3,4-dihydro-1<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6(2<i>H</i>)-dione (<b>46</b>)</h4><div class="NLM_p last">LCMS <i>m</i>/<i>z</i> 433.1 (M + 1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 8.01 (d, <i>J</i> = 7.9 Hz, 1H), 7.76 (s, 1H), 7.67–7.57 (m, 2H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.19–7.14 (m, 1H), 7.11 (t, <i>J</i> = 7.5 Hz, 1H), 4.35 (t, <i>J</i> = 5.0 Hz, 2H), 4.28–4.24 (m, 2H), 3.93 (t, <i>J</i> = 5.3 Hz, 2H), 3.86–3.82 (m, 2H), 2.30 (s, 3H). HPLC purity >95%.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-[2-(2-Chlorophenoxy)ethyl]-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-1<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6(2<i>H</i>)-dione (<b>47</b>)</h4><div class="NLM_p last">LCMS <i>m</i>/<i>z</i> 399.1 (M + 1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.01 (d, <i>J</i> = 7.5 Hz, 1H), 7.75 (s, 1H), 7.42 (d, <i>J</i> = 7.9 Hz, 1H), 7.33–7.28 (m, 1H), 7.20–7.15 (m, 2H), 6.97 (t, <i>J</i> = 7.7 Hz, 1H), 4.30–4.28 (m, 4H), 3.94–3.92 (m, 4H), 2.30 (s, 3H). HPLC purity >95%.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 7-(4-Methyl-1<i>H</i>-imidazol-1-yl)-2-{2-[3-(trifluoromethyl)phenoxy]ethyl}-3,4-dihydro-1<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6(2<i>H</i>)-dione (<b>48</b>)</h4><div class="NLM_p last">LCMS <i>m</i>/<i>z</i> 433.1 (M + 1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (br s, 1H), 8.00 (d, <i>J</i> = 7.9 Hz, 1H), 7.74 (s, 1H), 7.56–7.49 (m, 1H), 7.32–7.26 (m, 2H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 4.30 (t, <i>J</i> = 5.5 Hz, 2H), 4.28–4.23 (m, 2H), 3.91 (t, <i>J</i> = 5.3 Hz, 2H), 3.89–3.86 (m, 2H), 2.30 (s, 3H). HPLC purity >95%.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 7-(4-Methyl-1<i>H</i>-imidazol-1-yl)-2-{2-[4-(trifluoromethyl)phenoxy]ethyl}-3,4-dihydro-1<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6(2<i>H</i>)-dione (<b>49</b>)</h4><div class="NLM_p last">LCMS <i>m</i>/<i>z</i> 433.1 (M + 1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.43 (s, 1H), 8.05 (dd, <i>J</i> = 7.7, 2.0 Hz, 1H), 7.82 (s, 1H), 7.66 (d, <i>J</i> = 7.0 Hz, 2H), 7.12–7.20 (m, 3H), 4.24–4.34 (m, 4H), 3.85–3.94 (m, 4H), 2.33 (s, 3H). HPLC purity >95%.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-[2-(7-Fluoronaphthalen-1-yloxy)ethyl]-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-1<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6(2<i>H</i>)-dione (<b>52</b>)</h4><div class="NLM_p last">LCMS <i>m</i>/<i>z</i> 433.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (s, 1H), 7.79 (dd, <i>J</i> = 5.5, 9.0 Hz, 1H), 7.69 (dd, <i>J</i> = 2.5, 10.4 Hz, 1H), 7.46–7.38 (m, 2H), 7.32 (t, <i>J</i> = 7.9 Hz, 1H), 7.29–7.22 (m, 2H), 7.10 (s, 1H), 6.83 (d, <i>J</i> = 7.6 Hz, 1H), 4.42 (t, <i>J</i> = 4.8 Hz, 2H), 4.40–4.34 (m, 2H), 4.11 (t, <i>J</i> = 4.8 Hz, 2H), 4.00–3.94 (m, 2H), 2.26 (s, 3H). HPLC purity >95%.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(2-Bromoethoxy)-4-fluoro-2-(trifluoromethyl)benzene</h4><div class="NLM_p last">A mixture of 4-fluoro-2-(trifluoromethyl)phenol (1.05 g, 5.83 mmol), 2-bromoethanol (0.62 mL, 8.7 mmol), and triphenylphosphine (2.29 g, 8.73 mmol) in tetrahydrofuran (20 mL) was stirred for 5 min. Diisopropyl azodicarboxylate (94%, 1.84 mL, 8.71 mmol) was added dropwise over 20 min, and the reaction was stirred at room temperature for 16 h. Water (50 mL) was added, and the mixture was extracted with dichloromethane (2 × 75 mL). The combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification via chromatography on silica gel (gradient: 0% to 10% ethyl acetate in heptane) afforded the title compound as a white solid (600 mg, 36%). GCMS <i>m</i>/<i>z</i> 286. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.66 (dd, <i>J =</i> 6.6, 6.4 Hz, 2H), 4.35 (dd, <i>J =</i> 6.5, 6.4 Hz, 2H), 6.97 (br dd, <i>J =</i> 9.0, 4.1 Hz, 1H), 7.18–7.24 (m, 1H), 7.32 (br dd, <i>J =</i> 8.3, 3.2 Hz, 1H).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-({2-[4-Fluoro-2-(trifluoromethyl)phenoxy]ethyl}amino)ethanol</h4><div class="NLM_p last">A mixture of 1-(2-bromoethoxy)-4-fluoro-2-(trifluoromethyl)benzene (600 mg, 2.09 mmol) and 2-aminoethanol (2.20 mL, 52.4 mmol) was heated to 80 °C for 1.5 h. The reaction was allowed to cool to room temperature, diluted with ethyl acetate (75 mL), and washed with aqueous sodium hydroxide solution (1 N, 4 × 50 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure to provide the title compound as a white solid (550 mg, 99%). LCMS <i>m</i>/<i>z</i> 268.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.80 (br dd, <i>J =</i> 5.5, 5.4 Hz, 2H), 3.04 (dd, <i>J =</i> 5.4, 5.2 Hz, 2H), 3.68 (br dd, <i>J =</i> 5.6, 5.4 Hz, 2H), 4.20 (dd, <i>J =</i> 5.3, 5.3 Hz, 2H), 7.22 (br dd, <i>J =</i> 8.8, 4.2 Hz, 1H), 7.30–7.37 (m, 2H).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-{2-[4-Fluoro-2-(trifluoromethyl)phenoxy]ethyl}-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione (<b>50</b>)</h4><div class="NLM_p last">5-(4-Methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrobromide salt (<b>34</b>) (201 mg, 0.729 mmol) and 2-({2-[4-fluoro-2-(trifluoromethyl)phenoxy]ethyl}amino)ethanol (214 mg, 0.801 mmol) were combined in dichloromethane (15 mL) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.508 mL, 2.92 mmol), and the mixture was stirred for 5 min at room temperature. HATU (97%, 857 mg, 2.19 mmol) was added in one portion, and the reaction was stirred for an additional 16 h. Water (50 mL) was added, and the mixture was extracted with dichloromethane (3 × 50 mL). The combined organic layers were washed with saturated aqueous sodium bicarbonate solution (50 mL), water (50 mL), and saturated aqueous sodium chloride solution (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification was carried out twice by chromatography on silica gel (gradient 1: 0% to 20% methanol in dichloromethane; gradient 2: 0% to 70% [10% 2 N ammonia in methanol/90% ethyl acetate] in ethyl acetate) to afford the title compound as a white solid (268 mg, 82%). LCMS <i>m</i>/<i>z</i> 451.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.24 (d, <i>J =</i> 0.9 Hz, 3H), 3.90–3.95 (m, 2H), 4.01 (dd, <i>J =</i> 5.1, 5.1 Hz, 2H), 4.32–4.37 (m, 4H), 7.21–7.26 (m, 1H), 7.25 (d, <i>J =</i> 7.8 Hz, 1H), 7.30–7.32 (m, 1H), 7.32–7.39 (m, 2H), 7.76 (d, <i>J =</i> 7.8 Hz, 1H), 8.30 (d, <i>J =</i> 1.3 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.0, 157.3, 155.7, 155.3, 152.2, 138.3, 136.2, 134.3, 130.4, 127.5, 119.9, 119.7, 114.7, 113.8, 113.7, 108.4, 67.9, 47.9, 46.5, 40.1, 13.4. HPLC purity >95%.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-Bromoethoxy)-4-chloro-2-(trifluoromethyl)benzene</h4><div class="NLM_p last">Cesium carbonate (16.60 g, 50.95 mmol) was added to a solution of 4-chloro-2-(trifluoromethyl)phenol (5.00 g, 25.4 mmol) and 1,2-dibromoethane (23.90 g, 127.2 mmol) in acetonitrile (70 mL), and the reaction was heated to 70 °C for 16 h. The mixture was allowed to cool to room temperature, diluted with ethyl acetate, and washed with water. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification via chromatography on silica gel (gradient: 10% to 30% ethyl acetate in heptanes) afforded the title compound as a clear viscous oil (7.05 g, 91%). GCMS <i>m</i>/<i>z</i> 302 (M<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (d, <i>J</i> = 2.5 Hz, 1H), 7.46 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 1H), 4.36 (t, <i>J</i> = 6.6 Hz, 2H), 3.66 (t, <i>J</i> = 6.6 Hz, 2H).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-({2-[4-Chloro-2-(trifluoromethyl)phenoxy]ethyl}amino)ethanol</h4><div class="NLM_p last">A solution of 1-(2-bromoethoxy)-4-chloro-2-(trifluoromethyl)benzene (7.05 g, 23.2 mmol) in 2-aminoethanol (14.20 g, 232.5 mmol) was heated to 80 °C for 4 h. The reaction mixture was allowed to cool to room temperature, diluted with dichloromethane, and washed with aqueous sodium hydroxide solution (0.5 N) and water. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure to provide the title compound as a white solid (6.31 g, 96%). LCMS <i>m</i>/<i>z</i> 284.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (d, <i>J</i> = 2.7 Hz, 1H), 7.45 (dd, <i>J</i> = 2.6, 8.9 Hz, 1H), 6.95 (d, <i>J</i> = 8.8 Hz, 1H), 4.15 (t, <i>J</i> = 5.0 Hz, 2H), 3.69–3.63 (m, 2H), 3.07 (t, <i>J</i> = 5.0 Hz, 2H), 2.89–2.84 (m, 2H).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-{2-[4-Chloro-2-(trifluoromethyl)phenoxy]ethyl}-7-(4-methyl-1<i>H</i>-imidazol-1-yl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-a]pyrazine-1,6-dione (<b>51</b>)</h4><div class="NLM_p last">HATU (15.7 g, 40.5 mmol) was added to a solution of 5-(4-methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrobromide salt (<b>34</b>) (4.85 g, 16.2 mmol), 2-({2-[4-chloro-2-(trifluoromethyl)phenoxy]ethyl}amino)ethanol (5.04 g, 17.2 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (8.62 mL, 2.92 mmol) in dichloromethane (100 mL). The reaction was stirred at room temperature for 16 h, whereupon it was diluted with dichloromethane and washed with a saturated aqueous solution of sodium bicarbonate and with water. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification was carried out twice by chromatography on silica gel (gradient: 0% to 30% methanol in dichloromethane) to afford the title compound as a white solid (4.01 g, 53%). LCMS <i>m</i>/<i>z</i> 467.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.24 (d, <i>J =</i> 0.9 Hz, 3H), 3.90–3.94 (m, 2H), 4.01 (dd, <i>J =</i> 5.1, 5.0 Hz, 2H), 4.32–4.39 (m, 4H), 7.21–7.27 (m, 2H), 7.30–7.32 (m, 1H), 7.56–7.60 (m, 2H), 7.76 (d, <i>J =</i> 7.7 Hz, 1H), 8.30 (d, <i>J =</i> 1.3 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.1, 155.7, 154.6, 138.2, 136.1, 133.3, 130.3, 127.5, 127.4, 126.1, 123.9, 121.8, 114.7, 113.7, 108.4, 67.7, 47.9, 46.5, 40.1, 13.3. HRMS: calcd for C<sub>21</sub>H<sub>19</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 467.1098, found =467.1091. HPLC purity >95%.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> [3-(2-Bromoethoxy)phenyl][4-(pent-4-ynyloxy)phenyl]methanone</h4><div class="NLM_p last">Dibromoethane (0.60 mL, 7.0 mmol) and cesium carbonate (456 mg, 1.40 mmol) were added to a solution of (3-hydroxyphenyl)[4-(pent-4-ynyloxy)phenyl]methanone (196 mg, 0.70 mmol) in acetonitrile (15 mL). The reaction mixture was heated to 70 °C and was stirred overnight, whereupon it was allowed to cool to room temperature. The reaction mixture was then poured into dichloromethane (25 mL), washed with water (2 × 20 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 10% to 30% ethyl acetate in heptane) to afford the title compound (271 mg, 54%). LCMS <i>m</i>/<i>z</i> 387.2 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 7.29–7.37 (m, 3H), 7.10 (d, <i>J</i> = 8 Hz, 1H), 6.94 (d, <i>J</i> = 8.4 Hz, 2H), 4.32 (t, <i>J</i> = 6.2 Hz, 2H), 4.14 (t, <i>J</i> = 6.2 Hz, 2H), 3.63 (t, <i>J</i> = 6.2 Hz, 2H), 2.40 (td, <i>J</i> = 6.9, 6.9 Hz, 2H), 2.01 (m, 2H), 1.95 (m, 1H).</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> {3-[2-(2-Hydroxyethylamino)ethoxy]phenyl}[4-(pent-4-ynyloxy)phenyl]methanone</h4><div class="NLM_p last">A solution of [3-(2-bromoethoxy)phenyl][4-(pent-4-ynyloxy)phenyl]methanone (147 mg, 0.38 mmol) in ethanolamine (0.23 mL, 3.8 mmol) was heated to 80 °C for 3 h. The reaction was allowed to cool to room temperature and was diluted with dichloromethane (15 mL). The mixture was washed with 0.5 N hydrochloric acid (2 × 15 mL), water (15 mL), and brine (10 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure to provide the title compound (87 mg, 62%) as a white solid. LCMS <i>m</i>/<i>z</i> 368.3 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.79 (d, <i>J</i> = 8.8 Hz, 2H), 7.34 (m, 2H), 7.28 (m, 1H), 7.08 (d, <i>J</i> = 8.4 Hz, 1H), 6.93 (d, <i>J</i> = 7.2 Hz, 2H), 4.11 (m, 4H), 3.64 (m, 2H), 3.02 (m, 2H), 2.83 (m, 2H), 2.41 (m, 2H), 2.00 (m, 3H).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 7-(4-Methyl-1<i>H</i>-imidazol-1-yl)-2-(2-{3-[4-(pent-4-yn-1-yloxy)benzoyl]phenoxy}ethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-a]pyrazine-1,6-dione (<b>53</b>)</h4><div class="NLM_p last">HATU (212 mg, 0.558 mmol) was added to a solution of 5-(4-methyl-1<i>H</i>-imidazol-1-yl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid, hydrobromide salt (<b>34</b>) (60 mg, 0.22 mmol), {3-[2-(2-hydroxyethylamino)ethoxy]phenyl}[4-(pent-4-ynyloxy)phenyl]methanone (87 mg, 0.24 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.16 mL, 0.87 mmol) in dichloromethane (2 mL), and the reaction was stirred for 19 h at room temperature. The mixture was diluted with dichloromethane (15 mL) and washed with a saturated aqueous solution of sodium bicarbonate (15 mL) and with water (15 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting residue was purified by chromatography on silica gel (gradient: 0% to 40% methanol in ethyl acetate) to provide the title compound (76 mg, 63%) as a solid. LCMS <i>m</i>/<i>z</i> 551.2 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.99–2.09 (m, 3H), 2.29 (s, 3H), 2.42–2.48 (m, 2H), 3.91–3.96 (m, 2H), 3.98–4.03 (m, 2H), 4.15–4.20 (m, 2H), 4.30–4.34 (m, 2H), 4.36–4.42 (m, 2H), 6.95–7.00 (m, 2H), 7.07–7.12 (m, 1H), 7.14 (br s, 1H), 7.26–7.47 (m, 5 H, assumed; partially obscured by solvent peak), 7.79–7.83 (m, 2H), 8.23 (br s, 1H). HPLC purity >95%.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/jm401782h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The following experimental information is provided: cell-based Aβ production assay, determination of Aβ lowering activity in vivo, and photoaffinity labeling of HeLa membranes with clickable GSMs followed by Western blot analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401782h/suppl_file/jm401782h_si_001.pdf">jm401782h_si_001.pdf (130.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401782h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Pettersson</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e4a98596908d8acab4819090819697978b8aa494828d9e8196ca878b89"><span class="__cf_email__" data-cfemail="c588a4b7b1acabeb95a0b1b1a0b7b6b6aaab85b5a3acbfa0b7eba6aaa8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas S. Johnson</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chakrapani Subramanyam</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly R. Bales</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher W. am Ende</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin A. Fish</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael E. Green</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory W. Kauffman</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick B. Mullins</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thayalan Navaratnam</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Subas M. Sakya</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cory M. Stiff</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tuan P. Tran</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longfei Xie</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liming Zhang</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie R. Pustilnik</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beth C. Vetelino</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen M. Wood</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolay Pozdnyakov</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick R. Verhoest</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. O’Donnell</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3334e3893-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Stacey Becker, Emily Miller, Michael Marconi, Emily Sylvain, and Karin Wallace for their contributions to the in vivo studies. We also thank Katherine Brighty for editing the manuscript, and the Pfizer ADME technology group for generating the in vitro pharmacokinetic data to support the SAR efforts.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β peptide</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">AB</td><td class="NLM_def"><p class="first last">apical to basolateral</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">basolateral to apical</p></td></tr><tr><td class="NLM_term">CL<sub>int,app</sub></td><td class="NLM_def"><p class="first last">apparent intrinsic clearance</p></td></tr><tr><td class="NLM_term">CNS MPO</td><td class="NLM_def"><p class="first last">central nervous system multiparameter optimization</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">γ-secretase modulator</p></td></tr><tr><td class="NLM_term">HHEP</td><td class="NLM_def"><p class="first last">human hepatocytes</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein (P-glycoprotein, P-gp)</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">presenilin</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Thies, W.; Bleiler, L.</span> 2013 <span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.jalz.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=23507120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3svns1Cjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=208-245&author=W.+Thies&author=L.+Bleiler&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">2013 Alzheimer's disease facts and figures</span></div><div class="casAuthors">Thies William; Bleiler Laura</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general.  It also explores the roles and unique challenges of long-distance caregivers, as well as interventions that target those challenges.  An estimated 5.2 million Americans have AD.  Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million comprise the older onset AD population.  Throughout the coming decades, the baby boom generation is projected to add about 10 million to the total number of people in the United States with AD.  Today, someone in America develops AD every 68 seconds.  By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million.  AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older.  Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%.  The number of deaths from AD as determined by official death certificates (83,494 in 2010) likely underrepresents the number of AD-related deaths in the United States.  A projected 450,000 older Americans with AD will die in 2013, and a large proportion will die as a result of complications of AD.  In 2012, more than 15 million family members and other unpaid caregivers provided an estimated 17.5 billion hours of care to people with AD and other dementias, a contribution valued at more than $216 billion.  Medicare payments for services to beneficiaries age 65 years and older with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great.  Total payments in 2013 for health care, long-term care, and hospice services for people age 65 years and older with dementia are expected to be $203 billion (not including the contributions of unpaid caregivers).  An estimated 2.3 million caregivers of people with AD and other dementias live at least 1 hour away from the care recipient.  These "long-distance caregivers" face unique challenges, including difficulty in assessing the care recipient's true health condition and needs, high rates of family disagreement regarding caregiving decisions, and high out-of-pocket expenses for costs related to caregiving.  Out-of-pocket costs for long-distance caregivers are almost twice as high as for local caregivers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbeVACuiHSctj_Vg2vObihfW6udTcc2eYjANERFKec-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svns1Cjsw%253D%253D&md5=50fc6e9496936a518432bc7901743fb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DThies%26aufirst%3DW.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D208%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bertram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">The genetics of Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Mol. Biol. Transl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2FB978-0-12-385883-2.00008-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Klsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=79-100&author=L.+Bertramauthor=R.+E.+Tanzi&title=The+genetics+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The genetics of Alzheimer's disease</span></div><div class="casAuthors">Bertram, Lars; Tanzi, Rudolph E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">Molecular Biology of Neurodegenerative Diseases</span>),
    <span class="NLM_cas:pages">79-100</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic factors play a major role in detg. a person's risk to develop Alzheimer's disease (AD).  Rare mutations transmitted in a Mendelian fashion within affected families, for example, APP, PSEN1, and PSEN2, cause AD.  In the absence of mutations in these genes, disease risk is largely detd. by common polymorphisms that, in concert with each other and nongenetic risk factors, modestly impact risk for AD (e.g., the ε4-allele in APOE).  Recent genome-wide screening approaches have revealed several addnl. AD susceptibility loci and more are likely to be discovered over the coming years.  In this chapter, we review the current state of AD genetics research with a particular focus on loci that now can be considered established disease genes.  In addn. to reviewing the potential pathogenic relevance of these genes, we provide an outlook into the future of AD genetics research based on recent advances in high-throughput sequencing technologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoiWkH-GuZ7Vg90H21EOLACvtfcHk0lhN3Bn89FwY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Klsr3P&md5=a7d05046fddae89bb788985e3c04ba99</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385883-2.00008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385883-2.00008-4%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520genetics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2012%26volume%3D107%26spage%3D79%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers - a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers+-+a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0liFadt3ny8R6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%2520-%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0liFadt3ny8R6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bateman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMattos, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span> </span><span class="NLM_article-title">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1002%2Fana.21623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=19360898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=48-54&author=R.+J.+Batemanauthor=E.+R.+Siemersauthor=K.+G.+Mawuenyegaauthor=G.+Wenauthor=K.+R.+Browningauthor=W.+C.+Sigurdsonauthor=K.+E.+Yarasheskiauthor=S.+W.+Friedrichauthor=R.+B.+DeMattosauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=A+%CE%B3-secretase+inhibitor+decreases+amyloid-%CE%B2+production+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span></div><div class="casAuthors">Bateman, Randall J.; Siemers, Eric R.; Mawuenyega, Kwasi G.; Wen, Guolin; Browning, Karen R.; Sigurdson, Wendy C.; Yarasheski, Kevin E.; Friedrich, Stuart W.; De Mattos, Ronald B.; May, Patrick C.; Paul, Steven M.; Holtzman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Accumulation of amyloid-β (Aβ) by overprodn. or underclearance in the central nervous system (CNS) is hypothesized to be a necessary event in the pathogenesis of Alzheimer's disease.  However, previously, there has not been a method to det. drug effects on Aβ prodn. or clearance in the human CNS.  The objective of this study was to det. the effects of a γ-secretase inhibitor on the prodn. of Aβ in the human CNS.  Methods: We utilized a recently developed method of stable-isotope labeling combined with cerebrospinal fluid sampling to directly measure Aβ prodn. during treatment of a γ-secretase inhibitor, LY450139.  We assessed whether this drug could decrease CNS Aβ prodn. in healthy men (age range, 21-50 years) at single oral doses of 100, 140, or 280mg (n = 5 per group).  Results: LY450139 significantly decreased the prodn. of CNS Aβ in a dose-dependent fashion, with inhibition of Aβ generation of 47, 52, and 84% over a 12-h period with doses of 100, 140, and 280mg, resp.  There was no difference in Aβ clearance.  Interpretation: Stable isotope labeling of CNS proteins can be utilized to assess the effects of drugs on the prodn. and clearance rates of proteins targeted as potential disease-modifying treatments for Alzheimer's disease and other CNS disorders.  Results from this approach can assist in making decisions about drug dosing and frequency in the design of larger and longer clin. trials for diseases such as Alzheimer's disease, and may accelerate effective drug validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcrw_WczwGLVg90H21EOLACvtfcHk0liFadt3ny8R6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM&md5=8f950c978d6fc83d0436ab1138227dd6</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fana.21623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21623%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DBrowning%26aufirst%3DK.%2BR.%26aulast%3DSigurdson%26aufirst%3DW.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DFriedrich%26aufirst%3DS.%2BW.%26aulast%3DDeMattos%26aufirst%3DR.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DA%2520%25CE%25B3-secretase%2520inhibitor%2520decreases%2520amyloid-%25CE%25B2%2520production%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span> </span><span class="NLM_article-title">Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1007%2Fs40261-012-0006-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=23018285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=761-769&author=G.+Tongauthor=L.+Castanedaauthor=J.-S.+Wangauthor=O.+Sverdlovauthor=S.-P.+Huangauthor=R.+Slemmonauthor=H.+Guauthor=O.+Wongauthor=H.+Liauthor=R.+M.+Bermanauthor=C.+Smithauthor=C.+Albrightauthor=R.+C.+Dockens&title=Effects+of+single+doses+of+avagacestat+%28BMS-708163%29+on+cerebrospinal+fluid+A%CE%B2+levels+in+healthy+young+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men</span></div><div class="casAuthors">Tong, Gary; Castaneda, Lorna; Wang, Jun-Sheng; Sverdlov, Oleksandr; Huang, Shu-Pang; Slemmon, Randy; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles; Dockens, Randy C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">Background: The concn. of amyloid β (Aβ) peptides in cerebrospinal fluid (CSF) is a biomarker for Alzheimer's disease (AD) pathol., and has been used to evaluate the effectiveness of γ-secretase inhibition.  Avagacestat is a selective γ-secretase inhibitor in development for the treatment of AD.  The primary objective of this study was to assess the effects of single oral doses of avagacestat on the CSF Aβ concns. in healthy male subjects.  Secondary objectives included single-dose pharmacokinetics in CSF and plasma, safety and tolerability.  Methods: This was a double-blind, placebo-controlled, randomized, single-dose study.  Healthy male subjects were assigned to one of three sequential avagacestat dose panels (50, 200 and 400 mg) or placebo as single oral doses.  Results: 34 subjects were enrolled.  Administration of a single dose of 200 or 400 mg of avagacestat resulted in a marked decrease in CSF Aβ1-38, Aβ1-40 and Aβ1-42 concns. vs placebo; with smaller decreases obsd. in the 50 mg dose group.  Avagacestat was quickly absorbed into the systemic circulation, with a mean time to reach max. plasma concn. (tmax) of approx. 1-2 h, and a CSF tmax of approx. 3 h.  Adverse events were uncommon and occurred with similar frequency in the placebo and avagacestat groups.  Conclusion: Avagacestat was safe, well tolerated, and resulted in a notable decrease in CSF AP concns., suggestive of γ-secretase inhibition. The results warrant further clin. study in patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLVITHcfMxbVg90H21EOLACvtfcHk0ljjgabaldQKRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFemsQ%253D%253D&md5=a91183f5c4d6df8417766c81a8d85820</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs40261-012-0006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40261-012-0006-4%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DG.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26atitle%3DEffects%2520of%2520single%2520doses%2520of%2520avagacestat%2520%2528BMS-708163%2529%2520on%2520cerebrospinal%2520fluid%2520A%25CE%25B2%2520levels%2520in%2520healthy%2520young%2520men%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2012%26volume%3D32%26spage%3D761%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Therapeutic intervention for Alzheimer’s disease with γ-secretase inhibitors: Still a viable option?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=325-341&author=B.+P.+Imbimboauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=G.+D%E2%80%99Onofrioauthor=G.+Logroscinoauthor=D.+Seripaauthor=A.+Pilotto&title=Therapeutic+intervention+for+Alzheimer%E2%80%99s+disease+with+%CE%B3-secretase+inhibitors%3A+Still+a+viable+option%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DTherapeutic%2520intervention%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520%25CE%25B3-secretase%2520inhibitors%253A%2520Still%2520a%2520viable%2520option%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D325%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sambamurti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnwell, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappolla, M. A.</span><span> </span><span class="NLM_article-title">Targets for AD treatment: conflicting messages from γ-secretase inhibitors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1471-4159.2011.07213.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21320126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Oju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=359-374&author=K.+Sambamurtiauthor=N.+H.+Greigauthor=T.+Utsukiauthor=E.+L.+Barnwellauthor=E.+Sharmaauthor=C.+Mazellauthor=N.+R.+Bhatauthor=M.+S.+Kindyauthor=D.+K.+Lahiriauthor=M.+A.+Pappolla&title=Targets+for+AD+treatment%3A+conflicting+messages+from+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Targets for AD treatment: conflicting messages from γ-secretase inhibitors</span></div><div class="casAuthors">Sambamurti, Kumar; Greig, Nigel H.; Utsuki, Tadanobu; Barnwell, Eliza L.; Sharma, Ekta; Mazell, Cheryl; Bhat, Narayan R.; Kindy, Mark S.; Lahiri, Debomoy K.; Pappolla, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Current evidence suggests that Alzheimer's disease (AD) is a multi-factorial disease that starts with accumulation of multiple proteins.  We have previously proposed that inhibition of γ-secretase may impair membrane recycling causing neurodegeneration starting at synapses.  We also proposed familal AD mutations increase Aβ42 by inhibiting γ-secretase.  Herein, we discuss the failure of Eli Lilly's γ-secretase inhibitor, semagacestat, in clin. trials in the light of our hypothesis, which extends the problem beyond toxicity of Aβ aggregates.  We elaborate that γ-secretase inhibitors lead to accumulation of amyloid precursor protein C-terminal fragments that can later be processed by γ-secretase to yields bursts of Aβ to facilitate aggregation.  Although we do not exclude a role for toxic Aβ aggregates, inhibition of γ-secretase can affect numerous substrates other than amyloid precursor protein to affect multiple pathways and the combined accumulation of multiple peptides in the membrane may impair its function and turnover.  Taken together, protein processing and turnover pathways play an important role in maintaining cellular homeostasis and unless we clearly see consistent disease-related increase in their levels or activity, we need to focus on preserving their function rather than inhibiting them for treatment of AD and similar diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINYQOUvRA17Vg90H21EOLACvtfcHk0ljjgabaldQKRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Oju7s%253D&md5=e9b270917a0944f35ea27aed153e2a39</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07213.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07213.x%26sid%3Dliteratum%253Aachs%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DBarnwell%26aufirst%3DE.%2BL.%26aulast%3DSharma%26aufirst%3DE.%26aulast%3DMazell%26aufirst%3DC.%26aulast%3DBhat%26aufirst%3DN.%2BR.%26aulast%3DKindy%26aufirst%3DM.%2BS.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26aulast%3DPappolla%26aufirst%3DM.%2BA.%26atitle%3DTargets%2520for%2520AD%2520treatment%253A%2520conflicting%2520messages%2520from%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D117%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schor, N. F.</span><span> </span><span class="NLM_article-title">What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1002%2Fana.22365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21387368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2lsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=237-239&author=N.+F.+Schor&title=What+the+halted+phase+III+%CE%B3-secretase+inhibitor+trial+may+%28or+may+not%29+be+telling+us"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us</span></div><div class="casAuthors">Schor, Nina F.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-239</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The aborted trial of semagacestat has led some to invoke unanticipated effects of γ-secretase inhibition on formation of amyloid β.  However, the many substrates for γ-secretases and the varied biol. effects of each of the resultant cleavage products make ascribing causality much more complex than that.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ99wd6qY3YrVg90H21EOLACvtfcHk0lgQT64wQTE3mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2lsL8%253D&md5=92fd473a4261170f794eb54a16e4e99a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fana.22365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22365%26sid%3Dliteratum%253Aachs%26aulast%3DSchor%26aufirst%3DN.%2BF.%26atitle%3DWhat%2520the%2520halted%2520phase%2520III%2520%25CE%25B3-secretase%2520inhibitor%2520trial%2520may%2520%2528or%2520may%2520not%2529%2520be%2520telling%2520us%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiovitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1430</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1001%2Farchneurol.2012.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22892585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=1430-1440&author=V.+Coricauthor=C.+H.+van+Dyckauthor=S.+Sallowayauthor=N.+Andreasenauthor=M.+Brodyauthor=R.+W.+Richterauthor=H.+Soininenauthor=S.+Theinauthor=T.+Shiovitzauthor=G.+Pilcherauthor=S.+Colbyauthor=L.+Rollinauthor=R.+Dockensauthor=C.+Pachaiauthor=E.+Porteliusauthor=U.+Andreassonauthor=K.+Blennowauthor=H.+Soaresauthor=C.+Albrightauthor=H.+H.+Feldmanauthor=R.+M.+Berman&title=Safety+and+tolerability+of+the+%CE%B3-secretase+inhibitor+avagacestat+in+a+phase+2+study+of+mild+to+moderate+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span></div><div class="casAuthors">Coric Vladimir; van Dyck Christopher H; Salloway Stephen; Andreasen Niels; Brody Mark; Richter Ralph W; Soininen Hilkka; Thein Stephen; Shiovitz Thomas; Pilcher Gary; Colby Susan; Rollin Linda; Dockens Randy; Pachai Chahin; Portelius Erik; Andreasson Ulf; Blennow Kaj; Soares Holly; Albright Charles; Feldman Howard H; Berman Robert M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1430-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the safety, tolerability, and pharmacokinetic and pharmacodynamic effects of the -secretase inhibitor avagacestat in patients with mild to moderate Alzheimer disease (AD).  DESIGN:  Randomized, double-blind, placebo-controlled,24-week phase 2 study.  SETTING:  Global, multicenter trial.  PATIENTS:  A total of 209 outpatients with mild to moderate AD were randomized into the double-blind treatment phase.  The median age of the patients was 75 years,58.9% were APOE ε4 carriers, and baseline measures of disease severity were similar among groups.  INTERVENTION:  Avagacestat, 25, 50, 100, or 125 mg daily,or placebo administered orally daily.  MAIN OUTCOME MEASURES:  Safety and tolerability of avagacestat.  RESULTS:  Discontinuation rates for the 25-mg and 50-mg doses of avagacestat were comparable with placebo but were higher in the 100-mg and 125-mg dose groups.Trends for worsening cognition, as measured by change from baseline Alzheimer Disease Assessment Scale cognitive subscale score, were observed in the 100-mg and125-mg dose groups.  Treatment-emergent serious adverse events were similar across placebo and treatment groups.  The most common reason for discontinuation was adverse events, predominantly gastrointestinal anddermatologic.  Other adverse events occurring more frequentlyin patients undergoing treatment included reversibleglycosuria (without associated serum glucose changes), nonmelanoma skin cancer, and asymptomaticmagnetic resonance imaging findings.  Exploratory cerebrospinal fluid amyloid isoforms and tau biomarker analysis demonstrated dose-dependent but not statistically significant reductions in a small subset of patients.  CONCLUSIONS:  Avagacestat dosed at 25 and 50 mg daily was relatively well tolerated and had low discontinuation rates.  The 100-mg and 125-mg dose arms were poorly tolerated with trends for cognitive worsening.  Exploratory cerebrospinal fluid biomarker substudies provide preliminary support for -secretase target engagement,but additional studies are warranted to better characterize pharmacodynamic effects at the 25- and 50-mg doses.This study establishes an acceptable safety and tolerability dose range for future avagacestat studies in AD.  TRIAL REGISTRATION:  clinicaltrials.gov Identifier: NCT00810147</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuwXa-F7HH9okFb3mqPUYDfW6udTcc2eb8bNx9Sq8iHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D&md5=b0935144b0569050bd45f25029694282</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2012.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2012.2194%26sid%3Dliteratum%253Aachs%26aulast%3DCoric%26aufirst%3DV.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DBrody%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DR.%2BW.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DThein%26aufirst%3DS.%26aulast%3DShiovitz%26aufirst%3DT.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DColby%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DL.%26aulast%3DDockens%26aufirst%3DR.%26aulast%3DPachai%26aufirst%3DC.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520avagacestat%2520in%2520a%2520phase%25202%2520study%2520of%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2012%26volume%3D69%26spage%3D1430%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Haapasalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span> </span><span class="NLM_article-title">The many substrates of presenilin/γ-secretase</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.3233%2FJAD-2011-101065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21335653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3-28&author=A.+Haapasaloauthor=D.+M.+Kovacs&title=The+many+substrates+of+presenilin%2F%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Substrates of Presenilin/γ-Secretase</span></div><div class="casAuthors">Haapasalo, Annakaisa; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The Alzheimer's disease (AD)-assocd. amyloid-β protein precursor (AβPP) is cleaved by α-, β-, and presenilin (PS)/γ-secretases through sequential regulated proteolysis.  These proteolytic events control the generation of the pathogenic amyloid-β (Aβ) peptide, which excessively accumulates in the brains of individuals afflicted by AD.  A growing no. of addnl. proteins cleaved by PS/γ-secretase continue to be discovered.  Similarly to AβPP, most of these proteins are type-I transmembrane proteins involved in vital signaling functions regulating cell fate, adhesion, migration, neurite outgrowth, or synaptogenesis.  All the identified proteins share common structural features, which are typical for their proteolysis.  The consequences of the PS/γ-secretase-mediated cleavage on the function of many of these proteins are largely unknown.  Here, we review the current literature on the proteolytic processing mediated by the versatile PS/γ-secretase complex.  We begin by discussing the steps of AβPP processing and PS/γ-secretase complex compn. and localization, which give clues to how and where the processing of other PS/γ-secretase substrates may take place.  Then we summarize the typical features of PS/γ-secretase-mediated protein processing.  Finally, we recapitulate the current knowledge on the possible physiol. function of PS/γ-secretase-mediated cleavage of specific substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphYizFVw4_A7Vg90H21EOLACvtfcHk0lgQT64wQTE3mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D&md5=22ce56939b97019e5c130556f9db7d5f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-101065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-101065%26sid%3Dliteratum%253Aachs%26aulast%3DHaapasalo%26aufirst%3DA.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DThe%2520many%2520substrates%2520of%2520presenilin%252F%25CE%25B3-secretase%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D25%26spage%3D3%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+%CE%B3-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0lgQT64wQTE3mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2F35102591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=11700559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+A%CE%B242+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span></div><div class="casAuthors">Weggen, Sascha; Eriksen, Jason L.; Das, Pritam; Sagl, Sarah A.; Wang, Rong; Pletrzik, Claus U.; Findlay, Kirk A.; Smith, Tawnya E.; Murphy, Michael P.; Bulter, Thomas; Kang, David E.; Marquez-Steriling, Numa; Golde, Todd E.; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epidemiol. studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs).  It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved.  Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulfide preferentially decrease the highly amyloidogenic Aβ42 peptide (the 42-residue isoform of the amyloid-β peptide) produced from a variety of cultured cells by as much as 80%.  This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacol. target of NSAIDs.  Furthermore, short-term administration of ibuprofen to mice that produce mutant β-amyloid precursor protein (APP) lowered their brain levels of Aβ42.  In cultured cells, the decrease in Aβ42 secretion was accompanied by an increase in the Aβ(1-38) isoform, indicating that NSAIDs subtly alter γ-secretase activity without significantly perturbing other APP processing pathways or Notch cleavage.  Our findings suggest that NSAIDs directly affect amyloid pathol. in the brain by reducing Aβ42 peptide levels independently of COX activity and that this Aβ42-lowering activity could be optimized to selectively target the pathogenic Aβ42 species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOE6e2axj77Vg90H21EOLACvtfcHk0liw-OOhzCMoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D&md5=134200e7533409c6f6ad5092f680be70</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520A%25CE%25B242%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+%CE%B3-secretase+and+lower+A%CE%B242+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520%25CE%25B3-secretase%2520and%2520lower%2520A%25CE%25B242%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Aβ42-Lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">30748</span><span class="NLM_x">–</span> <span class="NLM_lpage">30754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30748-30754&author=S.+Weggenauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=C.+U.+Pietrzikauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A%CE%B242-Lowering+nonsteroidal+anti-inflammatory+drugs+preserve+intramembrane+cleavage+of+the+amyloid+precursor+protein+%28APP%29+and+ErbB-4+receptor+and+signaling+through+the+APP+intracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%25CE%25B242-Lowering%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520preserve%2520intramembrane%2520cleavage%2520of%2520the%2520amyloid%2520precursor%2520protein%2520%2528APP%2529%2520and%2520ErbB-4%2520receptor%2520and%2520signaling%2520through%2520the%2520APP%2520intracellular%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D30748%26epage%3D30754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">31831</span><span class="NLM_x">–</span> <span class="NLM_lpage">31837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=31831-31837&author=S.+Weggenauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=C.+U.+Pietrzikauthor=V.+Ozolsauthor=A.+Fauqauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=Evidence+that+nonsteroidal+anti-inflammatory+drugs+decrease+amyloid+%CE%B242+production+by+direct+modulation+of+%CE%B3-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DOzols%26aufirst%3DV.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DEvidence%2520that%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520decrease%2520amyloid%2520%25CE%25B242%2520production%2520by%2520direct%2520modulation%2520of%2520%25CE%25B3-secretase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D31831%26epage%3D31837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators for the treatment of Alzheimer’s disease: a review focusing on patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+a+review+focusing+on+patents+from+2010+to+2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0ljlIwWNcm4OiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520focusing%2520on%2520patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0ljlIwWNcm4OiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span> </span><span class="NLM_article-title">Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2009&pages=2557-2564&author=R.+C.+Greenauthor=L.+S.+Schneiderauthor=D.+A.+Amatoauthor=A.+P.+Beelenauthor=G.+Wilcockauthor=E.+A.+Swabbauthor=K.+H.+Zavitz&title=Effect+of+tarenflurbil+on+cognitive+decline+and+activities+of+daily+living+in+patients+with+mild+Alzheimer+disease%3A+A+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DAmato%26aufirst%3DD.%2BA.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DWilcock%26aufirst%3DG.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26atitle%3DEffect%2520of%2520tarenflurbil%2520on%2520cognitive%2520decline%2520and%2520activities%2520of%2520daily%2520living%2520in%2520patients%2520with%2520mild%2520Alzheimer%2520disease%253A%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2009%26volume%3D302%26spage%3D2557%26epage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Aβ38 and Aβ42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and γ-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+P%C3%A9rez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+A%CE%B238+and+A%CE%B242+is+independently+and+differentially+affected+by+familial+Alzheimer+disease-associated+presenilin+mutations+and+%CE%B3-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520A%25CE%25B238%2520and%2520A%25CE%25B242%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520familial%2520Alzheimer%2520disease-associated%2520presenilin%2520mutations%2520and%2520%25CE%25B3-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ohki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4815</span><span class="NLM_x">–</span> <span class="NLM_lpage">4824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4815-4824&author=Y.+Ohkiauthor=T.+Higoauthor=K.+Uemuraauthor=N.+Shimadaauthor=S.+Osawaauthor=O.+Berezovskaauthor=S.+Yokoshimaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Phenylpiperidine-type+%CE%B3-secretase+modulators+target+the+transmembrane+domain+1+of+presenilin+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhki%26aufirst%3DY.%26aulast%3DHigo%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DN.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DPhenylpiperidine-type%2520%25CE%25B3-secretase%2520modulators%2520target%2520the%2520transmembrane%2520domain%25201%2520of%2520presenilin%25201%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4815%26epage%3D4824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Piperidine acetic acid based γ-secretase modulators directly bind to presenilin-1</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200098p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=705-710&author=C.+J.+Crumpauthor=B.+A.+Fishauthor=S.+V.+Castroauthor=D.-M.+Chauauthor=N.+Gertsikauthor=K.+Ahnauthor=C.+Stiffauthor=N.+Pozdnyakovauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Piperidine+acetic+acid+based+%CE%B3-secretase+modulators+directly+bind+to+presenilin-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1</span></div><div class="casAuthors">Crump, Christina J.; Fish, Benjamin A.; Castro, Suita V.; Chau, De-Ming; Gertsik, Natalya; Ahn, Kwangwook; Stiff, Cory; Pozdnyakov, Nikolay; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis.  γ-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of Aβ42.  However, the binding partner of acid based GSMs was unresolved until now.  We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the γ-secretase complex.  Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the γ-secretase complex leading to the obsd. modulation of γ-secretase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLOY1hkibKrVg90H21EOLACvtfcHk0lhsvgnGxtjDJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM&md5=6129b8b4d150647165a04d2dd40e9ba9</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Fcn200098p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200098p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DPiperidine%2520acetic%2520acid%2520based%2520%25CE%25B3-secretase%2520modulators%2520directly%2520bind%2520to%2520presenilin-1%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D705%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator - pharmacology</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&issue=Suppl&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator+-+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator%2520-%2520pharmacology%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26issue%3DSuppl%26spage%3DS242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=20634579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3cfitlahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1005-1012&author=E.+Porteliusauthor=B.+Van+Broeckauthor=U.+Andreassonauthor=M.+K.+Gustavssonauthor=M.+Merckenauthor=H.+Zetterbergauthor=H.+Borghysauthor=K.+Blennow&title=Acute+effect+on+the+A%CE%B2+isoform+pattern+in+CSF+in+response+to+%CE%B3-secretase+modulator+and+inhibitor+treatment+in+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs</span></div><div class="casAuthors">Portelius Erik; Van Broeck Bianca; Andreasson Ulf; Gustavsson Mikael K; Mercken Marc; Zetterberg Henrik; Borghys Herman; Blennow Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1005-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is associated with deposition of amyloid-β (Aβ) in the brain, which is reflected by low concentration of the Aβ(1-42) peptide in the cerebrospinal fluid (CSF).  The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.  Less is known about the potent γ-secretase modulator E2012.  Using targeted proteomics techniques, we recently identified several shorter Aβ isoforms in CSF, such as Aβ(1-16), which is produced by a novel pathway.  In a Phase II clinical trial on AD patients, Aβ(1-14), Aβ(1-15) and Aβ(1-16) increased several-fold during γ-secretase inhibitor treatment.  In the present study, 9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle with a dosing interval of 1 week.  The CSF Aβ isoform pattern was analyzed by immunoprecipitation combined with MALDI-TOF mass spectrometry.  We show here that Aβ(1-15) and Aβ(1-16) increase while Aβ(1-34) decreases in response to treatment with the γ-secretase inhibitor LY450139, which is in agreement with previous studies.  The isoform Aβ(1-37) was significantly increased in a dose-dependent manner in response to treatment with E2012, while Aβ(1-39), Aβ(1-40) and A(1-42) decreased.  The data presented suggests that the γ-secretase modulator E-2012 alters the cleavage site preference of γ-secretase.  The increase in Aβ(1-37) may inhibit Aβ(1-42) oligomerization and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUARWsTeA6I0BuFdjgVNKSfW6udTcc2ebTX2K3_-O3Grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfitlahug%253D%253D&md5=e7188ea5c1fa9ddeff264b5ca4114742</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DGustavsson%26aufirst%3DM.%2BK.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DAcute%2520effect%2520on%2520the%2520A%25CE%25B2%2520isoform%2520pattern%2520in%2520CSF%2520in%2520response%2520to%2520%25CE%25B3-secretase%2520modulator%2520and%2520inhibitor%2520treatment%2520in%2520dogs%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D21%26spage%3D1005%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Presenilins and γ-secretase: structure, function, and role in Alzheimer disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1101%2Fcshperspect.a006304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22315713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006304&author=B.+De+Strooperauthor=T.+Iwatsuboauthor=M.+S.+Wolfe&title=Presenilins+and+%CE%B3-secretase%3A+structure%2C+function%2C+and+role+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilins and γ-secretase: structure, function, and role in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Iwatsubo, Takeshi; Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006304/1-a006304/19</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Presenilins were first discovered as sites of missense mutations responsible for early-onset Alzheimer disease (AD).  The encoded multipass membrane proteins were subsequently found to be the catalytic components of γ-secretases, membrane-embedded aspartyl protease complexes responsible for generating the carboxyl terminus of the amyloid β-protein (Aβ) from the amyloid protein precursor (APP).  The protease complex also cleaves a variety of other type 1 integral membrane proteins, most notably the Notch receptor, signaling from which is involved in many cell differentiation events.  Although γ-secretase is a top target for developing disease-modifying AD therapeutics, interference with Notch signaling should be avoided.  Compds. that alter Aβ prodn. by γ-secretase without affecting Notch proteolysis and signaling have been identified and are currently at various stages in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCnpnC3xUb5bVg90H21EOLACvtfcHk0lia1k6PSaV8LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7g%253D&md5=69116a83a2418c8649531e94f3e140b2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006304%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DPresenilins%2520and%2520%25CE%25B3-secretase%253A%2520structure%252C%2520function%252C%2520and%2520role%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Development and mechanism of γ-secretase modulators for Alzheimer’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3197</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi400377p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3197-3216&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Development+and+mechanism+of+%CE%B3-secretase+modulators+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fbi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400377p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DDevelopment%2520and%2520mechanism%2520of%2520%25CE%25B3-secretase%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3197%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">9710</span><span class="NLM_x">–</span> <span class="NLM_lpage">9720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9710-9720&author=N.+Pozdnyakovauthor=H.+E.+Murreyauthor=C.+J.+Crumpauthor=M.+Petterssonauthor=T.+E.+Ballardauthor=C.+W.+am+Endeauthor=K.+Ahnauthor=Y.-M.+Liauthor=K.+R.+Balesauthor=D.+S.+Johnson&title=%CE%B3-Secretase+modulator+%28GSM%29+photoaffinity+probes+reveal+distinct+allosteric+binding+sites+on+presenilin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3D%25CE%25B3-Secretase%2520modulator%2520%2528GSM%2529%2520photoaffinity%2520probes%2520reveal%2520distinct%2520allosteric%2520binding%2520sites%2520on%2520presenilin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D9710%26epage%3D9720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Development of clickable active site-directed photoaffinity probes for γ-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2997-3000&author=C.+J.+Crumpauthor=C.+W.+am+Endeauthor=T.+E.+Ballardauthor=N.+Pozdnyakovauthor=M.+Petterssonauthor=D.-M.+Chauauthor=K.+R.+Balesauthor=Y.-M.+Liauthor=D.+S.+Johnson&title=Development+of+clickable+active+site-directed+photoaffinity+probes+for+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DDevelopment%2520of%2520clickable%2520active%2520site-directed%2520photoaffinity%2520probes%2520for%2520%25CE%25B3-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2997%26epage%3D3000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Target of γ-secretase modulators, presenilin marks the spot</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4696</span><span class="NLM_x">–</span> <span class="NLM_lpage">4698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4696-4698&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Target+of+%CE%B3-secretase+modulators%2C+presenilin+marks+the+spot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DTarget%2520of%2520%25CE%25B3-secretase%2520modulators%252C%2520presenilin%2520marks%2520the%2520spot%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4696%26epage%3D4698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ebke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Novel γ-secretase enzyme modulators directly target presenilin protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37181</span><span class="NLM_x">–</span> <span class="NLM_lpage">37186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37181-37186&author=A.+Ebkeauthor=T.+Luebbersauthor=A.+Fukumoriauthor=K.+Shirotaniauthor=C.+Haassauthor=K.+Baumannauthor=H.+Steiner&title=Novel+%CE%B3-secretase+enzyme+modulators+directly+target+presenilin+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbke%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DShirotani%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520enzyme%2520modulators%2520directly%2520target%2520presenilin%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37181%26epage%3D37186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Presenilin is the molecular target of acidic γ-secretase modulators in living cells</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30484&author=T.+Jumpertzauthor=A.+Rennhackauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=B.+Bulicauthor=S.+Weggen&title=Presenilin+is+the+molecular+target+of+acidic+%CE%B3-secretase+modulators+in+living+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DPresenilin%2520is%2520the%2520molecular%2520target%2520of%2520acidic%2520%25CE%25B3-secretase%2520modulators%2520in%2520living%2520cells%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26spage%3De30484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0lgSa6Egd-A2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">For some alternative, recent examples, see</p></div><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of bicyclic heterocycles as potent gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+Gijsen&title=Design+and+synthesis+of+bicyclic+heterocycles+as+potent+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demorin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-methylpyridine-based biaryl amides as gamma-secretase modulators for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+Demorinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-methylpyridine-based+biaryl+amides+as+gamma-secretase+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDemorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-methylpyridine-based%2520biaryl%2520amides%2520as%2520gamma-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent gamma-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9089</span><span class="NLM_x">–</span> <span class="NLM_lpage">9106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+Macdonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520gamma-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators: Can we combine potency with safety?</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">295207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=295207&author=H.+J.+Gijsenauthor=M.+Mercken&title=%CE%B3-Secretase+modulators%3A+Can+we+combine+potency+with+safety%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators: Can We Combine Potency with Safety?</span></div><div class="casAuthors">Gijsen Harrie J M; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">γ-Secretase modulation has been proposed as a potential disease modifying anti-Alzheimer's approach.  γ-Secretase modulators (GSMs) cause a product shift from the longer amyloid-beta (Aβ) peptide isoforms to shorter, more soluble, and less amyloidogenic isoforms, without inhibiting APP or Notch proteolytic processing.  As such, modulating γ-secretase may avoid some of the adverse effects observed with γ-secretase inhibitors.  Since the termination of the GSM tarenfurbil in 2008 due to negative phase III trial results, a considerable progress has been made towards more potent and better brain penetrable compounds.  However, an analysis of their lipophilic efficiency indices indicates that their increased potency can be largely attributed to their increased lipophilicity.  The need for early and chronic dosing with GSMs will require high-safety margins.  This will be a challenge to achieve with the current, highly lipophilic GSMs.  We will demonstrate that by focusing on the drug-like properties of GSMs, a combination of high in vitro potency and reduced lipophilicity can be achieved and does result in better tolerated compounds.  The next hurdle will be to translate this knowledge into GSMs which are highly efficacious and safe in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoRn2xTT3rypZoeNcnHOQ9fW6udTcc2eYjtk12-t0WXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D&md5=f3c1425fa7619625bb4dc56ee2b5f5fb</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%253A%2520Can%2520we%2520combine%2520potency%2520with%2520safety%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D295207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sun, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: Discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502.</span><div class="note"><p class="first last">Also see ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>. For comprehensive reviews, see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a></p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502.&author=Z.+Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+Maccossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+Discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18eR"><div class="casContent"><span class="casTitleNuber">18e</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lh03VRAcvuVJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520Discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>Values for clogP were calculated using the BIOBYTE (<a href="http://www.biobyte.com" class="extLink">www.biobyte.com</a>) program clogP, version 4.3.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Values+for+clogP+were+calculated+using+the+BIOBYTE+%28www.biobyte.com%29+program+clogP%2C+version+4.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+A+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0liXa1ijWNdjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0liXa1ijWNdjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chrzanowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozwadowska, M. D.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of isoquinoline alkaloids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr030692k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3341-3370&author=M.+Chrzanowskaauthor=M.+D.+Rozwadowska&title=Asymmetric+synthesis+of+isoquinoline+alkaloids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Isoquinoline Alkaloids</span></div><div class="casAuthors">Chrzanowska, Maria; Rozwadowska, Maria D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3341-3370</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of the asym. synthesis of isoquinoline alkaloids is presented.  The review covers stereochem. modified traditional methods, followed by recent achievements, obtained with the "C1-Cα connectivity approach", as well as other novel approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo08lVO2IFlk7Vg90H21EOLACvtfcHk0liXa1ijWNdjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFyhsL4%253D&md5=b005eab161a2891840a1622b8ed20a99</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr030692k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030692k%26sid%3Dliteratum%253Aachs%26aulast%3DChrzanowska%26aufirst%3DM.%26aulast%3DRozwadowska%26aufirst%3DM.%2BD.%26atitle%3DAsymmetric%2520synthesis%2520of%2520isoquinoline%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26spage%3D3341%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hendrickson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span> </span><span class="NLM_article-title">An efficient synthesis of substituted isoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3344</span><span class="NLM_x">–</span> <span class="NLM_lpage">3346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00167a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=3344-3346&author=J.+B.+Hendricksonauthor=C.+Rodr%C3%ADguez&title=An+efficient+synthesis+of+substituted+isoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00167a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00167a043%26sid%3Dliteratum%253Aachs%26aulast%3DHendrickson%26aufirst%3DJ.%2BB.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520substituted%2520isoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D3344%26epage%3D3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7783</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+Diricoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors</span></div><div class="casAuthors">Stepan, Antonia F.; Karki, Kapil; McDonald, W. Scott; Dorff, Peter H.; Dutra, Jason K.; DiRico, Kenneth J.; Won, Annie; Subramanyam, Chakrapani; Efremov, Ivan V.; O'Donnell, Christopher J.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Sneed, Blossom; Sun, Hao; Lu, Yasong; Robshaw, Ashley E.; Riddell, David; O'Sullivan, Theresa J.; Sibley, Evelyn; Capetta, Steven; Atchison, Kevin; Hallgren, Andrew J.; Miller, Emily; Wood, Anthony; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7772-7783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A metab.-based approach toward the optimization of a series of N-arylsulfonamide-based γ-secretase inhibitors is reported.  The lead cyclohexyl analog 6 suffered from extensive oxidn. on the cycloalkyl motif by cytochrome P 450 3A4, translating into poor human liver microsomal stability.  Knowledge of the metabolic pathways of 6 triggered a structure-activity relationship study aimed at lowering lipophilicity through the introduction of polarity.  This effort led to several tetrahydropyran and THF analogs, wherein the 3- and 4-substituted variants exhibited greater microsomal stability relative to their 2-substituted counterparts.  Further redn. in lipophilicity led to the potent γ-secretase inhibitor and 3-substituted oxetane 1 with a reduced propensity toward oxidative metab., relative to its 2-substituted isomer.  The slower rates of metab. with 3-substituted cyclic ethers most likely originate from redns. in lipophilicity and/or unfavorable CYP active site interactions with the heteroatom.  Preliminary animal pharmacol. studies with a representative oxetane indicate that the series is generally capable of lowering Aβ in vivo.  As such, the study also illustrates the improvement in drug likeness of mols. through the use of the oxetane motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1kWyZJuyD97Vg90H21EOLACvtfcHk0lgUV0fB5vHPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK&md5=b3e9725954a155900563cc5d2f73263b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Assay method adapted from published protocols:</p></div><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span> </span><span class="NLM_article-title">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1124%2Fdmd.105.004259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=15932954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1304-1311&author=R.+J.+Rileyauthor=D.+F.+McGinnityauthor=R.+P.+Austin&title=A+unified+model+for+predicting+human+hepatic%2C+metabolic+clearance+from+in+vitro+intrinsic+clearance+data+in+hepatocytes+and+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span></div><div class="casAuthors">Riley, Robert J.; McGinnity, D. F.; Austin, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1304-1311</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate a unified method for predicting human in vivo intrinsic clearance (CLint, in vivo) and hepatic clearance (CLh) from in vitro data in hepatocytes and microsomes by applying the unbound fraction in blood (fub) and in vitro incubations (fuinc).  Human CLint, in vivo was projected using in vitro data together with biol. scaling factors and compared with the unbound intrinsic clearance (CLint, ub, in vivo) estd. from clin. data using liver models with and without the various fu terms.  For incubations conducted with fetal calf serum (n = 14), the obsd. CLint, in vivo was modeled well assuming fuinc and fub were equiv.  CLint, ub, in vivo was predicted best using both fub and fuinc for other hepatocyte data (n = 56; r2 = 0.78, p = 3.3×10-19, av. fold error = 5.2).  A similar model for CLint, ub, in vivo was established for microsomal data (n = 37; r2 = 0.77, p = 1.2×10-12, av. fold error = 6.1).  Using the model for CLint, ub, in vivo (including a further empirical scaling factor), the CLh in humans was also calcd. according to the well stirred liver model for the most extensive dataset.  CLint, in vivo and CLh were both predicted well using in vitro human data from several labs. for acidic, basic, and neutral drugs.  The direct use of this model using only in vitro human data to predict the metabolic component of CLh is attractive, as it does not require extra information from preclin. studies in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrU05rRTm6LVg90H21EOLACvtfcHk0lgUV0fB5vHPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D&md5=79b80848977739267e4dd0ae82e5cbab</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.004259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.004259%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26atitle%3DA%2520unified%2520model%2520for%2520predicting%2520human%2520hepatic%252C%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520intrinsic%2520clearance%2520data%2520in%2520hepatocytes%2520and%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1304%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lgsGcqAf9dCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgsGcqAf9dCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">A compound with a MDR efflux ratio (MDR Er) less than 2.5 is considered to have minimal P-gp efflux liability.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+compound+with+a+MDR+efflux+ratio+%28MDR+Er%29+less+than+2.5+is+considered+to+have+minimal+P-gp+efflux+liability."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, G. G.</span><span> </span><span class="NLM_article-title">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1365-2125.2011.03961.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21392072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=235-246&author=E.+Callegariauthor=B.+Malhotraauthor=P.+J.+Bungayauthor=R.+Websterauthor=K.+S.+Fennerauthor=S.+Kempshallauthor=J.+L.+LaPerleauthor=M.+C.+Michelauthor=G.+G.+Kay&title=A+comprehensive+non-clinical+evaluation+of+the+CNS+penetration+potential+of+antimuscarinic+agents+for+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span></div><div class="casAuthors">Callegari, Ernesto; Malhotra, Bimal; Bungay, Peter J.; Webster, Rob; Fenner, Katherine S.; Kempshall, Sarah; LaPerle, Jennifer L.; Michel, Martin C.; Kay, Gary G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To assess and compare the mechanisms of central nervous system (CNS) penetration of antimuscarinic overactive bladder (OAB) agents.  METHODS: Phys. properties were computed or compiled from the literature.  Rats were administered 5-hydroxymethyl tolterodine (HMT), darifenacin, oxybutynin, solifenacin, tolterodine or trospium s.c.  At 1 h postdose, plasma, brain and cerebrospinal fluid (CSF) concns. were detd. using LC-MS/MS assays.  Brain and plasma protein binding were detd. in vitro.  Permeability in the presence and absence of the efflux transporter P-glycoprotein (P-gp) was assessed in RRCK and MDCK-MDR1 transwell assays.  RESULTS: Oxybutynin displayed extensive CNS penetration, with brain: plasma ratios (B:P), unbound brain:unbound plasma ratios (Kp,free) and CSF:free plasma ratios each >1.  Tolterodine (B:P = 2.95, Kp,free = 0.23 and CSF:free plasma = 0.16) and solifenacin (B:P = 3.04, Kp,free = 0.28 and CSF:free plasma = 1.41) showed significant CNS penetration but with some restriction from CNS as indicated by Kp,free values significantly <1.5-HMT, darifenacin and trospium displayed much lower B:P (0.03-0.16), Kp,free (0.01-0.04) and CSF:free plasma (0.004-0.06), consistent with poor CNS penetration.  Permeability in RRCK cells was low for trospium (0.63 × 10-6 cm s-1), moderate for 5-HMT (11.7 × 10-6 cm s-1) and high for darifenacin, solifenacin, tolterodine and oxybutynin (21.5-38.2 × 10-6 cm s-1).  In MDCK-MDR1 cells 5-HMT, darifenacin and trospium, were P-gp substrates, whereas oxybutynin, solifenacin and tolterodine were not P-gp substrates.  CONCLUSIONS: Brain penetration was low for antimuscarinics that are P-gp substrates (5-HMT, darifenacin and trospium), and significant for those that are not P-gp substrates (oxybutynin, solifenacin and tolterodine).  CNS adverse events reported in randomized controlled clin. trials show general alignment with the preclin. data described in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9FelRyq-h7Vg90H21EOLACvtfcHk0lgsGcqAf9dCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM&md5=dbd56eb7943853a1f58f9d56d92316bb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03961.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03961.x%26sid%3Dliteratum%253Aachs%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DMalhotra%26aufirst%3DB.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DLaPerle%26aufirst%3DJ.%2BL.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DKay%26aufirst%3DG.%2BG.%26atitle%3DA%2520comprehensive%2520non-clinical%2520evaluation%2520of%2520the%2520CNS%2520penetration%2520potential%2520of%2520antimuscarinic%2520agents%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D72%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Parkinson, A.; Ogilvie, B. W.</span><span> </span><span class="NLM_article-title">Biotransformation of Xenobiotics</span>. In  <span class="citation_source-book">Casarett & Doull’s Toxicology, The Basic Science of Poisons</span>, <span class="NLM_edition">7</span>th ed.; <span class="NLM_contrib-group">Klaassen, C. D.</span>, Ed.; <span class="NLM_publisher-name">The McGraw-Hill Co., Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Chapter 6, pp  <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span>. Also available online: <a href="http://ilmufarmasis.files.wordpress.com/2011/07/&#xA;casarett- and-doulls-toxicology-the-basic-science-of-poisons7th-ed.pdf" class="extLink">http://ilmufarmasis.files.wordpress.com/2011/07/ casarett- and-doulls-toxicology-the-basic-science-of-poisons7th-ed.pdf</a> (accessed Oct 23, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=161-304&author=A.+Parkinson&author=B.+W.+Ogilvieauthor=C.+D.+Klaassen&title=Casarett+%26+Doull%E2%80%99s+Toxicology%2C+The+Basic+Science+of+Poisons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DBiotransformation%2520of%2520Xenobiotics%26btitle%3DCasarett%2520%2526%2520Doull%25E2%2580%2599s%2520Toxicology%252C%2520The%2520Basic%2520Science%2520of%2520Poisons%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DThe%2520McGraw-Hill%2520Co.%252C%2520Inc%26date%3D2008%26spage%3D161%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5595</span><span class="NLM_x">–</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5595-5599&author=J.+S.+Waiauthor=B.+Kimauthor=T.+E.+Fisherauthor=L.+Zhuangauthor=M.+W.+Embreyauthor=P.+D.+Williamsauthor=D.+D.+Staasauthor=C.+Culbersonauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.-W.+Chenauthor=J.+D.+Ellisauthor=R.+Mallaiauthor=S.+D.+Young&title=Dihydroxypyridopyrazine-1%2C6-dione+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DMallai%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDihydroxypyridopyrazine-1%252C6-dione%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5595%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kawahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, H.</span><span> </span><span class="NLM_article-title">A Synthesis of pyrido[1,2-<i>a</i>]quinoxalines and pyrido[1,2-<i>a</i>]pyrazines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1983&pages=1721-1725&author=N.+Kawaharaauthor=T.+Nakajimaauthor=T.+Itohauthor=H.+Ogura&title=A+Synthesis+of+pyrido%5B1%2C2-a%5Dquinoxalines+and+pyrido%5B1%2C2-a%5Dpyrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DH.%26atitle%3DA%2520Synthesis%2520of%2520pyrido%255B1%252C2-a%255Dquinoxalines%2520and%2520pyrido%255B1%252C2-a%255Dpyrazines%26jtitle%3DHeterocycles%26date%3D1983%26volume%3D20%26spage%3D1721%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">HATU: <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N,N,N′,N′</i>-tetramethyluronium hexafluorophosphate.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol303463e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=642-645&author=T.+P.+Tranauthor=P.+B.+Mullinsauthor=C.+W.+am+Endeauthor=M.+Pettersson&title=Synthesis+of+pyridopyrazine-1%2C6-diones+from+6-hydroxypicolinic+acids+via+a+one-pot+coupling%2Fcyclization+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fol303463e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303463e%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520pyridopyrazine-1%252C6-diones%2520from%25206-hydroxypicolinic%2520acids%2520via%2520a%2520one-pot%2520coupling%252Fcyclization%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D642%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">am Ende, C. W.; Johnson, D. S.; O’Donnell, C. J.; Pettersson, M. Y.; Subramanyam, C.</span><span> </span><span class="NLM_article-title">Preparation of heteroaryl imidazoles and heteroaryl triazoles as γ-secretase modulators</span>. WO2011048525A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+W.+am+Ende&author=D.+S.+Johnson&author=C.+J.+O%E2%80%99Donnell&author=M.+Y.+Pettersson&author=C.+Subramanyam&title=Preparation+of+heteroaryl+imidazoles+and+heteroaryl+triazoles+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520heteroaryl%2520imidazoles%2520and%2520heteroaryl%2520triazoles%2520as%2520%25CE%25B3-secretase%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><div class="note"><p class="first last">Assay method adapted from published protocol:</p></div><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, M.</span><span> </span><span class="NLM_article-title">Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1864-1870&author=T.+Hayauthor=R.+Jonesauthor=K.+Beaumontauthor=M.+Kemp&title=Modulation+of+the+partition+coefficient+between+octanol+and+buffer+at+pH+7.4+and+pKa+to+achieve+the+optimum+balance+of+blood+clearance+and+volume+of+distribution+for+a+series+of+tetrahydropyran+histamine+type+3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520partition%2520coefficient%2520between%2520octanol%2520and%2520buffer%2520at%2520pH%25207.4%2520and%2520pKa%2520to%2520achieve%2520the%2520optimum%2520balance%2520of%2520blood%2520clearance%2520and%2520volume%2520of%2520distribution%2520for%2520a%2520series%2520of%2520tetrahydropyran%2520histamine%2520type%25203%2520receptor%2520antagonists%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1864%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><div class="note"><p class="first last">Solubility was measured by Analiza, Inc., Cleveland, OH. (<a href="http://analiza.com/physchem/logd.html#qf" class="extLink">http://analiza.com/physchem/logd.html#qf</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Solubility+was+measured+by+Analiza%2C+Inc.%2C+Cleveland%2C+OH.+%28http%3A%2F%2Fanaliza.com%2Fphyschem%2Flogd.html%23qf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (gsms) modulate amyloid-beta (abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28gsms%29+modulate+amyloid-beta+%28abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528gsms%2529%2520modulate%2520amyloid-beta%2520%2528abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lapinsky, D. J.</span><span> </span><span class="NLM_article-title">Tandem photoaffinity labeling-bioorthogonal conjugation in medicinal chemistry</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6237</span><span class="NLM_x">–</span> <span class="NLM_lpage">6247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6237-6247&author=D.+J.+Lapinsky&title=Tandem+photoaffinity+labeling-bioorthogonal+conjugation+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapinsky%26aufirst%3DD.%2BJ.%26atitle%3DTandem%2520photoaffinity%2520labeling-bioorthogonal%2520conjugation%2520in%2520medicinal%2520chemistry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6237%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">GSM <b>54</b> refers to a proprietary GSM containing the same pyridone imidazole core as GSM <b>52</b>, but a structurally distinct right-hand fragment attached to the lactam nitrogen.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c','cit18d','cit18e'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':[],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danica A.  Rankic</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, and <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>  . </span><span class="cited-content_cbyCitation_article-title">Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12791-12797. <a href="https://doi.org/10.1021/acs.joc.7b02079" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02079%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DProtocol%252Bfor%252Bthe%252BDirect%252BConversion%252Bof%252BLactones%252Bto%252BLactams%252BMediated%252Bby%252B1%25252C5%25252C7-Triazabicyclo%25255B4.4.0%25255Ddec-5-ene%25253A%252BSynthesis%252Bof%252BPyridopyrazine-1%25252C6-diones%26aulast%3DRankic%26aufirst%3DDanica%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16082017%26date%3D01112017%26date%3D01122017%26date%3D19102017%26volume%3D82%26issue%3D23%26spage%3D12791%26epage%3D12797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, and <span class="hlFld-ContribAuthor ">Jean-François  Blain</span>  . </span><span class="cited-content_cbyCitation_article-title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7389-7409. <a href="https://doi.org/10.1021/acs.jmedchem.5b01960" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGamma%252BSecretase%252BModulators%25253A%252BNew%252BAlzheimer%2525E2%252580%252599s%252BDrugs%252Bon%252Bthe%252BHorizon%25253F%26aulast%3DBursavich%26aufirst%3DMatthew%2BG.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D18122015%26date%3D05042016%26date%3D25082016%26date%3D23032016%26volume%3D59%26issue%3D16%26spage%3D7389%26epage%3D7409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Max  Kuhn</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, and <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>  . </span><span class="cited-content_cbyCitation_article-title">Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5284-5296. <a href="https://doi.org/10.1021/acs.jmedchem.6b00027" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuantitative%252BAssessment%252Bof%252Bthe%252BImpact%252Bof%252BFluorine%252BSubstitution%252Bon%252BP-Glycoprotein%252B%252528P-gp%252529%252BMediated%252BEfflux%25252C%252BPermeability%25252C%252BLipophilicity%25252C%252Band%252BMetabolic%252BStability%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07012016%26date%3D26052016%26date%3D09062016%26volume%3D59%26issue%3D11%26spage%3D5284%26epage%3D5296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuchun  Xie</span>, <span class="hlFld-ContribAuthor ">Bingbing X.  Li</span>, <span class="hlFld-ContribAuthor ">Alina  Kassenbrock</span>, <span class="hlFld-ContribAuthor ">Changhui  Xue</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">David Z.  Qian</span>, <span class="hlFld-ContribAuthor ">Rosalie C.  Sears</span>, and <span class="hlFld-ContribAuthor ">Xiangshu  Xiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 5075-5087. <a href="https://doi.org/10.1021/acs.jmedchem.5b00468" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00468%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%252BInhibitor%252Bof%252BCREB-Mediated%252BGene%252BTranscription%252Bwith%252BEfficacious%252Bin%252BVivo%252BAnticancer%252BActivity%26aulast%3DXie%26aufirst%3DFuchun%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D22032015%26date%3D05062015%26date%3D25062015%26date%3D29052015%26volume%3D58%26issue%3D12%26spage%3D5075%26epage%3D5087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Todd W.  Butler</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Fish</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Patrick B.  Mullins</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Beth Cooper  Vetelino</span>, <span class="hlFld-ContribAuthor ">Eddie  Yang</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, and <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 596-601. <a href="https://doi.org/10.1021/acsmedchemlett.5b00070" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00070%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252BPyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-Secretase%252BModulators%252Bthat%252BAlign%252BPotency%25252C%252BMDR%252BEfflux%252BRatio%25252C%252Band%252BMetabolic%252BStability%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11022015%26date%3D27032015%26date%3D03042015%26date%3D14052015%26volume%3D6%26issue%3D5%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rukmankesh  Mehra</span>, <span class="hlFld-ContribAuthor ">Kasper P.  Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Computational prediction and molecular mechanism of γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>157 </em>, 105626. <a href="https://doi.org/10.1016/j.ejps.2020.105626" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105626%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DComputational%252Bprediction%252Band%252Bmolecular%252Bmechanism%252Bof%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DMehra%26aufirst%3DRukmankesh%26date%3D2021%26volume%3D157%26spage%3D105626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shekar  Mekala</span>, <span class="hlFld-ContribAuthor ">Grady  Nelson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1003-1022. <a href="https://doi.org/10.1039/D0MD00196A" title="DOI URL">https://doi.org/10.1039/D0MD00196A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00196A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00196A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bof%252Bsmall%252Bmolecule%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMekala%26aufirst%3DShekar%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D1003%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Shao</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A concise and unexpected one-pot methodology for the synthesis of pyrazinone-fused pyridones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (18)
                                     , 2657-2663. <a href="https://doi.org/10.1039/D0QO00590H" title="DOI URL">https://doi.org/10.1039/D0QO00590H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00590H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00590H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bconcise%252Band%252Bunexpected%252Bone-pot%252Bmethodology%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrazinone-fused%252Bpyridones%26aulast%3DLei%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D18%26spage%3D2657%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  de Sena M. Pinheiro</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Rodolfo  do Couto Maia</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Thota</span>, <span class="hlFld-ContribAuthor ">Carlos A.M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Conformational Restriction in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1712-1733. <a href="https://doi.org/10.2174/1568026619666190712205025" title="DOI URL">https://doi.org/10.2174/1568026619666190712205025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205025%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DThe%252BUse%252Bof%252BConformational%252BRestriction%252Bin%252BMedicinal%252BChemistry%26aulast%3Dde%2BSena%2BM.%2BPinheiro%26aufirst%3DPedro%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1712%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 623-652. <a href="https://doi.org/10.1080/14737175.2019.1621750" title="DOI URL">https://doi.org/10.1080/14737175.2019.1621750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2019.1621750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2019.1621750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DChallenges%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Brecent%252Bprogress%252Band%252Btreatment%252Bstrategies%252Bof%252Bpharmaceuticals%252Btargeting%252Bnotable%252Bpathological%252Bfactors%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D623%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Anindya  Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (22)
                                     , 2351-2373. <a href="https://doi.org/10.1002/cmdc.201800518" title="DOI URL">https://doi.org/10.1002/cmdc.201800518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800518%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BCurtius%252BRearrangement%25253A%252BApplications%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D22%26spage%3D2351%26epage%3D2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Gerlach</span>, <span class="hlFld-ContribAuthor ">Scott  Hobson</span>, <span class="hlFld-ContribAuthor ">Christian  Eickmeier</span>, <span class="hlFld-ContribAuthor ">Ulrike  Groß</span>, <span class="hlFld-ContribAuthor ">Clemens  Braun</span>, <span class="hlFld-ContribAuthor ">Peter  Sieger</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Niklas  Heine</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3227-3241. <a href="https://doi.org/10.1016/j.bmc.2018.04.053" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btetrahydroindazoles%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bin%252Bvivo%252Befficacious%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DGerlach%26aufirst%3DKai%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3227%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Peter H.  St George-Hyslop</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Chemical Biology of Presenilin Complexes. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Medicine</span><span> <strong>2017,</strong> <em>7 </em>
                                    (12)
                                     , a024067. <a href="https://doi.org/10.1101/cshperspect.a024067" title="DOI URL">https://doi.org/10.1101/cshperspect.a024067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a024067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a024067%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Medicine%26atitle%3DStructural%252Band%252BChemical%252BBiology%252Bof%252BPresenilin%252BComplexes%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D12%26spage%3Da024067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paramita  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Jason K.  Dutra</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethyl Oxetanes: Synthesis and Evaluation as a
              tert
              -Butyl Isostere. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (19)
                                     , 1574-1577. <a href="https://doi.org/10.1002/cmdc.201700333" title="DOI URL">https://doi.org/10.1002/cmdc.201700333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700333%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTrifluoromethyl%252BOxetanes%25253A%252BSynthesis%252Band%252BEvaluation%252Bas%252Ba%252Btert%252B-Butyl%252BIsostere%26aulast%3DMukherjee%26aufirst%3DParamita%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D19%26spage%3D1574%26epage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Danica A.  Rankic</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Todd W.  Butler</span>, <span class="hlFld-ContribAuthor ">Brian  Boscoe</span>, <span class="hlFld-ContribAuthor ">Edelweiss  Evrard</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Eddie  Yang</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Eva  Hajos-Korcsok</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Betty  Pettersen</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">David S.  Ramirez</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 730-743. <a href="https://doi.org/10.1039/C6MD00406G" title="DOI URL">https://doi.org/10.1039/C6MD00406G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00406G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00406G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bcyclopropyl%252Bchromane-derived%252Bpyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-secretase%252Bmodulators%252Bwith%252Brobust%252Bcentral%252Befficacy%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D730%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-118. <a href="https://doi.org/10.1007/7355_2016_19" title="DOI URL">https://doi.org/10.1007/7355_2016_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_19%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%252Bas%252BA%2525CE%2525B242-Lowering%252BPharmacological%252BAgents%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26spage%3D87%26epage%3D118%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">A.I.  Velter</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting γ-Secretase for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 280-325. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13789-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13789-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13789-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13789-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B3-Secretase%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D280%26epage%3D325%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Douglas S  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biology. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (16)
                                     , 2143-2171. <a href="https://doi.org/10.4155/fmc.15.136" title="DOI URL">https://doi.org/10.4155/fmc.15.136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.136%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Band%252Bapplications%252Bof%252Bclickable%252Bphotoprobes%252Bin%252Bmedicinal%252Bchemistry%252Band%252Bchemical%252Bbiology%26aulast%3DLapinsky%26aufirst%3DDavid%2BJ%26date%3D2015%26volume%3D7%26issue%3D16%26spage%3D2143%26epage%3D2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Christian  Fischer</span>, <span class="hlFld-ContribAuthor ">Chaomin  Li</span>, <span class="hlFld-ContribAuthor ">Alexey  Rivkin</span>, <span class="hlFld-ContribAuthor ">Sean P.  Ahearn</span>, <span class="hlFld-ContribAuthor ">William Colby  Brown</span>, <span class="hlFld-ContribAuthor ">Sam  Kattar</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Kelley</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Mampreian</span>, <span class="hlFld-ContribAuthor ">Adam  Schell</span>, <span class="hlFld-ContribAuthor ">Andrew  Rosenau</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Richard  Ball</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Valentina V.  Jeliazkova-Mecheva</span>, <span class="hlFld-ContribAuthor ">Damaris  Diaz</span>, <span class="hlFld-ContribAuthor ">Lily Y.  Moy</span>, <span class="hlFld-ContribAuthor ">Candia M.  Kenific</span>, <span class="hlFld-ContribAuthor ">Chris  Moxham</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>, <span class="hlFld-ContribAuthor ">Hugh  Nuthall</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Szewczak</span>, <span class="hlFld-ContribAuthor ">Armetta  Hill</span>, <span class="hlFld-ContribAuthor ">Bethany  Hughes</span>, <span class="hlFld-ContribAuthor ">Nadya  Smotrov</span>, <span class="hlFld-ContribAuthor ">Benito  Munoz</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Miller</span>, <span class="hlFld-ContribAuthor ">Mark S.  Shearman</span>. </span><span class="cited-content_cbyCitation_article-title">Potent benzoazepinone γ-secretase modulators with improved bioavailability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3495-3500. <a href="https://doi.org/10.1016/j.bmcl.2015.06.032" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Bbenzoazepinone%252B%2525CE%2525B3-secretase%252Bmodulators%252Bwith%252Bimproved%252Bbioavailability%26aulast%3DMethot%26aufirst%3DJoey%2BL.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3495%26epage%3D3500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Edelweiss  Evrard</span>, <span class="hlFld-ContribAuthor ">Ivan  Efremov</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Eva  Hajos-Korcsok</span>, <span class="hlFld-ContribAuthor ">Heather E.  Murrey</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 908-913. <a href="https://doi.org/10.1016/j.bmcl.2014.12.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bindole-derived%252Bpyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-secretase%252Bmodulators%252Bthat%252Btarget%252Bpresenilin%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D908%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana I.  Velter</span>, <span class="hlFld-ContribAuthor ">François P.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Didier  Berthelot</span>, <span class="hlFld-ContribAuthor ">Michel  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Libuse  Jaroskova</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Garrett  Minne</span>, <span class="hlFld-ContribAuthor ">Serge  Pieters</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Yves  Van Roosbroeck</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Tongfei  Wu</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>, <span class="hlFld-ContribAuthor ">Chantal  Masungi</span>, <span class="hlFld-ContribAuthor ">Harrie  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Anilinotriazoles as potent gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (24)
                                     , 5805-5813. <a href="https://doi.org/10.1016/j.bmcl.2014.10.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.10.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.10.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnilinotriazoles%252Bas%252Bpotent%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DVelter%26aufirst%3DAdriana%2BI.%26date%3D2014%26volume%3D24%26issue%3D24%26spage%3D5805%26epage%3D5813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayavant D.  Patil</span>, <span class="hlFld-ContribAuthor ">Suyog N.  Korade</span>, <span class="hlFld-ContribAuthor ">Dattaprasad M.  Pore</span>. </span><span class="cited-content_cbyCitation_article-title">1,1′-Sulfinyldipyridinium bis (hydrogen sulfate) ionic liquid: synthesis and application in the temperature-influenced synthesis of novel pyranopyrimidinediones and pyranopyrimidinetriones. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (92)
                                     , 50449-50455. <a href="https://doi.org/10.1039/C4RA10410B" title="DOI URL">https://doi.org/10.1039/C4RA10410B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA10410B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA10410B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3D1%25252C1%2525E2%252580%2525B2-Sulfinyldipyridinium%252Bbis%252B%252528hydrogen%252Bsulfate%252529%252Bionic%252Bliquid%25253A%252Bsynthesis%252Band%252Bapplication%252Bin%252Bthe%252Btemperature-influenced%252Bsynthesis%252Bof%252Bnovel%252Bpyranopyrimidinediones%252Band%252Bpyranopyrimidinetriones%26aulast%3DPatil%26aufirst%3DJayavant%2BD.%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D92%26spage%3D50449%26epage%3D50455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative acid GSMs <b>1</b>, <b>2</b>, and heteroaryl GSM <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of the Amide Series from Heteroaryl GSM <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design of Constrained Amide GSMs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2-dimethoxyethanamine, toluene, reflux; (b) EtOCOCl, THF, −10 °C to rt; then P(OMe)<sub>3</sub>; (c) TiCl<sub>4</sub>, dichloromethane, reflux, 57% over three steps; (d) <i>m-</i>CPBA, dichloromethane, rt, 46%; (e) Ac<sub>2</sub>O, reflux; (f) sodium hydroxide, 100 °C, 84% over two steps; (g) NaH, 1-(2-bromoethyl)-3-chlorobenzene, DMA, rt, 62%; (h) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 135 °C, 7%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>25b</b>, <b>27</b>, and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) malonic acid, piperidine, pyridine, 120 °C, 50% (<b>18</b>), 19% (<b>19</b>); (b) SOCl<sub>2</sub>, rt, then 90 °C; (c) NaN<sub>3</sub>, H<sub>2</sub>O, acetone, 0 °C; (d) 1,2-dichlorobenzene, 140 °C, 1 h; then catalytic I<sub>2</sub>, 185 °C, 1.5 h, 51% (<b>22</b>, three steps), 16% (<b>23</b>, three steps); (e) NaH, 1-(2-bromoethyl)-3-chlorobenzene, DMA, rt 45%; (f) NaH, 3-CF<sub>3</sub>-benzyl bromide, DMA, rt, 97%; (g) 4-methylimidazole, CuI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 20%; (h) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 27%. (i) H<sub>2</sub>, Pd/C, H-Cube, 97%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Design Strategy Leading to a Novel Pyridopyrazine-1,6-dione Series</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis Employed for Preparation of <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBr, HOAc, 150 °C, 79%; (b) HCl, 1,4-dioxane, 150 °C, quant; (c) NaBH(OAc)<sub>3</sub>, DIPEA, THF; (d) HCl, MeOH, (e) HATU, DIPEA, dichloromethane, rt, 30–80%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis Employed for Initial Preparation of <b>46</b>–<b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 56%; (b) K<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C, 30–60%.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response of <b>51</b> in guinea pig efficacy model reported as percent of vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/medium/jm-2013-01782h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSM-827-BPyne (<b>53</b>) specifically labels PS1-NTF in HeLa membranes. Photoaffinity labeling of <b>53</b> (5 μM, lanes 1–5) in HeLa membranes in the absence (lane 1) or presence of 50 μM GSM <b>52</b> (lane 2), 50 μM GSM <b>54</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (lane 3), 1 μM GSI L458 (lane 4) or 50 μM <b>3</b> (lane 5), followed by click chemistry with biotin azide, streptavidin pull-down, and Western blot analysis with PS1-NTF antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401782h/production/images/large/jm-2013-01782h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401782h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Thies, W.; Bleiler, L.</span> 2013 <span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.jalz.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=23507120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3svns1Cjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=208-245&author=W.+Thies&author=L.+Bleiler&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">2013 Alzheimer's disease facts and figures</span></div><div class="casAuthors">Thies William; Bleiler Laura</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general.  It also explores the roles and unique challenges of long-distance caregivers, as well as interventions that target those challenges.  An estimated 5.2 million Americans have AD.  Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million comprise the older onset AD population.  Throughout the coming decades, the baby boom generation is projected to add about 10 million to the total number of people in the United States with AD.  Today, someone in America develops AD every 68 seconds.  By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million.  AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older.  Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%.  The number of deaths from AD as determined by official death certificates (83,494 in 2010) likely underrepresents the number of AD-related deaths in the United States.  A projected 450,000 older Americans with AD will die in 2013, and a large proportion will die as a result of complications of AD.  In 2012, more than 15 million family members and other unpaid caregivers provided an estimated 17.5 billion hours of care to people with AD and other dementias, a contribution valued at more than $216 billion.  Medicare payments for services to beneficiaries age 65 years and older with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great.  Total payments in 2013 for health care, long-term care, and hospice services for people age 65 years and older with dementia are expected to be $203 billion (not including the contributions of unpaid caregivers).  An estimated 2.3 million caregivers of people with AD and other dementias live at least 1 hour away from the care recipient.  These "long-distance caregivers" face unique challenges, including difficulty in assessing the care recipient's true health condition and needs, high rates of family disagreement regarding caregiving decisions, and high out-of-pocket expenses for costs related to caregiving.  Out-of-pocket costs for long-distance caregivers are almost twice as high as for local caregivers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbeVACuiHSctj_Vg2vObihfW6udTcc2eazKUBLlkfuUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svns1Cjsw%253D%253D&md5=50fc6e9496936a518432bc7901743fb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DThies%26aufirst%3DW.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D208%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bertram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">The genetics of Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Mol. Biol. Transl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2FB978-0-12-385883-2.00008-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Klsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=79-100&author=L.+Bertramauthor=R.+E.+Tanzi&title=The+genetics+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The genetics of Alzheimer's disease</span></div><div class="casAuthors">Bertram, Lars; Tanzi, Rudolph E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">Molecular Biology of Neurodegenerative Diseases</span>),
    <span class="NLM_cas:pages">79-100</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic factors play a major role in detg. a person's risk to develop Alzheimer's disease (AD).  Rare mutations transmitted in a Mendelian fashion within affected families, for example, APP, PSEN1, and PSEN2, cause AD.  In the absence of mutations in these genes, disease risk is largely detd. by common polymorphisms that, in concert with each other and nongenetic risk factors, modestly impact risk for AD (e.g., the ε4-allele in APOE).  Recent genome-wide screening approaches have revealed several addnl. AD susceptibility loci and more are likely to be discovered over the coming years.  In this chapter, we review the current state of AD genetics research with a particular focus on loci that now can be considered established disease genes.  In addn. to reviewing the potential pathogenic relevance of these genes, we provide an outlook into the future of AD genetics research based on recent advances in high-throughput sequencing technologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoiWkH-GuZ7Vg90H21EOLACvtfcHk0lgeyJ8beYlx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Klsr3P&md5=a7d05046fddae89bb788985e3c04ba99</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385883-2.00008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385883-2.00008-4%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520genetics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2012%26volume%3D107%26spage%3D79%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers - a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers+-+a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lgeyJ8beYlx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%2520-%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lgeyJ8beYlx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bateman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMattos, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span> </span><span class="NLM_article-title">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1002%2Fana.21623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=19360898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=48-54&author=R.+J.+Batemanauthor=E.+R.+Siemersauthor=K.+G.+Mawuenyegaauthor=G.+Wenauthor=K.+R.+Browningauthor=W.+C.+Sigurdsonauthor=K.+E.+Yarasheskiauthor=S.+W.+Friedrichauthor=R.+B.+DeMattosauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=A+%CE%B3-secretase+inhibitor+decreases+amyloid-%CE%B2+production+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span></div><div class="casAuthors">Bateman, Randall J.; Siemers, Eric R.; Mawuenyega, Kwasi G.; Wen, Guolin; Browning, Karen R.; Sigurdson, Wendy C.; Yarasheski, Kevin E.; Friedrich, Stuart W.; De Mattos, Ronald B.; May, Patrick C.; Paul, Steven M.; Holtzman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Accumulation of amyloid-β (Aβ) by overprodn. or underclearance in the central nervous system (CNS) is hypothesized to be a necessary event in the pathogenesis of Alzheimer's disease.  However, previously, there has not been a method to det. drug effects on Aβ prodn. or clearance in the human CNS.  The objective of this study was to det. the effects of a γ-secretase inhibitor on the prodn. of Aβ in the human CNS.  Methods: We utilized a recently developed method of stable-isotope labeling combined with cerebrospinal fluid sampling to directly measure Aβ prodn. during treatment of a γ-secretase inhibitor, LY450139.  We assessed whether this drug could decrease CNS Aβ prodn. in healthy men (age range, 21-50 years) at single oral doses of 100, 140, or 280mg (n = 5 per group).  Results: LY450139 significantly decreased the prodn. of CNS Aβ in a dose-dependent fashion, with inhibition of Aβ generation of 47, 52, and 84% over a 12-h period with doses of 100, 140, and 280mg, resp.  There was no difference in Aβ clearance.  Interpretation: Stable isotope labeling of CNS proteins can be utilized to assess the effects of drugs on the prodn. and clearance rates of proteins targeted as potential disease-modifying treatments for Alzheimer's disease and other CNS disorders.  Results from this approach can assist in making decisions about drug dosing and frequency in the design of larger and longer clin. trials for diseases such as Alzheimer's disease, and may accelerate effective drug validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcrw_WczwGLVg90H21EOLACvtfcHk0ljKNEtw0inLfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM&md5=8f950c978d6fc83d0436ab1138227dd6</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fana.21623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21623%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DBrowning%26aufirst%3DK.%2BR.%26aulast%3DSigurdson%26aufirst%3DW.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DFriedrich%26aufirst%3DS.%2BW.%26aulast%3DDeMattos%26aufirst%3DR.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DA%2520%25CE%25B3-secretase%2520inhibitor%2520decreases%2520amyloid-%25CE%25B2%2520production%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span> </span><span class="NLM_article-title">Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1007%2Fs40261-012-0006-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=23018285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=761-769&author=G.+Tongauthor=L.+Castanedaauthor=J.-S.+Wangauthor=O.+Sverdlovauthor=S.-P.+Huangauthor=R.+Slemmonauthor=H.+Guauthor=O.+Wongauthor=H.+Liauthor=R.+M.+Bermanauthor=C.+Smithauthor=C.+Albrightauthor=R.+C.+Dockens&title=Effects+of+single+doses+of+avagacestat+%28BMS-708163%29+on+cerebrospinal+fluid+A%CE%B2+levels+in+healthy+young+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men</span></div><div class="casAuthors">Tong, Gary; Castaneda, Lorna; Wang, Jun-Sheng; Sverdlov, Oleksandr; Huang, Shu-Pang; Slemmon, Randy; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles; Dockens, Randy C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">Background: The concn. of amyloid β (Aβ) peptides in cerebrospinal fluid (CSF) is a biomarker for Alzheimer's disease (AD) pathol., and has been used to evaluate the effectiveness of γ-secretase inhibition.  Avagacestat is a selective γ-secretase inhibitor in development for the treatment of AD.  The primary objective of this study was to assess the effects of single oral doses of avagacestat on the CSF Aβ concns. in healthy male subjects.  Secondary objectives included single-dose pharmacokinetics in CSF and plasma, safety and tolerability.  Methods: This was a double-blind, placebo-controlled, randomized, single-dose study.  Healthy male subjects were assigned to one of three sequential avagacestat dose panels (50, 200 and 400 mg) or placebo as single oral doses.  Results: 34 subjects were enrolled.  Administration of a single dose of 200 or 400 mg of avagacestat resulted in a marked decrease in CSF Aβ1-38, Aβ1-40 and Aβ1-42 concns. vs placebo; with smaller decreases obsd. in the 50 mg dose group.  Avagacestat was quickly absorbed into the systemic circulation, with a mean time to reach max. plasma concn. (tmax) of approx. 1-2 h, and a CSF tmax of approx. 3 h.  Adverse events were uncommon and occurred with similar frequency in the placebo and avagacestat groups.  Conclusion: Avagacestat was safe, well tolerated, and resulted in a notable decrease in CSF AP concns., suggestive of γ-secretase inhibition. The results warrant further clin. study in patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLVITHcfMxbVg90H21EOLACvtfcHk0ljKNEtw0inLfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFemsQ%253D%253D&md5=a91183f5c4d6df8417766c81a8d85820</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs40261-012-0006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40261-012-0006-4%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DG.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26atitle%3DEffects%2520of%2520single%2520doses%2520of%2520avagacestat%2520%2528BMS-708163%2529%2520on%2520cerebrospinal%2520fluid%2520A%25CE%25B2%2520levels%2520in%2520healthy%2520young%2520men%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2012%26volume%3D32%26spage%3D761%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Therapeutic intervention for Alzheimer’s disease with γ-secretase inhibitors: Still a viable option?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=325-341&author=B.+P.+Imbimboauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=G.+D%E2%80%99Onofrioauthor=G.+Logroscinoauthor=D.+Seripaauthor=A.+Pilotto&title=Therapeutic+intervention+for+Alzheimer%E2%80%99s+disease+with+%CE%B3-secretase+inhibitors%3A+Still+a+viable+option%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DTherapeutic%2520intervention%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520%25CE%25B3-secretase%2520inhibitors%253A%2520Still%2520a%2520viable%2520option%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D325%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sambamurti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnwell, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappolla, M. A.</span><span> </span><span class="NLM_article-title">Targets for AD treatment: conflicting messages from γ-secretase inhibitors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1471-4159.2011.07213.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21320126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Oju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=359-374&author=K.+Sambamurtiauthor=N.+H.+Greigauthor=T.+Utsukiauthor=E.+L.+Barnwellauthor=E.+Sharmaauthor=C.+Mazellauthor=N.+R.+Bhatauthor=M.+S.+Kindyauthor=D.+K.+Lahiriauthor=M.+A.+Pappolla&title=Targets+for+AD+treatment%3A+conflicting+messages+from+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Targets for AD treatment: conflicting messages from γ-secretase inhibitors</span></div><div class="casAuthors">Sambamurti, Kumar; Greig, Nigel H.; Utsuki, Tadanobu; Barnwell, Eliza L.; Sharma, Ekta; Mazell, Cheryl; Bhat, Narayan R.; Kindy, Mark S.; Lahiri, Debomoy K.; Pappolla, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Current evidence suggests that Alzheimer's disease (AD) is a multi-factorial disease that starts with accumulation of multiple proteins.  We have previously proposed that inhibition of γ-secretase may impair membrane recycling causing neurodegeneration starting at synapses.  We also proposed familal AD mutations increase Aβ42 by inhibiting γ-secretase.  Herein, we discuss the failure of Eli Lilly's γ-secretase inhibitor, semagacestat, in clin. trials in the light of our hypothesis, which extends the problem beyond toxicity of Aβ aggregates.  We elaborate that γ-secretase inhibitors lead to accumulation of amyloid precursor protein C-terminal fragments that can later be processed by γ-secretase to yields bursts of Aβ to facilitate aggregation.  Although we do not exclude a role for toxic Aβ aggregates, inhibition of γ-secretase can affect numerous substrates other than amyloid precursor protein to affect multiple pathways and the combined accumulation of multiple peptides in the membrane may impair its function and turnover.  Taken together, protein processing and turnover pathways play an important role in maintaining cellular homeostasis and unless we clearly see consistent disease-related increase in their levels or activity, we need to focus on preserving their function rather than inhibiting them for treatment of AD and similar diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINYQOUvRA17Vg90H21EOLACvtfcHk0lhn_9Iz95DXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Oju7s%253D&md5=e9b270917a0944f35ea27aed153e2a39</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07213.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07213.x%26sid%3Dliteratum%253Aachs%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DBarnwell%26aufirst%3DE.%2BL.%26aulast%3DSharma%26aufirst%3DE.%26aulast%3DMazell%26aufirst%3DC.%26aulast%3DBhat%26aufirst%3DN.%2BR.%26aulast%3DKindy%26aufirst%3DM.%2BS.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26aulast%3DPappolla%26aufirst%3DM.%2BA.%26atitle%3DTargets%2520for%2520AD%2520treatment%253A%2520conflicting%2520messages%2520from%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D117%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schor, N. F.</span><span> </span><span class="NLM_article-title">What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1002%2Fana.22365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21387368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2lsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=237-239&author=N.+F.+Schor&title=What+the+halted+phase+III+%CE%B3-secretase+inhibitor+trial+may+%28or+may+not%29+be+telling+us"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us</span></div><div class="casAuthors">Schor, Nina F.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-239</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The aborted trial of semagacestat has led some to invoke unanticipated effects of γ-secretase inhibition on formation of amyloid β.  However, the many substrates for γ-secretases and the varied biol. effects of each of the resultant cleavage products make ascribing causality much more complex than that.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ99wd6qY3YrVg90H21EOLACvtfcHk0lhn_9Iz95DXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2lsL8%253D&md5=92fd473a4261170f794eb54a16e4e99a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fana.22365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22365%26sid%3Dliteratum%253Aachs%26aulast%3DSchor%26aufirst%3DN.%2BF.%26atitle%3DWhat%2520the%2520halted%2520phase%2520III%2520%25CE%25B3-secretase%2520inhibitor%2520trial%2520may%2520%2528or%2520may%2520not%2529%2520be%2520telling%2520us%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiovitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1430</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1001%2Farchneurol.2012.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22892585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=1430-1440&author=V.+Coricauthor=C.+H.+van+Dyckauthor=S.+Sallowayauthor=N.+Andreasenauthor=M.+Brodyauthor=R.+W.+Richterauthor=H.+Soininenauthor=S.+Theinauthor=T.+Shiovitzauthor=G.+Pilcherauthor=S.+Colbyauthor=L.+Rollinauthor=R.+Dockensauthor=C.+Pachaiauthor=E.+Porteliusauthor=U.+Andreassonauthor=K.+Blennowauthor=H.+Soaresauthor=C.+Albrightauthor=H.+H.+Feldmanauthor=R.+M.+Berman&title=Safety+and+tolerability+of+the+%CE%B3-secretase+inhibitor+avagacestat+in+a+phase+2+study+of+mild+to+moderate+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span></div><div class="casAuthors">Coric Vladimir; van Dyck Christopher H; Salloway Stephen; Andreasen Niels; Brody Mark; Richter Ralph W; Soininen Hilkka; Thein Stephen; Shiovitz Thomas; Pilcher Gary; Colby Susan; Rollin Linda; Dockens Randy; Pachai Chahin; Portelius Erik; Andreasson Ulf; Blennow Kaj; Soares Holly; Albright Charles; Feldman Howard H; Berman Robert M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1430-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the safety, tolerability, and pharmacokinetic and pharmacodynamic effects of the -secretase inhibitor avagacestat in patients with mild to moderate Alzheimer disease (AD).  DESIGN:  Randomized, double-blind, placebo-controlled,24-week phase 2 study.  SETTING:  Global, multicenter trial.  PATIENTS:  A total of 209 outpatients with mild to moderate AD were randomized into the double-blind treatment phase.  The median age of the patients was 75 years,58.9% were APOE ε4 carriers, and baseline measures of disease severity were similar among groups.  INTERVENTION:  Avagacestat, 25, 50, 100, or 125 mg daily,or placebo administered orally daily.  MAIN OUTCOME MEASURES:  Safety and tolerability of avagacestat.  RESULTS:  Discontinuation rates for the 25-mg and 50-mg doses of avagacestat were comparable with placebo but were higher in the 100-mg and 125-mg dose groups.Trends for worsening cognition, as measured by change from baseline Alzheimer Disease Assessment Scale cognitive subscale score, were observed in the 100-mg and125-mg dose groups.  Treatment-emergent serious adverse events were similar across placebo and treatment groups.  The most common reason for discontinuation was adverse events, predominantly gastrointestinal anddermatologic.  Other adverse events occurring more frequentlyin patients undergoing treatment included reversibleglycosuria (without associated serum glucose changes), nonmelanoma skin cancer, and asymptomaticmagnetic resonance imaging findings.  Exploratory cerebrospinal fluid amyloid isoforms and tau biomarker analysis demonstrated dose-dependent but not statistically significant reductions in a small subset of patients.  CONCLUSIONS:  Avagacestat dosed at 25 and 50 mg daily was relatively well tolerated and had low discontinuation rates.  The 100-mg and 125-mg dose arms were poorly tolerated with trends for cognitive worsening.  Exploratory cerebrospinal fluid biomarker substudies provide preliminary support for -secretase target engagement,but additional studies are warranted to better characterize pharmacodynamic effects at the 25- and 50-mg doses.This study establishes an acceptable safety and tolerability dose range for future avagacestat studies in AD.  TRIAL REGISTRATION:  clinicaltrials.gov Identifier: NCT00810147</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuwXa-F7HH9okFb3mqPUYDfW6udTcc2ebv0y0caObtjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D&md5=b0935144b0569050bd45f25029694282</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2012.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2012.2194%26sid%3Dliteratum%253Aachs%26aulast%3DCoric%26aufirst%3DV.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DBrody%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DR.%2BW.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DThein%26aufirst%3DS.%26aulast%3DShiovitz%26aufirst%3DT.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DColby%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DL.%26aulast%3DDockens%26aufirst%3DR.%26aulast%3DPachai%26aufirst%3DC.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520avagacestat%2520in%2520a%2520phase%25202%2520study%2520of%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2012%26volume%3D69%26spage%3D1430%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Haapasalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span> </span><span class="NLM_article-title">The many substrates of presenilin/γ-secretase</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.3233%2FJAD-2011-101065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21335653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3-28&author=A.+Haapasaloauthor=D.+M.+Kovacs&title=The+many+substrates+of+presenilin%2F%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Substrates of Presenilin/γ-Secretase</span></div><div class="casAuthors">Haapasalo, Annakaisa; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The Alzheimer's disease (AD)-assocd. amyloid-β protein precursor (AβPP) is cleaved by α-, β-, and presenilin (PS)/γ-secretases through sequential regulated proteolysis.  These proteolytic events control the generation of the pathogenic amyloid-β (Aβ) peptide, which excessively accumulates in the brains of individuals afflicted by AD.  A growing no. of addnl. proteins cleaved by PS/γ-secretase continue to be discovered.  Similarly to AβPP, most of these proteins are type-I transmembrane proteins involved in vital signaling functions regulating cell fate, adhesion, migration, neurite outgrowth, or synaptogenesis.  All the identified proteins share common structural features, which are typical for their proteolysis.  The consequences of the PS/γ-secretase-mediated cleavage on the function of many of these proteins are largely unknown.  Here, we review the current literature on the proteolytic processing mediated by the versatile PS/γ-secretase complex.  We begin by discussing the steps of AβPP processing and PS/γ-secretase complex compn. and localization, which give clues to how and where the processing of other PS/γ-secretase substrates may take place.  Then we summarize the typical features of PS/γ-secretase-mediated protein processing.  Finally, we recapitulate the current knowledge on the possible physiol. function of PS/γ-secretase-mediated cleavage of specific substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphYizFVw4_A7Vg90H21EOLACvtfcHk0ljREb0JxLG42Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D&md5=22ce56939b97019e5c130556f9db7d5f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-101065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-101065%26sid%3Dliteratum%253Aachs%26aulast%3DHaapasalo%26aufirst%3DA.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DThe%2520many%2520substrates%2520of%2520presenilin%252F%25CE%25B3-secretase%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D25%26spage%3D3%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+%CE%B3-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0ljKEUDpd_wvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2F35102591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=11700559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+A%CE%B242+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span></div><div class="casAuthors">Weggen, Sascha; Eriksen, Jason L.; Das, Pritam; Sagl, Sarah A.; Wang, Rong; Pletrzik, Claus U.; Findlay, Kirk A.; Smith, Tawnya E.; Murphy, Michael P.; Bulter, Thomas; Kang, David E.; Marquez-Steriling, Numa; Golde, Todd E.; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epidemiol. studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs).  It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved.  Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulfide preferentially decrease the highly amyloidogenic Aβ42 peptide (the 42-residue isoform of the amyloid-β peptide) produced from a variety of cultured cells by as much as 80%.  This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacol. target of NSAIDs.  Furthermore, short-term administration of ibuprofen to mice that produce mutant β-amyloid precursor protein (APP) lowered their brain levels of Aβ42.  In cultured cells, the decrease in Aβ42 secretion was accompanied by an increase in the Aβ(1-38) isoform, indicating that NSAIDs subtly alter γ-secretase activity without significantly perturbing other APP processing pathways or Notch cleavage.  Our findings suggest that NSAIDs directly affect amyloid pathol. in the brain by reducing Aβ42 peptide levels independently of COX activity and that this Aβ42-lowering activity could be optimized to selectively target the pathogenic Aβ42 species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOE6e2axj77Vg90H21EOLACvtfcHk0ljKEUDpd_wvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D&md5=134200e7533409c6f6ad5092f680be70</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520A%25CE%25B242%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+%CE%B3-secretase+and+lower+A%CE%B242+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520%25CE%25B3-secretase%2520and%2520lower%2520A%25CE%25B242%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Aβ42-Lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">30748</span><span class="NLM_x">–</span> <span class="NLM_lpage">30754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30748-30754&author=S.+Weggenauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=C.+U.+Pietrzikauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A%CE%B242-Lowering+nonsteroidal+anti-inflammatory+drugs+preserve+intramembrane+cleavage+of+the+amyloid+precursor+protein+%28APP%29+and+ErbB-4+receptor+and+signaling+through+the+APP+intracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%25CE%25B242-Lowering%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520preserve%2520intramembrane%2520cleavage%2520of%2520the%2520amyloid%2520precursor%2520protein%2520%2528APP%2529%2520and%2520ErbB-4%2520receptor%2520and%2520signaling%2520through%2520the%2520APP%2520intracellular%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D30748%26epage%3D30754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">31831</span><span class="NLM_x">–</span> <span class="NLM_lpage">31837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=31831-31837&author=S.+Weggenauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=C.+U.+Pietrzikauthor=V.+Ozolsauthor=A.+Fauqauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=Evidence+that+nonsteroidal+anti-inflammatory+drugs+decrease+amyloid+%CE%B242+production+by+direct+modulation+of+%CE%B3-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DOzols%26aufirst%3DV.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DEvidence%2520that%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520decrease%2520amyloid%2520%25CE%25B242%2520production%2520by%2520direct%2520modulation%2520of%2520%25CE%25B3-secretase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D31831%26epage%3D31837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators for the treatment of Alzheimer’s disease: a review focusing on patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+a+review+focusing+on+patents+from+2010+to+2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0ljrB1h96Tr6Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520focusing%2520on%2520patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0ljrB1h96Tr6Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span> </span><span class="NLM_article-title">Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2009&pages=2557-2564&author=R.+C.+Greenauthor=L.+S.+Schneiderauthor=D.+A.+Amatoauthor=A.+P.+Beelenauthor=G.+Wilcockauthor=E.+A.+Swabbauthor=K.+H.+Zavitz&title=Effect+of+tarenflurbil+on+cognitive+decline+and+activities+of+daily+living+in+patients+with+mild+Alzheimer+disease%3A+A+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DAmato%26aufirst%3DD.%2BA.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DWilcock%26aufirst%3DG.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26atitle%3DEffect%2520of%2520tarenflurbil%2520on%2520cognitive%2520decline%2520and%2520activities%2520of%2520daily%2520living%2520in%2520patients%2520with%2520mild%2520Alzheimer%2520disease%253A%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2009%26volume%3D302%26spage%3D2557%26epage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Aβ38 and Aβ42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and γ-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+P%C3%A9rez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+A%CE%B238+and+A%CE%B242+is+independently+and+differentially+affected+by+familial+Alzheimer+disease-associated+presenilin+mutations+and+%CE%B3-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520A%25CE%25B238%2520and%2520A%25CE%25B242%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520familial%2520Alzheimer%2520disease-associated%2520presenilin%2520mutations%2520and%2520%25CE%25B3-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ohki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4815</span><span class="NLM_x">–</span> <span class="NLM_lpage">4824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4815-4824&author=Y.+Ohkiauthor=T.+Higoauthor=K.+Uemuraauthor=N.+Shimadaauthor=S.+Osawaauthor=O.+Berezovskaauthor=S.+Yokoshimaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Phenylpiperidine-type+%CE%B3-secretase+modulators+target+the+transmembrane+domain+1+of+presenilin+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhki%26aufirst%3DY.%26aulast%3DHigo%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DN.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DPhenylpiperidine-type%2520%25CE%25B3-secretase%2520modulators%2520target%2520the%2520transmembrane%2520domain%25201%2520of%2520presenilin%25201%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4815%26epage%3D4824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Piperidine acetic acid based γ-secretase modulators directly bind to presenilin-1</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200098p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=705-710&author=C.+J.+Crumpauthor=B.+A.+Fishauthor=S.+V.+Castroauthor=D.-M.+Chauauthor=N.+Gertsikauthor=K.+Ahnauthor=C.+Stiffauthor=N.+Pozdnyakovauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Piperidine+acetic+acid+based+%CE%B3-secretase+modulators+directly+bind+to+presenilin-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1</span></div><div class="casAuthors">Crump, Christina J.; Fish, Benjamin A.; Castro, Suita V.; Chau, De-Ming; Gertsik, Natalya; Ahn, Kwangwook; Stiff, Cory; Pozdnyakov, Nikolay; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis.  γ-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of Aβ42.  However, the binding partner of acid based GSMs was unresolved until now.  We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the γ-secretase complex.  Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the γ-secretase complex leading to the obsd. modulation of γ-secretase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLOY1hkibKrVg90H21EOLACvtfcHk0lhMzkGRi_5DAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM&md5=6129b8b4d150647165a04d2dd40e9ba9</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Fcn200098p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200098p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DPiperidine%2520acetic%2520acid%2520based%2520%25CE%25B3-secretase%2520modulators%2520directly%2520bind%2520to%2520presenilin-1%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D705%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator - pharmacology</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&issue=Suppl&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator+-+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator%2520-%2520pharmacology%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26issue%3DSuppl%26spage%3DS242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=20634579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3cfitlahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1005-1012&author=E.+Porteliusauthor=B.+Van+Broeckauthor=U.+Andreassonauthor=M.+K.+Gustavssonauthor=M.+Merckenauthor=H.+Zetterbergauthor=H.+Borghysauthor=K.+Blennow&title=Acute+effect+on+the+A%CE%B2+isoform+pattern+in+CSF+in+response+to+%CE%B3-secretase+modulator+and+inhibitor+treatment+in+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs</span></div><div class="casAuthors">Portelius Erik; Van Broeck Bianca; Andreasson Ulf; Gustavsson Mikael K; Mercken Marc; Zetterberg Henrik; Borghys Herman; Blennow Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1005-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is associated with deposition of amyloid-β (Aβ) in the brain, which is reflected by low concentration of the Aβ(1-42) peptide in the cerebrospinal fluid (CSF).  The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.  Less is known about the potent γ-secretase modulator E2012.  Using targeted proteomics techniques, we recently identified several shorter Aβ isoforms in CSF, such as Aβ(1-16), which is produced by a novel pathway.  In a Phase II clinical trial on AD patients, Aβ(1-14), Aβ(1-15) and Aβ(1-16) increased several-fold during γ-secretase inhibitor treatment.  In the present study, 9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle with a dosing interval of 1 week.  The CSF Aβ isoform pattern was analyzed by immunoprecipitation combined with MALDI-TOF mass spectrometry.  We show here that Aβ(1-15) and Aβ(1-16) increase while Aβ(1-34) decreases in response to treatment with the γ-secretase inhibitor LY450139, which is in agreement with previous studies.  The isoform Aβ(1-37) was significantly increased in a dose-dependent manner in response to treatment with E2012, while Aβ(1-39), Aβ(1-40) and A(1-42) decreased.  The data presented suggests that the γ-secretase modulator E-2012 alters the cleavage site preference of γ-secretase.  The increase in Aβ(1-37) may inhibit Aβ(1-42) oligomerization and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUARWsTeA6I0BuFdjgVNKSfW6udTcc2eYyaPKArz8Dgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfitlahug%253D%253D&md5=e7188ea5c1fa9ddeff264b5ca4114742</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DGustavsson%26aufirst%3DM.%2BK.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DAcute%2520effect%2520on%2520the%2520A%25CE%25B2%2520isoform%2520pattern%2520in%2520CSF%2520in%2520response%2520to%2520%25CE%25B3-secretase%2520modulator%2520and%2520inhibitor%2520treatment%2520in%2520dogs%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D21%26spage%3D1005%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Presenilins and γ-secretase: structure, function, and role in Alzheimer disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1101%2Fcshperspect.a006304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22315713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006304&author=B.+De+Strooperauthor=T.+Iwatsuboauthor=M.+S.+Wolfe&title=Presenilins+and+%CE%B3-secretase%3A+structure%2C+function%2C+and+role+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilins and γ-secretase: structure, function, and role in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Iwatsubo, Takeshi; Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006304/1-a006304/19</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Presenilins were first discovered as sites of missense mutations responsible for early-onset Alzheimer disease (AD).  The encoded multipass membrane proteins were subsequently found to be the catalytic components of γ-secretases, membrane-embedded aspartyl protease complexes responsible for generating the carboxyl terminus of the amyloid β-protein (Aβ) from the amyloid protein precursor (APP).  The protease complex also cleaves a variety of other type 1 integral membrane proteins, most notably the Notch receptor, signaling from which is involved in many cell differentiation events.  Although γ-secretase is a top target for developing disease-modifying AD therapeutics, interference with Notch signaling should be avoided.  Compds. that alter Aβ prodn. by γ-secretase without affecting Notch proteolysis and signaling have been identified and are currently at various stages in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCnpnC3xUb5bVg90H21EOLACvtfcHk0lip-dPSPi66nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7g%253D&md5=69116a83a2418c8649531e94f3e140b2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006304%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DPresenilins%2520and%2520%25CE%25B3-secretase%253A%2520structure%252C%2520function%252C%2520and%2520role%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Development and mechanism of γ-secretase modulators for Alzheimer’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3197</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi400377p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3197-3216&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Development+and+mechanism+of+%CE%B3-secretase+modulators+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fbi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400377p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DDevelopment%2520and%2520mechanism%2520of%2520%25CE%25B3-secretase%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3197%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">9710</span><span class="NLM_x">–</span> <span class="NLM_lpage">9720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9710-9720&author=N.+Pozdnyakovauthor=H.+E.+Murreyauthor=C.+J.+Crumpauthor=M.+Petterssonauthor=T.+E.+Ballardauthor=C.+W.+am+Endeauthor=K.+Ahnauthor=Y.-M.+Liauthor=K.+R.+Balesauthor=D.+S.+Johnson&title=%CE%B3-Secretase+modulator+%28GSM%29+photoaffinity+probes+reveal+distinct+allosteric+binding+sites+on+presenilin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3D%25CE%25B3-Secretase%2520modulator%2520%2528GSM%2529%2520photoaffinity%2520probes%2520reveal%2520distinct%2520allosteric%2520binding%2520sites%2520on%2520presenilin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D9710%26epage%3D9720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Development of clickable active site-directed photoaffinity probes for γ-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2997-3000&author=C.+J.+Crumpauthor=C.+W.+am+Endeauthor=T.+E.+Ballardauthor=N.+Pozdnyakovauthor=M.+Petterssonauthor=D.-M.+Chauauthor=K.+R.+Balesauthor=Y.-M.+Liauthor=D.+S.+Johnson&title=Development+of+clickable+active+site-directed+photoaffinity+probes+for+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DDevelopment%2520of%2520clickable%2520active%2520site-directed%2520photoaffinity%2520probes%2520for%2520%25CE%25B3-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2997%26epage%3D3000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Target of γ-secretase modulators, presenilin marks the spot</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4696</span><span class="NLM_x">–</span> <span class="NLM_lpage">4698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4696-4698&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Target+of+%CE%B3-secretase+modulators%2C+presenilin+marks+the+spot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DTarget%2520of%2520%25CE%25B3-secretase%2520modulators%252C%2520presenilin%2520marks%2520the%2520spot%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4696%26epage%3D4698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ebke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Novel γ-secretase enzyme modulators directly target presenilin protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37181</span><span class="NLM_x">–</span> <span class="NLM_lpage">37186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37181-37186&author=A.+Ebkeauthor=T.+Luebbersauthor=A.+Fukumoriauthor=K.+Shirotaniauthor=C.+Haassauthor=K.+Baumannauthor=H.+Steiner&title=Novel+%CE%B3-secretase+enzyme+modulators+directly+target+presenilin+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbke%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DShirotani%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520enzyme%2520modulators%2520directly%2520target%2520presenilin%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37181%26epage%3D37186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Presenilin is the molecular target of acidic γ-secretase modulators in living cells</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30484&author=T.+Jumpertzauthor=A.+Rennhackauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=B.+Bulicauthor=S.+Weggen&title=Presenilin+is+the+molecular+target+of+acidic+%CE%B3-secretase+modulators+in+living+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DPresenilin%2520is%2520the%2520molecular%2520target%2520of%2520acidic%2520%25CE%25B3-secretase%2520modulators%2520in%2520living%2520cells%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26spage%3De30484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0lggq4sbuiW5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">For some alternative, recent examples, see</p></div><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of bicyclic heterocycles as potent gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+Gijsen&title=Design+and+synthesis+of+bicyclic+heterocycles+as+potent+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demorin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-methylpyridine-based biaryl amides as gamma-secretase modulators for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+Demorinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-methylpyridine-based+biaryl+amides+as+gamma-secretase+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDemorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-methylpyridine-based%2520biaryl%2520amides%2520as%2520gamma-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent gamma-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9089</span><span class="NLM_x">–</span> <span class="NLM_lpage">9106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+Macdonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520gamma-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators: Can we combine potency with safety?</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">295207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=295207&author=H.+J.+Gijsenauthor=M.+Mercken&title=%CE%B3-Secretase+modulators%3A+Can+we+combine+potency+with+safety%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators: Can We Combine Potency with Safety?</span></div><div class="casAuthors">Gijsen Harrie J M; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">γ-Secretase modulation has been proposed as a potential disease modifying anti-Alzheimer's approach.  γ-Secretase modulators (GSMs) cause a product shift from the longer amyloid-beta (Aβ) peptide isoforms to shorter, more soluble, and less amyloidogenic isoforms, without inhibiting APP or Notch proteolytic processing.  As such, modulating γ-secretase may avoid some of the adverse effects observed with γ-secretase inhibitors.  Since the termination of the GSM tarenfurbil in 2008 due to negative phase III trial results, a considerable progress has been made towards more potent and better brain penetrable compounds.  However, an analysis of their lipophilic efficiency indices indicates that their increased potency can be largely attributed to their increased lipophilicity.  The need for early and chronic dosing with GSMs will require high-safety margins.  This will be a challenge to achieve with the current, highly lipophilic GSMs.  We will demonstrate that by focusing on the drug-like properties of GSMs, a combination of high in vitro potency and reduced lipophilicity can be achieved and does result in better tolerated compounds.  The next hurdle will be to translate this knowledge into GSMs which are highly efficacious and safe in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoRn2xTT3rypZoeNcnHOQ9fW6udTcc2eZs6fmn2eMw6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D&md5=f3c1425fa7619625bb4dc56ee2b5f5fb</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%253A%2520Can%2520we%2520combine%2520potency%2520with%2520safety%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D295207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sun, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: Discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502.</span><div class="note"><p class="first last">Also see ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>. For comprehensive reviews, see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a></p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502.&author=Z.+Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+Maccossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+Discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18eR"><div class="casContent"><span class="casTitleNuber">18e</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lgMXFQBeSCiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520Discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>Values for clogP were calculated using the BIOBYTE (<a href="http://www.biobyte.com" class="extLink">www.biobyte.com</a>) program clogP, version 4.3.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Values+for+clogP+were+calculated+using+the+BIOBYTE+%28www.biobyte.com%29+program+clogP%2C+version+4.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgMXFQBeSCiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+A+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhpE9VNmG4-Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhpE9VNmG4-Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhpE9VNmG4-Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljeOKD_LGTo1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chrzanowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozwadowska, M. D.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of isoquinoline alkaloids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr030692k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3341-3370&author=M.+Chrzanowskaauthor=M.+D.+Rozwadowska&title=Asymmetric+synthesis+of+isoquinoline+alkaloids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Isoquinoline Alkaloids</span></div><div class="casAuthors">Chrzanowska, Maria; Rozwadowska, Maria D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3341-3370</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of the asym. synthesis of isoquinoline alkaloids is presented.  The review covers stereochem. modified traditional methods, followed by recent achievements, obtained with the "C1-Cα connectivity approach", as well as other novel approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo08lVO2IFlk7Vg90H21EOLACvtfcHk0ljeOKD_LGTo1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFyhsL4%253D&md5=b005eab161a2891840a1622b8ed20a99</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr030692k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030692k%26sid%3Dliteratum%253Aachs%26aulast%3DChrzanowska%26aufirst%3DM.%26aulast%3DRozwadowska%26aufirst%3DM.%2BD.%26atitle%3DAsymmetric%2520synthesis%2520of%2520isoquinoline%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26spage%3D3341%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hendrickson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span> </span><span class="NLM_article-title">An efficient synthesis of substituted isoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3344</span><span class="NLM_x">–</span> <span class="NLM_lpage">3346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00167a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=3344-3346&author=J.+B.+Hendricksonauthor=C.+Rodr%C3%ADguez&title=An+efficient+synthesis+of+substituted+isoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00167a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00167a043%26sid%3Dliteratum%253Aachs%26aulast%3DHendrickson%26aufirst%3DJ.%2BB.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520substituted%2520isoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D3344%26epage%3D3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7783</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+Diricoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors</span></div><div class="casAuthors">Stepan, Antonia F.; Karki, Kapil; McDonald, W. Scott; Dorff, Peter H.; Dutra, Jason K.; DiRico, Kenneth J.; Won, Annie; Subramanyam, Chakrapani; Efremov, Ivan V.; O'Donnell, Christopher J.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Sneed, Blossom; Sun, Hao; Lu, Yasong; Robshaw, Ashley E.; Riddell, David; O'Sullivan, Theresa J.; Sibley, Evelyn; Capetta, Steven; Atchison, Kevin; Hallgren, Andrew J.; Miller, Emily; Wood, Anthony; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7772-7783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A metab.-based approach toward the optimization of a series of N-arylsulfonamide-based γ-secretase inhibitors is reported.  The lead cyclohexyl analog 6 suffered from extensive oxidn. on the cycloalkyl motif by cytochrome P 450 3A4, translating into poor human liver microsomal stability.  Knowledge of the metabolic pathways of 6 triggered a structure-activity relationship study aimed at lowering lipophilicity through the introduction of polarity.  This effort led to several tetrahydropyran and THF analogs, wherein the 3- and 4-substituted variants exhibited greater microsomal stability relative to their 2-substituted counterparts.  Further redn. in lipophilicity led to the potent γ-secretase inhibitor and 3-substituted oxetane 1 with a reduced propensity toward oxidative metab., relative to its 2-substituted isomer.  The slower rates of metab. with 3-substituted cyclic ethers most likely originate from redns. in lipophilicity and/or unfavorable CYP active site interactions with the heteroatom.  Preliminary animal pharmacol. studies with a representative oxetane indicate that the series is generally capable of lowering Aβ in vivo.  As such, the study also illustrates the improvement in drug likeness of mols. through the use of the oxetane motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1kWyZJuyD97Vg90H21EOLACvtfcHk0liL36X18CONJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK&md5=b3e9725954a155900563cc5d2f73263b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Assay method adapted from published protocols:</p></div><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span> </span><span class="NLM_article-title">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1124%2Fdmd.105.004259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=15932954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1304-1311&author=R.+J.+Rileyauthor=D.+F.+McGinnityauthor=R.+P.+Austin&title=A+unified+model+for+predicting+human+hepatic%2C+metabolic+clearance+from+in+vitro+intrinsic+clearance+data+in+hepatocytes+and+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span></div><div class="casAuthors">Riley, Robert J.; McGinnity, D. F.; Austin, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1304-1311</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate a unified method for predicting human in vivo intrinsic clearance (CLint, in vivo) and hepatic clearance (CLh) from in vitro data in hepatocytes and microsomes by applying the unbound fraction in blood (fub) and in vitro incubations (fuinc).  Human CLint, in vivo was projected using in vitro data together with biol. scaling factors and compared with the unbound intrinsic clearance (CLint, ub, in vivo) estd. from clin. data using liver models with and without the various fu terms.  For incubations conducted with fetal calf serum (n = 14), the obsd. CLint, in vivo was modeled well assuming fuinc and fub were equiv.  CLint, ub, in vivo was predicted best using both fub and fuinc for other hepatocyte data (n = 56; r2 = 0.78, p = 3.3×10-19, av. fold error = 5.2).  A similar model for CLint, ub, in vivo was established for microsomal data (n = 37; r2 = 0.77, p = 1.2×10-12, av. fold error = 6.1).  Using the model for CLint, ub, in vivo (including a further empirical scaling factor), the CLh in humans was also calcd. according to the well stirred liver model for the most extensive dataset.  CLint, in vivo and CLh were both predicted well using in vitro human data from several labs. for acidic, basic, and neutral drugs.  The direct use of this model using only in vitro human data to predict the metabolic component of CLh is attractive, as it does not require extra information from preclin. studies in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrU05rRTm6LVg90H21EOLACvtfcHk0liL36X18CONJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D&md5=79b80848977739267e4dd0ae82e5cbab</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.004259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.004259%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26atitle%3DA%2520unified%2520model%2520for%2520predicting%2520human%2520hepatic%252C%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520intrinsic%2520clearance%2520data%2520in%2520hepatocytes%2520and%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1304%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0liL36X18CONJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0liL36X18CONJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">A compound with a MDR efflux ratio (MDR Er) less than 2.5 is considered to have minimal P-gp efflux liability.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+compound+with+a+MDR+efflux+ratio+%28MDR+Er%29+less+than+2.5+is+considered+to+have+minimal+P-gp+efflux+liability."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, G. G.</span><span> </span><span class="NLM_article-title">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401782h&amp;key=10.1111%2Fj.1365-2125.2011.03961.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401782h&amp;key=21392072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401782h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=235-246&author=E.+Callegariauthor=B.+Malhotraauthor=P.+J.+Bungayauthor=R.+Websterauthor=K.+S.+Fennerauthor=S.+Kempshallauthor=J.+L.+LaPerleauthor=M.+C.+Michelauthor=G.+G.+Kay&title=A+comprehensive+non-clinical+evaluation+of+the+CNS+penetration+potential+of+antimuscarinic+agents+for+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span></div><div class="casAuthors">Callegari, Ernesto; Malhotra, Bimal; Bungay, Peter J.; Webster, Rob; Fenner, Katherine S.; Kempshall, Sarah; LaPerle, Jennifer L.; Michel, Martin C.; Kay, Gary G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To assess and compare the mechanisms of central nervous system (CNS) penetration of antimuscarinic overactive bladder (OAB) agents.  METHODS: Phys. properties were computed or compiled from the literature.  Rats were administered 5-hydroxymethyl tolterodine (HMT), darifenacin, oxybutynin, solifenacin, tolterodine or trospium s.c.  At 1 h postdose, plasma, brain and cerebrospinal fluid (CSF) concns. were detd. using LC-MS/MS assays.  Brain and plasma protein binding were detd. in vitro.  Permeability in the presence and absence of the efflux transporter P-glycoprotein (P-gp) was assessed in RRCK and MDCK-MDR1 transwell assays.  RESULTS: Oxybutynin displayed extensive CNS penetration, with brain: plasma ratios (B:P), unbound brain:unbound plasma ratios (Kp,free) and CSF:free plasma ratios each >1.  Tolterodine (B:P = 2.95, Kp,free = 0.23 and CSF:free plasma = 0.16) and solifenacin (B:P = 3.04, Kp,free = 0.28 and CSF:free plasma = 1.41) showed significant CNS penetration but with some restriction from CNS as indicated by Kp,free values significantly <1.5-HMT, darifenacin and trospium displayed much lower B:P (0.03-0.16), Kp,free (0.01-0.04) and CSF:free plasma (0.004-0.06), consistent with poor CNS penetration.  Permeability in RRCK cells was low for trospium (0.63 × 10-6 cm s-1), moderate for 5-HMT (11.7 × 10-6 cm s-1) and high for darifenacin, solifenacin, tolterodine and oxybutynin (21.5-38.2 × 10-6 cm s-1).  In MDCK-MDR1 cells 5-HMT, darifenacin and trospium, were P-gp substrates, whereas oxybutynin, solifenacin and tolterodine were not P-gp substrates.  CONCLUSIONS: Brain penetration was low for antimuscarinics that are P-gp substrates (5-HMT, darifenacin and trospium), and significant for those that are not P-gp substrates (oxybutynin, solifenacin and tolterodine).  CNS adverse events reported in randomized controlled clin. trials show general alignment with the preclin. data described in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9FelRyq-h7Vg90H21EOLACvtfcHk0lh4DNlBINcLdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM&md5=dbd56eb7943853a1f58f9d56d92316bb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03961.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03961.x%26sid%3Dliteratum%253Aachs%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DMalhotra%26aufirst%3DB.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DLaPerle%26aufirst%3DJ.%2BL.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DKay%26aufirst%3DG.%2BG.%26atitle%3DA%2520comprehensive%2520non-clinical%2520evaluation%2520of%2520the%2520CNS%2520penetration%2520potential%2520of%2520antimuscarinic%2520agents%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D72%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Parkinson, A.; Ogilvie, B. W.</span><span> </span><span class="NLM_article-title">Biotransformation of Xenobiotics</span>. In  <span class="citation_source-book">Casarett & Doull’s Toxicology, The Basic Science of Poisons</span>, <span class="NLM_edition">7</span>th ed.; <span class="NLM_contrib-group">Klaassen, C. D.</span>, Ed.; <span class="NLM_publisher-name">The McGraw-Hill Co., Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Chapter 6, pp  <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span>. Also available online: <a href="http://ilmufarmasis.files.wordpress.com/2011/07/&#xA;casarett- and-doulls-toxicology-the-basic-science-of-poisons7th-ed.pdf" class="extLink">http://ilmufarmasis.files.wordpress.com/2011/07/ casarett- and-doulls-toxicology-the-basic-science-of-poisons7th-ed.pdf</a> (accessed Oct 23, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=161-304&author=A.+Parkinson&author=B.+W.+Ogilvieauthor=C.+D.+Klaassen&title=Casarett+%26+Doull%E2%80%99s+Toxicology%2C+The+Basic+Science+of+Poisons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DBiotransformation%2520of%2520Xenobiotics%26btitle%3DCasarett%2520%2526%2520Doull%25E2%2580%2599s%2520Toxicology%252C%2520The%2520Basic%2520Science%2520of%2520Poisons%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DThe%2520McGraw-Hill%2520Co.%252C%2520Inc%26date%3D2008%26spage%3D161%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5595</span><span class="NLM_x">–</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5595-5599&author=J.+S.+Waiauthor=B.+Kimauthor=T.+E.+Fisherauthor=L.+Zhuangauthor=M.+W.+Embreyauthor=P.+D.+Williamsauthor=D.+D.+Staasauthor=C.+Culbersonauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.-W.+Chenauthor=J.+D.+Ellisauthor=R.+Mallaiauthor=S.+D.+Young&title=Dihydroxypyridopyrazine-1%2C6-dione+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DMallai%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDihydroxypyridopyrazine-1%252C6-dione%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5595%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kawahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, H.</span><span> </span><span class="NLM_article-title">A Synthesis of pyrido[1,2-<i>a</i>]quinoxalines and pyrido[1,2-<i>a</i>]pyrazines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1983&pages=1721-1725&author=N.+Kawaharaauthor=T.+Nakajimaauthor=T.+Itohauthor=H.+Ogura&title=A+Synthesis+of+pyrido%5B1%2C2-a%5Dquinoxalines+and+pyrido%5B1%2C2-a%5Dpyrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DH.%26atitle%3DA%2520Synthesis%2520of%2520pyrido%255B1%252C2-a%255Dquinoxalines%2520and%2520pyrido%255B1%252C2-a%255Dpyrazines%26jtitle%3DHeterocycles%26date%3D1983%26volume%3D20%26spage%3D1721%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">HATU: <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N,N,N′,N′</i>-tetramethyluronium hexafluorophosphate.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol303463e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=642-645&author=T.+P.+Tranauthor=P.+B.+Mullinsauthor=C.+W.+am+Endeauthor=M.+Pettersson&title=Synthesis+of+pyridopyrazine-1%2C6-diones+from+6-hydroxypicolinic+acids+via+a+one-pot+coupling%2Fcyclization+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fol303463e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303463e%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520pyridopyrazine-1%252C6-diones%2520from%25206-hydroxypicolinic%2520acids%2520via%2520a%2520one-pot%2520coupling%252Fcyclization%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D642%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">am Ende, C. W.; Johnson, D. S.; O’Donnell, C. J.; Pettersson, M. Y.; Subramanyam, C.</span><span> </span><span class="NLM_article-title">Preparation of heteroaryl imidazoles and heteroaryl triazoles as γ-secretase modulators</span>. WO2011048525A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+W.+am+Ende&author=D.+S.+Johnson&author=C.+J.+O%E2%80%99Donnell&author=M.+Y.+Pettersson&author=C.+Subramanyam&title=Preparation+of+heteroaryl+imidazoles+and+heteroaryl+triazoles+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520heteroaryl%2520imidazoles%2520and%2520heteroaryl%2520triazoles%2520as%2520%25CE%25B3-secretase%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><div class="note"><p class="first last">Assay method adapted from published protocol:</p></div><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, M.</span><span> </span><span class="NLM_article-title">Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1864-1870&author=T.+Hayauthor=R.+Jonesauthor=K.+Beaumontauthor=M.+Kemp&title=Modulation+of+the+partition+coefficient+between+octanol+and+buffer+at+pH+7.4+and+pKa+to+achieve+the+optimum+balance+of+blood+clearance+and+volume+of+distribution+for+a+series+of+tetrahydropyran+histamine+type+3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520partition%2520coefficient%2520between%2520octanol%2520and%2520buffer%2520at%2520pH%25207.4%2520and%2520pKa%2520to%2520achieve%2520the%2520optimum%2520balance%2520of%2520blood%2520clearance%2520and%2520volume%2520of%2520distribution%2520for%2520a%2520series%2520of%2520tetrahydropyran%2520histamine%2520type%25203%2520receptor%2520antagonists%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1864%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><div class="note"><p class="first last">Solubility was measured by Analiza, Inc., Cleveland, OH. (<a href="http://analiza.com/physchem/logd.html#qf" class="extLink">http://analiza.com/physchem/logd.html#qf</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Solubility+was+measured+by+Analiza%2C+Inc.%2C+Cleveland%2C+OH.+%28http%3A%2F%2Fanaliza.com%2Fphyschem%2Flogd.html%23qf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (gsms) modulate amyloid-beta (abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28gsms%29+modulate+amyloid-beta+%28abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528gsms%2529%2520modulate%2520amyloid-beta%2520%2528abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lapinsky, D. J.</span><span> </span><span class="NLM_article-title">Tandem photoaffinity labeling-bioorthogonal conjugation in medicinal chemistry</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6237</span><span class="NLM_x">–</span> <span class="NLM_lpage">6247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6237-6247&author=D.+J.+Lapinsky&title=Tandem+photoaffinity+labeling-bioorthogonal+conjugation+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapinsky%26aufirst%3DD.%2BJ.%26atitle%3DTandem%2520photoaffinity%2520labeling-bioorthogonal%2520conjugation%2520in%2520medicinal%2520chemistry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6237%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">GSM <b>54</b> refers to a proprietary GSM containing the same pyridone imidazole core as GSM <b>52</b>, but a structurally distinct right-hand fragment attached to the lactam nitrogen.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/jm401782h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27316"></div></div></div></div></div><hr /></hr><p class="last">The following experimental information is provided: cell-based Aβ production assay, determination of Aβ lowering activity in vivo, and photoaffinity labeling of HeLa membranes with clickable GSMs followed by Western blot analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401782h/suppl_file/jm401782h_si_001.pdf">jm401782h_si_001.pdf (130.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401782h&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-3%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm401782h%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401782h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992704c85d195b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
